vancomycin has been researched along with Health Care Associated Infection in 989 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 57 (5.76) | 18.7374 |
| 1990's | 290 (29.32) | 18.2507 |
| 2000's | 245 (24.77) | 29.6817 |
| 2010's | 306 (30.94) | 24.3611 |
| 2020's | 91 (9.20) | 2.80 |
| Authors | Studies |
|---|---|
| Cirioni, O; Della Vittoria, A; Giacometti, A; Kamysz, W; Nadolski, P; Riva, A; Scalise, G; Silvestri, C; Łukasiak, J | 1 |
| Bryce, E; Gravel, D; Loeb, M; Louie, L; Matlow, A; McGeer, A; Mulvey, M; Ofner-Agostini, M; Simor, AE; Stuart, TL; Watt, C | 1 |
| Danese, P; DeVito, J; Franceschi, F; Lawrence, L; Sutcliffe, J | 1 |
| Laohavaleeson, S; Nicolau, DP; Tessier, PR | 1 |
| Cheung, CM; Leonard, SN; Rybak, MJ | 1 |
| Béliveau, C; Labbé, AC; Laverdière, M; Louie, T; Maccannell, D; Pépin, J; Poirier, L; Savoie, M | 1 |
| Cui, L; Hiramatsu, K; Neoh, HM; Watanabe, Y | 1 |
| Karlowsky, JA; Laing, NM; Zhanel, GG | 1 |
| Ike, Y; Inoue, T; Tomita, H; Zheng, B | 1 |
| Appelbaum, PC; Bhagwat, SS; Kosowska-Shick, K; McGhee, P; Patel, MV | 1 |
| Chen, H; Chen, M; Du, N; Liu, Y; Niu, J; Shen, E; Wang, H; Ye, H | 1 |
| Bortolozzo, Lde S; de Castro Siqueira, AM; Jorge, SD; Palace-Berl, F; Pasqualoto, KF; Tavares, LC; Zorzi, RR | 1 |
| Dey, S; Dhawan, B; Kumar, S; Shekhar, S; Singh, K | 1 |
| Kumamoto, HM; Yaita, K | 1 |
| Aslam, S; Christner, M; Coppenhagen-Glazer, S; Fischer, L; Gelman, D; Harbauer, T; Hazan, R; Herden, U; Khalifa, L; Merabishvili, M; Muntau, AC; Nir-Paz, R; Paul, K; Pirnay, JP; Rohde, C; Rohde, H; Schulz-Jürgensen, S; Singer, D; Yerushalmy, O | 1 |
| Bathoorn, E; Chlebowicz-Fliss, MA; Couto, N; Friedrich, AW; Harmsen, HJM; Lisotto, P; Lokate, M; Raangs, EC; Rosema, S; Rossen, JWA; Zhou, X | 1 |
| Beukers, AG; Keighley, CL; McIver, CJ; Pratama, R; Taylor, PC; van Hal, SJ | 1 |
| Brennan, GI; Coleman, DC; Egan, SA; Kavanagh, NL; McManus, BA; Mollerup, S; O'Connell, B; Pinholt, M; Samaniego Castruita, JA; Shore, AC; Westh, H | 1 |
| Joshi, S; Shallal, A; Zervos, M | 1 |
| Ayobami, O; Brinkwirth, S; Eckmanns, T; Markwart, R | 1 |
| Cieslinski, J; Dos Santos Oliveira, D; Gasparetto, J; Ribeiro, VST; Telles, JP; Tuon, FF; Yamada, CH | 1 |
| Boutin, S; Büchler, MW; Eichel, VM; Frank, U; Heeg, K; Heininger, A; Mutters, NT; Nurjadi, D; Weigand, MA | 1 |
| Braakman-Jansen, LMA; Lokate, M; Stein, A; van Gemert-Pijnen, JEWC; van Niekerk, JM | 1 |
| Benin, AL; Edwards, JR; Leaptrot, D; Li, Q; O'Leary, EN; Wu, H; Xu, K | 1 |
| Bond, K; Gorrie, CL; Grayson, ML; Higgs, C; Horan, K; Howden, BP; Kinsella, P; Kwong, JC; Marshall, C; Seemann, T; Sherry, NL; Stinear, TP; Walpola, H; Williamson, DA | 1 |
| Babcock, HH; Bilker, W; Burnham, JP; Cressman, L; Donceras, O; Fuchs, B; Garcia, D; Gaynes, S; Habrock-Bach, T; Han, JH; Kelly, BJ; Lautenbach, E; Martin, ND; Omorogbe, J; Pegues, D; Reddy, SC; Tolomeo, P; Trick, WE; Warren, DK; Welbel, SF; Ziegler, MJ | 1 |
| Cheung, J; Freedberg, DE; Lynch, E; Nattakom, M; Richardson, M; Wang, HH; Zachariah, P | 1 |
| Kong, Y; Ma, J; Shi, G; Tian, Y; Ye, Y | 1 |
| Bartels, MD; Gisselø, K; Knudsen, MJS; Mollerup, S; Petersen, AM; Pinholt, M; Rubin, IMC; Westh, H | 1 |
| Golding, GR; Hota, SS; Kleinman, DR; McCracken, M; Mitchell, R; Smith, SW | 1 |
| Bujdáková, H; Jozefíková, A; Nováková, E; Šoltys, K; Valček, A | 1 |
| Antcliffe, DB; Arkell, P; Barnes, SC; Gilchrist, M; Holmes, A; Noel, AR; Rawson, TM; Watkins, K; Wilson, M; Wilson, R | 1 |
| Ang, B; Chow, A; Hon, PY; Htun, HL; Tan, R | 1 |
| Fujimori, T; Hagiya, H; Higashikage, A; Higashionna, T; Iio, K; Kakehi, A; Minabe, H; Okura, M; Otsuka, F; Yokoyama, Y | 1 |
| Hammerum, AM; Hasman, H; Ingmer, H; Jensen, CS; Kjerulf, A; Knudsen, JD; Lawaetz, AC; Pinholt, M; Skive, B | 1 |
| Abukhzam, B; Alsaedi, AA; Alshamrani, M; Althaqafi, A; Bhutta, MJ; El-Saed, A | 1 |
| Furuya, E; Ito, D; Kobayashi, E; Okamoto, G; Sawai, M; Terada, K | 1 |
| Jalali, M; Jalali, Y; Kolosova, A; Kyselovic, J; Liptakova, A; Payer, J; Sturdik, I | 1 |
| Elmeskov, C; Frees, D; Mollerup, S; Pedersen, MS; Pinholt, M; Sejersen, TS; Westh, H; Worning, P | 1 |
| Bogner, J; Briegel, J; Draenert, R; Frank, S; Grabein, B; Hinske, L; Irlbeck, M; Jung, J; Kilger, E; Krueger, WA; Liebchen, U; Möhnle, P; Ney, L; Niedermayer, S; Schubert, S; Wang, B; Weber, A; Weig, T; Zoller, M | 1 |
| Chen, PL; Fukushige, M; Ko, WC; Lee, NY; Lin, WL; Morikawa, K; Syue, LS | 1 |
| Hrynchuk, OB; Ishchak, OM; Kolesnik, AV; Rud, VO; Salmanov, AG; Terekhov, VA; Voloshynovych, NS | 1 |
| De Vito, D; Fruscio, G; Garrisi, VM; Hall, GG; Laforgia, M; Nardulli, P; Quarta, A; Ruggiero, R; Scacco, S | 1 |
| Al-Qamari, A; Bardowski, L; Bulger, C; Churyla, A; Fiehler, M; Malczynski, M; Oakley, R; Qi, C; Rathod, SN; Tanna, SD; Tse, I; Zembower, TR | 1 |
| Beam, E; Miller, VL; Sampathkumar, P; Yetmar, ZA | 1 |
| He, Z; Jin, D; Li, Y; Liu, S; Wang, J; Wang, Y | 1 |
| Behnke, M; Eisenbeis, S; Falgenhauer, JC; Falgenhauer, L; Gastmeier, P; Häcker, G; Higgins, PG; Hölzl, F; Imirzalioglu, C; Käding, N; Kern, WV; Kola, A; Kramme, E; Mischnik, A; Peter, S; Rieg, S; Rohde, AM; Rupp, J; Schneider, C; Schwab, F; Seifert, H; Tacconelli, E; Tobys, D; Trauth, J; Walker, S; Weber, A; Xanthopoulou, K; Zweigner, J | 1 |
| Harada, T; Ito, H; Kaga, Y; Kakimoto, K; Kawahara, R; Koshimo, N; Matsui, T; Nishiki, S; Oishi, K; Takahashi, H; Ueda, E; Yamagishi, T | 1 |
| Atkinson, A; Bittel, P; Buetti, N; Casanova, C; D'Incau, S; Jent, P; Kaspar, T; Marschall, J; Piezzi, V; Seth-Smith, HM; Sommerstein, R; Wassilew, N | 1 |
| Fujikawa, T; Hasegawa, D; Kasai, M; Kosaka, Y; Mizuno, S; Uemura, S | 1 |
| Liu, X; Tian, Z; Wang, M | 1 |
| Cumming, V; Leong, KWC; O'Toole, RF; Van Hal, SJ | 1 |
| Araújo, OR; Barbosa, LC; Carlesse, FAMC; Carreira, LY; Fonseca, FMCD; Lima, APC; Marques, LMA; Pignati, LT; Silva, AMPSD; Silva, DCBD; Sodré, JJM | 1 |
| Beatson, SA; Forde, BM; Harris, PNA; Henderson, BC; Lindsay, M; Paterson, DL; Permana, B; Playford, EG; Runnegar, N | 1 |
| Hammerum, AM; Hansen, F; Hansen, SGK; Hasman, H; Hoegh, SV; Holm, A; Karstensen, KT; Klein, K; Roer, L; Rosenvinge, FS; Skov, MN | 1 |
| Allen, O; Blane, B; Coll, F; Floto, RA; Gouliouris, T; Kappeler, ARM; Pai, S; Peacock, SJ; Raven, K | 1 |
| Cervo, A; Chester, J; Dessilani, A; Forghieri, F; Franceschini, E; Guaraldi, G; Kaleci, S; Luppi, M; Meschiari, M; Monica, M; Monte, MD; Mussini, C; Orlando, G; Ricchizzi, E; Santoro, A; Sarti, M; Scialpi, F; Venturelli, C | 1 |
| Achonu, C; Garber, G; Johnstone, J; Katz, KC; Li, Y; Ling, R | 1 |
| Hasegawa, Y; Ishida, T; Izumikawa, K; Kakeya, H; Kohno, S; Miyazaki, T; Mukae, H; Niki, Y; Shindo, Y; Soma, K; Tateda, K; Tomono, K; Watanabe, A; Yamamoto, Y; Yanagihara, K | 1 |
| Bonnefoy, M; Girard, R; Haïne, M; Mathis, B | 1 |
| Adomako, K; Brown, KA; Garber, G; Johnstone, J; Li, Y; Saedi, A; Shing, E | 1 |
| Abu Ahmad, W; Amit, S; Averbuch, D; Friedman, G; Masarwa, R; Oster, Y; Stepensky, P; Temper, V | 1 |
| Al Nasser, W; Alghoribi, M; Aljohany, SM; Almohrij, SA; Almunif, S; Alothman, A; Alqahtani, S; Alsaedi, A; Alshamrani, MM; Arabi, Y; Balkhy, HH; Bonnie, HB; El Gammal, A; El-Saed, A | 1 |
| Alonso, B; Bouza, E; Díaz, M; Fernández-Cruz, A; Guembe, M; Martín-Rabadán, P; Muñoz, P; Sánchez-Carrillo, C | 1 |
| Bogdan, C; Bollinger, T; Eisenberger, D; Friedrich, P; Höller, C; Hossain, H; Hussein, Z; Lehner-Reindl, V; Liebl, B; Nickel, S; Pöhlmann, C; Tuschak, C; Valenza, G; Werner, M; Würstl, B | 1 |
| Abu-Raideh, J; Al-Tamimi, M; Hawamdeh, H; Himsawi, N; Khasawneh, A | 1 |
| Kaya, H; Mollerup, S; Pedersen, MS; Petersen, AM; Pinholt, M; Rubin, IMC; Westh, H | 1 |
| Ahmed, MO; Baptiste, KE; Brouwer, E; Daw, MA; Elramalli, AK; Top, J; Willems, RJL; Zorgani, A | 1 |
| Buyukcam, A; Buyukeren, M; Celik, HT; Kara, A; Yigit, S; Yurdakok, M | 1 |
| Arias, CA; Carvajal, LP; Diaz, L; Dinh, A; Echeverri, AM; Kolokotronis, SO; Munita, JM; Murray, BE; Narechania, A; Panesso, D; Planet, PJ; Reyes, J; Rincon, S; Rios, R; Tran, TT | 1 |
| Dai, W; Niu, S; Sun, J; Wang, Z; Xia, Y; Yan, L; Yang, T; Zhang, C | 1 |
| Chankhamhaengdecha, S; Harnvoravongchai, P; Janvilisri, T; Ounjai, P; Phanchana, M; Phetruen, T; Raksat, P | 1 |
| Abutaleb, NS; Seleem, MN | 1 |
| Bootsveld, C; Boutin, S; Eichel, V; Frank, U; Heeg, K; Klein, S; Nurjadi, D | 1 |
| Bender, JK; Brockmann, D; Einsele, H; Fuchs, S; Kraus, S; Maier, BF; Neumann, B; Semmler, T; Vogel, U; Werner, G; Wieler, LH; Wittig, A | 1 |
| Gastmeier, P; Kola, A; Maechler, F; Schwab, F; Weber, A | 1 |
| Behnke, M; Dinkelacker, AG; Eisenbeis, S; Falgenhauer, J; Falgenhauer, L; Fritzenwanker, M; Gastmeier, P; Gölz, H; Häcker, G; Higgins, PG; Imirzalioglu, C; Käding, N; Kern, WV; Kola, A; Kramme, E; Mischnik, A; Peter, S; Rieg, S; Rohde, AM; Rupp, J; Seifert, H; Tacconelli, E; Tobys, D; Vehreschild, MJGT; Walker, SV; Xanthopoulou, K | 1 |
| Atkinson, A; Buetti, N; Gasser, M; Harbarth, S; Kronenberg, A; Marschall, J; Piezzi, V; Vuichard-Gysin, D | 1 |
| Chang, SC; Chen, YC; Chen, YH; Chung, PY; Fang, CT; Lin, HJ; Sheng, WH; Tien, KL; Tsan, CY; Wang, JT | 1 |
| Aqib, AI; Aslam, R; Fakhar-E-Alam Kulyar, M; Hasan, A; Manzoor, A; Mohsin, M; Muzammil, I; Naseer, MA; Rehman, TU; Sattar, H; Shoaib, M; Yao, W | 1 |
| Deng, Q; Wang, Y; Wang, Z; Wen, Z; Xiong, Y; Xu, G; Yu, Z; Zheng, J | 1 |
| Blane, B; Brown, NM; Coll, F; Crawley, C; Enoch, DA; Gouliouris, T; Harrison, EM; Ludden, C; Naydenova, P; Parkhill, J; Peacock, SJ; Raven, KE; Török, ME | 1 |
| Akalin, H; Ali, R; Bulbul, EN; Kazak, E; Kirkizlar, O; Kirkizlar, TA; Ozakin, C; Ozboz, ES; Ozkalemkas, F; Ozkocaman, V | 1 |
| Abdollahi, A; Asadollahi-Amin, A; Hasannezhad, M; Jafari, S; Sabahi, M; Salehi, M; Seifi, A | 1 |
| Brown, CA; Chanderraj, R; Dickson, RP; Falkowski, N; Hinkle, K; Ranjan, P; Woods, RJ | 1 |
| Bender, J; Griskaitis, M; Herrmann, E; Hogardt, M; Kempf, VAJ; Kessel, J; Lehn, A; Serve, H; Vehreschild, MJGT; Werner, G; Wichelhaus, TA; Zacharowski, K; Zeuzem, S | 1 |
| Lee, CM; Lee, MC; Lee, WY; Lu, CH | 1 |
| Sugimoto, H; Sugimoto, K; Yamamoto, T; Yoshihara, A | 1 |
| Dong, Y; Li, Z; Wang, G; Wang, H; Zhuang, H | 1 |
| Bosheva, M; Gujabidze, R; Hamed, KA; Károly, É; Nemeth, A; Saulay, M; Smart, JI | 1 |
| Adams, DJ; Nylund, CM; Stagliano, DR; Susi, A | 1 |
| Assaous, F; Benamrouche, N; Bentchouala, C; Djennane, F; Guettou, B; Henniche, FZ; Laouar, H; Rahal, K; Tali Maamar, H; Tiouit, D; Yamouni, F; Ziane, H | 1 |
| Buiting, AG; Gast, KB; Murk, JL; Stohr, JJJM; van Oudheusden, AJG; Verweij, JJ | 1 |
| Dos Santos, LDR; Furlan, JPR; Gallo, IFL; Ramos, MS; Savazzi, EA; Stehling, EG | 1 |
| Cho, SY; Choi, JR; Chung, DR; Huh, HJ; Huh, K; Kang, CI; Kim, HM; Lee, MA; Lee, NY; Peck, KR | 1 |
| Akaishi, T; Ishii, T; Kawamura, T; Kikuchi, A; Kohno, J; Takayama, S | 1 |
| Al Alawi, Z; Al Mutair, A; Al-Hadary, I; Al-Omari, A; Al-Shammari, H; Aldera, AH; AlHbabi, F; Alhmeed, N; Alhumaid, S; Alismail, M; Alresasi, AM; Alzahrani, AJ; Bu-Shehab, I; Rabaan, AA; Tobaiqy, M | 1 |
| Hamanaka, E; Kitagawa, D; Komatsu, M; Maeda, K; Masuo, K; Nakamura, A; Nakamura, F; Oka, M; Sato, M; Suzuki, S | 1 |
| Bae, S; Chang, MS; Choi, SI; Chung, KH; Kim, SH; Kim, T; Kim, YK; Woo, JH; Yoon, CJ | 1 |
| Baquero, F; Coque, TM; Freitas, AR; Lanza, VF; Novais, C; Peixe, L; Rodríguez, CM; Tedim, AP | 1 |
| Alevizakos, M; Detsis, M; Flokas, ME; Karageorgos, SA; Mylonakis, E | 1 |
| Alp, E; Çetin, M; Elmali, F; Kaynar, L; Kürkçüoglu, CA; Metan, G; Yozgat, N | 1 |
| Kim, YJ; Kim, YK; Kwon, HI; Lee, HS; Lee, JC; Lee, WK; Na, SH; Nicholas, A; Selasi, GN; Shin, JH; Song, KE | 1 |
| Capitano, B; El-Solh, AA; Liu, P; Stein, A | 1 |
| Dupont, J; Prat, D; Sztrymf, B | 1 |
| Armin, S; Azimi, L; Fallah, F; Karimi, A; Rashidan, M; Shirdust, M | 1 |
| Hooper, DC; Hou, T; Lee, H; Ryan, EE; Shenoy, ES; Walensky, RP; Ware, W | 1 |
| Hollenberg, SM; Khan, ZA | 1 |
| Agostinho, A; Bartolone, P; Betz, M; Guanziroli, N; Öztürk, M; Pires, D; Pittet, D; Tscholl, P; Uçkay, I | 1 |
| Gemperli, R; Gomez, DS; Levin, AS; Machado, AS; Oliveira, MS; Sanches, C; Santos, SRCJ; Silva Junior, CVD | 1 |
| Bhala, N; Iqbal, TH; Moore, D; Price, M; Quraishi, MN; Sharma, N; Widlak, M | 1 |
| Coombs, J; Ford, CD; Gazdik Stofer, MA; Lopansri, BK; Motyckova, G; Petersen, FB; Webb, BJ | 1 |
| Conway, EL; Fodero, K; Horey, A; Krajewski, MP; Mergenhagen, KA; Ott, MC; Sellick, JA | 1 |
| Anderson, FA; Ayturk, MD; Collins, CE; Psoinos, CM; Santry, HP | 1 |
| Corey, GR; Dryden, M; File, TM; Hadvary, P; Huang, DB; Shorr, AF; Torres, A; Wilcox, MH | 1 |
| de Frutos, M; Eiros, JM; López-Urrutia, L; Oteo, J | 1 |
| Boyle, E; Galperine, T; Guery, B; Héquette-Ruz, R; Herbaux, C; Robin, C | 1 |
| Klare, I; Layer, F; Strommenger, B; Weber, RE; Werner, G | 1 |
| Alvarez-Moreno, C; Arias, CA; Carcamo, C; Garcia, C; Gotuzzo, E; Guzmán-Blanco, M; Labarca, J; Luna, C; Mejía-Villatoro, C; Reyes, J; Rodríguez-Noriega, E; Salles, MJ; Seas, C; Zurita, J | 1 |
| Lloyd-Smith, P | 1 |
| Fasihi, Y; Kalantar-Neyestanaki, D; Kiaei, S | 1 |
| Alotaibi, SMI; Ayibiekea, A; Gumpert, H; Hammerum, AM; Ingmer, H; Jakobsen, L; Pedersen, AF; Pinholt, M; Westh, H | 1 |
| Blumenthal, KG; Kuhlen, JL; Lee, H; Li, Y; Ryan, EE; Shenoy, ES | 1 |
| Bishop, EJ; Botha, J; Kelley, PG; Marshall, C; Metcalfe, J; Tiruvoipati, R | 1 |
| Bongiorno, D; Bressan, R; Busetti, M; Campanile, F; Di Santolo, M; Dolzani, L; Knezevich, A; Lagatolla, C; Luzzati, R; Milan, A; Monticelli, J; Santagati, M; Stefani, S; Tonin, EA | 1 |
| Chotiprasitsakul, D; Cosgrove, SE; Gadala, A; Tamma, PD | 1 |
| Squellati, R | 1 |
| Ghahremani, M; Jazani, NH; Sharifi, Y | 1 |
| Corman, S; Gordon, LM; Leung, GH; Lodise, TP; McKinnell, JA; Patel, D | 1 |
| Cattoir, V; Earl, AM; Gilmore, MS; Lebreton, F; Schaufler, K; Valentino, MD | 1 |
| Ajami, NJ; Chesnel, L; Cope, JL; Petrosino, JF; Wong, MC | 1 |
| Goyal, H; Perisetti, A; Rehman, MR; Singla, U | 1 |
| Bedford, L; Brown, NM; Cartwright, EJP; Gouliouris, T; Limmathurotsakul, D; Peacock, SJ; Raven, KE; Török, ME; Warne, B; Weerasuriya, CK | 1 |
| Beukers, AG; Chen, SC; Ellem, JA; Ferguson, JK; Lee, A; Maley, MW; Newton, PJ; Sintchenko, V; Taylor, P; Timms, VJ; van Hal, SJ | 1 |
| Bak, N; Ballard, SA; Buultjens, AH; Carter, GC; Cheng, A; Coombs, GW; Ferguson, JK; Grabsch, EA; Heffernan, H; Howden, BP; Johnson, PDR; Kotsanas, D; Mahony, AA; Roberts, SA; Seemann, T; Stinear, TP; Stuart, RL; Xie, S | 1 |
| Abe, H; Fujii, H; Higashikawa, A; Kuniya, T; Nakajima, K; Niwa, K; Okazaki, H; Sakae, T; Shinozaki, T; Tonosu, J; Watanabe, K; Yamada, K | 1 |
| Drennan, K; Fabian, J; Gaylard, PC; Hepple, A; Karlsson, K; Lee, S; Lowman, W; McNamara, L; Simons, G | 1 |
| Chen, TC; Chen, YH; Chiu, YW; Lin, SY; Lu, PL; Shen, MC; Tu, HP | 1 |
| Alexandre, S; Amaratunga, KR; Choi, KB; Collet, JC; Davis, I; Du, T; Evans, GA; Frenette, C; Golding, GR; Gravel, D; Hota, S; Katz, KC; Kibsey, P; Langley, JM; Lee, BE; Lemieux, C; Longtin, Y; Mertz, D; Mieusement, LMD; Minion, J; Moore, DL; Mulvey, MR; Pelude, L; Richardson, S; Science, M; Simor, AE; Stagg, P; Suh, KN; Taljaard, M; Taylor, G; Thampi, N; Wong, A | 1 |
| Avendano, EE; Chan, J; Merchant, S; Puzniak, L; Raman, G | 1 |
| Freedberg, DE; Li, J; Salmasian, H; Yang, YX; Zachariah, P; Zhou, MJ | 1 |
| Berktold, M; Eschertzhuber, S; Fuchs, S; Hinterberger, G; Knabl, L; Kreidl, P; Lass-Flörl, C; Mayr, A; Obwegeser, A; Orth-Höller, D; Posch, W | 1 |
| Buetti, N; Casanova, C; Egli, A; Fietze, Y; Führer, U; Marschall, J; Rolli, E; Seth-Smith, HM; Wassilew, N | 1 |
| Kodadek, LM; Lipsett, PA | 1 |
| Butler-Laporte, G; Cheng, MP; De L'Étoile-Morel, S; Lee, TC; McDonald, EG | 1 |
| Hansen, TA; Ma, CMG; Nielsen, LG; Pedersen, MS; Pinholt, M; Schønning, K; Søes, LM; Westh, H; Worning, P; Østergaard, C | 1 |
| Abraham, S; Coombs, GW; Lee, T; Pang, S | 1 |
| Bernstein, AT; Esther, CR; Goralski, JL; Leigh, MW; McKinzie, CJ | 1 |
| Kiselinova, M; Piers, R; Van Den Noortgate, N; Velghe, A; Verhasselt, B | 1 |
| Alireza Taghavi, S; Amanati, A; Bazargani, A; Heidari, H; Kalantar, K; Motamedifar, M; Nikokar, I; Sedigh Ebrahim-Saraie, H | 1 |
| Abbott, IJ; Baines, SL; Cameron, DR; Dexter, C; Howden, BP; Jiang, JH; Kostoulias, X; Monk, IR; Nethercott, C; Peleg, AY; Spelman, DW | 1 |
| Freedberg, DE; Zachariah, P | 1 |
| Baines, SL; Ballard, SA; Buising, K; Chan, HT; Douglas, AP; Howden, BP; Madigan, V; Marshall, C; Ritchie, D; Slavin, MA; Szer, J | 1 |
| Alemkere, G; Engidawork, E; Tenna, A | 1 |
| Ahmed, A; Gardezi, A; Khadim, MT; Sabir, N; Satti, L; Zaman, G | 1 |
| Baggs, J; Guh, A; Hatfield, KM; Jernigan, JA; Kazakova, SV; McDonald, LC; Reddy, SC; Yi, SH | 1 |
| Arshadi, M; Douraghi, M; Mashhadi, R; Owlia, P; Pourmand, MR; Shokoohizadeh, L; Soltani, S | 1 |
| Kimura, T; Snijder, R; Sugitani, T | 1 |
| Esfahani, BN; Havaei, SA; Zalipour, M | 1 |
| Dancer, SJ; Hunter, IS; Lemonidis, K; Salih, TS; Tucker, NP | 1 |
| Alvarez, AM; Rathore, MH | 1 |
| Al Saif, S; Aljohany, SM; Alshaalan, M; AlShehri, A; Balkhy, HH; El-Metwally, A; El-Saed, A; Hijazi, O | 1 |
| Hayden, MK | 1 |
| Ayres, AM; Babiker, A; Cooper, VS; Ezeonwuka, C; Harrison, LH; Marsh, JW; Mustapha, MM; Pacey, MP; Pasculle, AW; Saul, MI; Shutt, KA; Snyder, GM; Sundermann, AJ; Van Tyne, D | 1 |
| Branch-Elliman, W; Davis, RB; Schrank, GM; Snyder, GM; Wright, SB | 1 |
| Abgueguen, P; Boutoille, D; Caillon, J; Crochette, N; Huon, JF; Moal, F; Navas, D; Orain, J; Potel, G | 1 |
| Bauer, MP; Debast, SB; Kuijper, EJ; Sanders, IM; Wilcox, MH | 1 |
| Bosco, JA; Hadley, S; Hutzler, L; Mehta, S; Phillips, M; Slover, J | 1 |
| Karaoglan, I; Kecik Bosnak, V; Namiduru, M; Ozlem Mete, A | 1 |
| Buntaran, L; Dwiyanti, R; Hatta, M; Sabir, M; Sultan, AR | 1 |
| Bateman, BT; Bykov, K; Choudhry, NK; Fischer, MA; Franklin, JM; Gagne, JJ; Kulik, A; Liu, J; Polinski, JM; Rassen, JA; Schneeweiss, S | 1 |
| Chiou, MJ; Huang, SH; Lee, SC; See, LC; Shih, HJ; Siu, LK; Wu, MS | 1 |
| Jiang, H; Tang, RN; Wang, J | 1 |
| Bauraing, C; Bogaerts, P; Deplano, A; Glupczynski, Y; Huang, D; Verroken, A; Wauters, G | 1 |
| Neurath, MF; Strauss, R | 1 |
| Baji, P; Banai, J; Brodszky, V; Gulácsi, L; Kertész, A; Kopcsóné Németh, I; Ludwig, E; Péntek, M; Prinz, G; Reményi, P; Strbák, B; Zsoldiné Urbán, E | 2 |
| Dhanashree, B; Fernandes, SC | 1 |
| Keynan, Y; Rubinstein, E | 2 |
| Guzek, A; Korzeniewski, K; Nitsch-Osuch, A; Prokop, E; Rybicki, Z | 1 |
| Chamberlain, D; Hendershot, J; Irvine, M; Massoud, N; Vettese, N; Wimer, S | 1 |
| Chen, H; He, W; Li, H; Wang, H; Wang, Q; Wang, X; Zhang, F; Zhao, C | 1 |
| Barriere, SL; Corey, GR; Genter, FC; Lentnek, AL; Luna, CM; Magana-Aquino, M; Niederman, MS; Rubinstein, E; Stryjewski, ME; Torres, A | 1 |
| Avery, TR; Bartsch, SM; Brown, ST; Christie, R; Epstein, JM; Eubank, S; Huang, SS; Lee, BY; Parker, JI; Song, Y; Wong, KF; Yilmaz, SL | 1 |
| Ballard, S; Coombs, GW; Grayson, ML; Holt, KE; Howden, BP; Johnson, PD; Lam, MM; Seemann, T; Stinear, TP; Tong, SY | 1 |
| Furuta, K; Mizokami, F; Mizuno, T; Noro, T; Shibasaki, M; Yoshizue, Y | 1 |
| Almirante, B; Calbo, E; Camoez, M; de Gopegui, ER; Dominguez, MA; Dueñas, C; García-Pardo, G; Gasch, O; Granados, A; Horcajada, JP; Jover-Sáenz, A; López-Medrano, F; Martín-Gandul, C; Padilla, B; Pintado, V; Pujol, M; Ramón Blanco, J | 1 |
| Barreto, JN; Huang, DB; Morrow, LE; Puzniak, LA | 1 |
| Mylonakis, E; Rice, LB; Thapa, R; Ziakas, PD | 1 |
| Fukami, K; Furuta, K; Ito, K; Mizokami, F; Mizuno, T; Nagamatsu, T; Shibasaki, M | 1 |
| Ebigbo, A; Messmann, H | 1 |
| Brandt, C; Frank, U; Mersch-Sundermann, V; Mutters, NT; Mutters, R; Schneider-Brachert, W | 1 |
| Chavanet, P | 1 |
| Keller, JM; Surawicz, CM | 1 |
| Kett, DH; Puttagunta, S; Quartin, AA; Scerpella, EG | 1 |
| Ibrahim, SA; Noreddin, AM; Salem, AH; Zhanel, GG | 1 |
| Cioara, A; Filipescu, I; Flonta, M; Lupse, M; Todor, N | 1 |
| Araki, K; Goto, H; Kikuchi, K; Koide, T; Makino, H; Ogawa, Y; Ohkuma, K; Saraya, T; Takizawa, H; Yonetani, S | 1 |
| Barriere, SL; Corey, GR; Hopkins, A; Kollef, MH; Rubinstein, E; Shorr, AF; Stryjewski, ME | 1 |
| Parija, SC; Praharaj, I; Sujatha, S | 1 |
| Barriere, SL | 1 |
| Caierão, J; d'Azevedo, PA; Dias, CA; Narvaez, GA; Prates, JG; Resende, M | 1 |
| Jain, N; Mathur, P; Misra, MC | 1 |
| Muscedere, J | 1 |
| Afifi, SA; Elkhodairy, KA; Zakaria, AS | 1 |
| Blasi, F; Chastre, J; Masterton, RG; Rello, J; Torres, A; Welte, T | 1 |
| Barriere, SL; Corey, GR; Genter, FC; Rubinstein, E; Stryjewski, ME | 1 |
| Calandra, T; Greub, G; Prod'hom, G; Senn, L; Taffe, P; Tissot, F; Zanetti, G | 1 |
| Panomket, P; Sranujit, RP; Thirat, S; Wanram, S | 1 |
| Miller, MA; Popiel, KY | 1 |
| Calvo-García, N; de Frutos-Serna, M; García-Sánchez, JE; Hernández-Egido, S; María-Blázquez, A; Siller-Ruiz, M | 1 |
| Ceriani Cernadas, JM; Fernández Jonusas, S; Garsd, A; Mariani, G; Márquez, M | 1 |
| Fernández-Martínez, LT; Manteca, A; Martín, JF; Martín-Martín, S; Ordóñez-Robles, M; Rodríguez García, A; Rodríguez-García, A; Santos-Beneit, F; Yagüe, P | 1 |
| Cui, Z; Hu, Z; Ji, J; Kang, H; Liu, S; Wang, J | 1 |
| Mylonakis, E; Rice, LB; Zacharioudakis, IM; Zervou, FN; Ziakas, PD | 1 |
| Chen, CM; Chen, WY; Chen, YH; Chen, YS; Cheng, YJ; Chiang, PC; Chuang, YC; Hsu, GJ; Hsueh, PR; Huang, CH; Jang, TN; Ko, WC; Kung, HC; Lee, CM; Lee, MH; Liao, CH; Lin, HC; Liu, CE; Liu, CY; Liu, JW; Liu, YC; Lu, CT; Lu, PL; Pan, SC; Shi, ZY; Sun, W; Thomas, CY; Tsao, SM; Wang, LS; Wang, WY; Yang, JL; Yu, KW | 1 |
| Charbonneau, C; Chastre, J; Gao, X; Nathwani, D; Niederman, M; Patel, DA; Shorr, AF; Simor, A; Stephens, JM | 1 |
| Aitken, SL; DuPont, HL; Garey, KW; Joseph, TB; Lasco, TM; Palmer, HR; Shah, DN; Xie, Y | 1 |
| Escosa-García, L; García-Gil, V; Gómez-Gil, MR; Hierro-Llanillo, L | 1 |
| Chastre, J; Gao, X; Haider, S; Li, JZ; Myers, DE; Niederman, MS; Solem, CT; Stephens, JM; Wan, Y | 1 |
| Alagoz, O; Codella, J; Heffernan, R; Safdar, N | 1 |
| Kudo, M; Nomura, T; Tanimoto, K; Tomita, H; Yomoda, S | 1 |
| Bezerra Neto, AM; Ferreira, EL; Leal, NC; Lima, JL; Loibman, SO; Maciel, MA; Rabelo, MA | 1 |
| Diekema, DJ; Kaye, KS; Morgan, DJ | 1 |
| Altman, DR; Holzman, RS; Kafer, JM; Mendes, RE; Rose, HR; Shopsin, B; Smyth, DS; Torres, VJ; Wasserman, GA; Wible, M | 1 |
| Dong, W; Dong, Y; He, H; Wang, T; Wang, Y; Xie, J; Xing, J; Zheng, X; Zou, Y | 1 |
| Brito, CI; Camargo, CH; Cunha, Mde L; Oliveira, Ad; Pereira, VC; Pinheiro, L | 1 |
| Belyaev, O; Chromik, AM; Deleites, C; Herzog, T; Uhl, W | 1 |
| Calfee, DP | 2 |
| Camargo, IL; Dabul, AN; Merlo, TP | 1 |
| Ejiofor, K; Khan, MS; Lobo, N; Thurairaja, R | 1 |
| Biswas, JS; Goldenberg, SD; Newsholme, W; Otter, JA; Patel, A; van Kleef, E; Wade, P | 1 |
| Cary, MS; Cluzet, VC; Fishman, NO; Lautenbach, E; Linkin, DR; Morales, KH; Nachamkin, I; Shih, NN | 1 |
| Arellano-Galindo, J; Cázares-Domínguez, V; Cruz-Córdova, A; Escalona, G; Hernández-Castro, R; López-Villegas, EO; Ochoa, SA; Rodríguez-Leviz, A; Xicohtencatl-Cortes, J | 1 |
| Arıca, D; Aydın, D; Demirel, N; Gedik, H; Kantürk, A; Şimşek, F; Yıldırmak, T; Yokuş, O | 1 |
| Al-Sohaibani, S; Kavitha, K; Murugan, K | 1 |
| Barbut, F; Blais, L; Hirschel, B; Khanafer, N; Vanhems, P | 1 |
| Curth, HM; Kütting, F; Pelc, A; Steffen, HM | 1 |
| Chrischilles, EA; Dawson, JD; Diekema, DJ; Goto, M; Herwaldt, LA; Jiang, L; McDanel, JS; Perencevich, EN; Schweizer, ML; Smith, TC | 1 |
| Gayatri, AA; Merati, TP; Somia, A; Utama, S | 1 |
| Aldrete, Sdel M; Banks, GG; Burd, EM; Chan, AW; Friedman-Moraco, RJ; Kraft, CS; Magee, MJ | 1 |
| Cardoso, CL; Gales, AC; Garcia, LB; Menegucci, TC; Sasaki, AL; Selhorst, GJ; Tognim, MC; Zarpellon, MN | 1 |
| Atalić, V; Bošnjak, Z; Loci-Zvocak, S; Majić, PR; Pastuović, T; Perić, M; Ružman, N; Talapko, J; Vuković, D | 1 |
| Amicizia, D; Cristina, ML; Orlando, P; Panatto, D; Perdelli, F; Spagnolo, AM | 1 |
| Gong, J; Gu, L; Guo, D; Li, J; Li, N; Wei, Y; Zhu, W | 1 |
| Duszynska, W; Hurkacz, M; Kübler, A; Taccone, FS; Wiela-Hojenska, A | 1 |
| Bonten, MJ; De Brauwer, EI; Penders, RJ; Top, J; van der Linden, CJ; Wagenvoort, JH; Willems, RJ | 1 |
| Biswas, P; Niederman, MS; Puzniak, LA; Shorr, AF | 1 |
| Baos, E; Candel, FJ; Nieto, M; Picazo, JJ | 1 |
| Collins, CD; Schwemm, AK | 1 |
| Barriere, SL; Corey, GR; Hardin, TC; Lacy, MK; Luke, DR; Nogid, B; Shorr, AF; Stryjewski, ME; Wang, W | 1 |
| Abbo, LM; Rosa, R; Sfeir, M; Smith, L; Wawrzyniak, A | 1 |
| Attridge, RT; Frei, CR; Mortensen, EM; Reveles, KR | 1 |
| Carfagna, P; Falcone, M; Goldoni, P; Iraci, F; Russo, A; Venditti, M; Vullo, V | 1 |
| Chen, Y; Gao, X; Haider, S; Li, Q; Liu, S; Wan, Y | 1 |
| Almirante, B; Benito, N; Bereciartua, E; Camoez, M; Cuervo, G; Dominguez, MÁ; Espejo, E; Fernandez-Mazarrasa, C; Gasch, O; Goenaga, MÁ; López-Medrano, F; Martinez, JA; Molina, J; Padilla, B; Pintado, V; Pujol, M; Rodriguez-Baño, J; Rodriguez-Lopez, F; Ruiz de Gopegui, E; Shaw, E | 1 |
| Bowie, WR; Bryce, EA; Forrester, LA; Lau, TT; Steiner, TS; Yeung, JK; Yeung, SS | 1 |
| Akamatsu, N; Hasegawa, H; Kawakami, K; Kimura, Y; Kosai, K; Matsuda, J; Matsuo, H; Morinaga, Y; Uno, N; Yamaryo, T; Yanagihara, K | 1 |
| Forbes, AR; Hulten, KG; Kaplan, SL; Kok, EY; Lamberth, L; Mason, EO; McNeil, JC; Vallejo, JG | 1 |
| Guo, L; Jiang, Y; Luo, Y; Ma, Y; Yang, J; Ye, L | 1 |
| Chen, AF; Ruder, JA; Ruffolo, MR; Springer, BD; Tan, TL | 1 |
| Cao, B; Chen, H; Chen, X; Chu, Y; Guo, P; Hu, B; Hu, Z; Jin, Y; Liao, K; Liu, W; Liu, Y; Luo, Y; Su, D; Tian, B; Wang, H; Wang, Y; Wang, Z; Xu, X; Zeng, J; Zhang, F; Zhang, R; Zhao, C; Zhou, C; Zhou, H; Zhuo, C; Zou, M | 1 |
| Darban-Sarokhalil, D; Emaneini, M; Gharibpour, F; Khoramrooz, SS; Malek Hosseini, SA; Marashifard, M; Mirzaii, M; Moein, M; Naraki, M; Parhizgari, N; Yazdanpanah, M | 1 |
| Ghafourian, S; Hatami, V; Mohammadi, F; Mohebi, R; Pakzad, I; Sadeghifard, N; Taherikalani, M; Valadbeigi, H | 1 |
| Acar, M; Akgun Karapınar, B; Akturk, H; Aydin, D; Cihan, R; Çoban, A; Ince, Z; Salman, N; Somer, A; Sutcu, M | 1 |
| Bryce, E; Fernandes, R; Frenette, C; Golding, G; Gravel, D; Katz, K; McGeer, A; Mulvey, MR; Pelude, L; Simor, AE; Smith, S; Weiss, K | 1 |
| Bender, JK; Fleige, C; Fuchs, S; Kalmbach, A; Klare, I; Werner, G | 1 |
| Allou, N; Augustin, P; Desmard, M; Grall, N; Guglielminotti, J; Marmuse, JP; Montravers, P | 1 |
| Charbonneau, C; Chastre, J; De Salas-Cansado, M; Gao, X; Mesa, F; Nieto, M; Rello, J; Solé-Violán, J; Solem, CT; Wan, Y | 1 |
| Bulanda, M; Talaga, K | 1 |
| Fukumori, S; Ishibashi, T; Iwamura, N; Kasai, H; Mizoguchi, A; To, H; Tsuji, Y | 1 |
| Chu, CM; Lee, CW; Lee, SC; Liu, YC; See, LC; Shih, TC | 1 |
| del Mar Gamboa-Coronado, M; López-Ureña, D; Montoya-Ramírez, M; Quesada-Gómez, C; Rodríguez, C; Rodríguez-Cavallini, E; Somogyi, T | 1 |
| Kautza, B; Zuckerbraun, BS | 1 |
| Lahkar, M; Phukan, C; Ranotkar, S; Saikia, KK | 1 |
| Changchien, CH; Chen, SW; Chen, YY; Chu, C | 1 |
| Adams, B; Ford, CD; Gazdik, MA; Hoda, D; Lopansri, BK; Petersen, FB; Snow, GL; Webb, B | 1 |
| Chau, PH; Chen, JH; Cheng, VC; Chuang, VW; Ho, PL; Lai, CK; So, SY; Tai, JW; Tsang, DN; Wong, SC; Yuen, KY | 1 |
| Brodsky, D; Halevi, CN; Nitzan, O; Pastukh, N; Peretz, A; Tkhawkho, L | 1 |
| Cheung Lam, AH; Chiang, SM; Do, TQ; Ernst, W; Fujii, G; Gilkes, J; Howard Xu, H; Kosina, S; Porter, E; Sandoval, N; Wadhwa, R | 1 |
| Choi, HJ; Choi, YJ; Jang, HC; Kang, CI; Kim, ES; Kim, HY; Kim, JY; Kim, MJ; Kim, SI; Kim, SW; Kim, YS; Lee, CS; Lee, MS; Lee, SS; Park, DW; Peck, KR; Ryu, SY; Sohn, JW; Yang, KS; Yoon, YK | 1 |
| Holt, S; Lipetzky, J; Sparks, ER; Thompson-Brazill, KA | 1 |
| Bitew, A; Dilnessa, T | 1 |
| Alla, F; Braquet, P; Chirouze, C; Cornu, C; Duval, X; Goehringer, F; Le Moing, V; Lechiche, C; Piroth, L; Revest, M | 1 |
| Bin, C; Rello, J | 1 |
| Fisher, D; Isenman, H | 1 |
| Adler, A; Carmeli, Y; Cohen, D; Miller-Roll, T; Na'amnih, W | 1 |
| Eckmann, C; Lyon, S | 1 |
| Chen, Z; Guo, Y; Li, D; Lv, J; Qi, X; Wang, L; Wang, S; Yu, F; Zhang, X | 1 |
| Hifumi, T; Inoue, J; Kanemura, T; Kato, H; Kiriu, N; Koido, Y; Nishimoto, N; Okada, I; Takada, H; Yoshioka, H | 1 |
| Chu, CI; Fang, Y; Jiang, HL; Li, YH; Wang, LS; Zhou, Z | 1 |
| Arhin, FF; Belley, A; Moeck, G; Pillar, CM; Shinabarger, DL; Stoneburner, A; Sweeney, D | 1 |
| Cook, F; Dhonneur, G; Hulin, A; Lobo, D; Mounier, R; Nebbad, B | 1 |
| Alonso-Isa, M; Benítez-Sala, R; García-Rojo, E; Gil-Moradillo, J; González-Padilla, DA; Justo-Quintas, J; Lara-Isla, A; Medina-Polo, J; Passas-Martínez, JB; Sopeña-Sutil, R; Tejido-Sánchez, Á | 1 |
| Humphreys, H | 1 |
| Hendrickx, APA; Martin, NI; van Harten, RM; Willems, RJL | 1 |
| Binatti, VB; Faria, YV; Hirata, R; Mattos-Guaraldi, AL; Pereira, JA; Pereira, PM; Ramos, JN; Santos, KR; Seabra, SH; Sued, BP; Vieira, VV | 1 |
| Arias, CA; Carvajal, LP; Chambers, HF; Diaz, L; Garavito, JD; Miller, WR; Munita, JM; Nigo, M; Panesso, D; Rios, R; Tran, TT; Wanger, A; Weinstock, G | 1 |
| Banaei, N; Deresinski, S; Gombar, S; Holubar, M; Madison, A; Schroeder, LF; Shah, N; Shepard, J; Sundararajan, G; Tekic, N; Tompkins, L; Truong, CY; Wilson, R | 1 |
| Rybak, MJ; Smith, JR; Yim, J | 1 |
| Arnold, C; Bosco, J; Clark, R; Shoemaker, C; Spitzer, AR | 1 |
| Hsu, RB; Huang, JH | 1 |
| Kluytmans, JA; van Rijen, MM | 1 |
| Albanese, A; Anile, C; Arduini, E; Cataldo, MA; Cauda, R; Fadda, G; Federico, G; Maira, G; Spanu, T; Tacconelli, E; Tumbarello, M | 1 |
| Cao, B; Li, R; Liu, Y; Song, S; Wang, C; Wang, H | 1 |
| Croos-Dabrera, RV; Ijzerman, MM; Lin, DF; Miao, JZ; Shen, HH; Sheng, RY; Sheng, W; Wang, F; Wu, JF; Zhang, YY; Zheng, JC; Zheng, LY; Zhou, X | 1 |
| Aligholi, M; Aminshahi, M; Emaneini, M | 1 |
| Babinchak, T; Beuran, M; Bochan, M; Cooper, CA; Dartois, N; Dimov, R; Dukart, G; Ellis-Grosse, EJ; Fichev, G; Florescu, I; Gandjini, H; Razbadauskas, A | 1 |
| Arias, CA; Contreras, GA; Cortes, L; Díaz, L; DiazGranados, CA; Murray, BE; Panesso, D; Prada, G; Reyes, J; Rincón, S; Vanegas, S | 1 |
| Khorvash, F; Mobasherizadeh, S; Mostafavizadeh, K | 1 |
| Connelly, SM; Dodds-Ashley, ES; Engemann, JJ; Friedman, ND; Johnson, MD; Kaye, D; Kaye, KS; Stout, J; Trinh, JV | 1 |
| Duarte, RS; Merquior, VL; Neves, FP; Ribeiro, RL; Teixeira, LM | 1 |
| Beeston, CJ; Chadwick, PR; Gupta, R; Young, RJ | 1 |
| Bouza, E; Croos-Dabrera, RV; Herr, DL; Ijzerman, MM; Knirsch, C; Kunkel, MJ; Ruf, BR; Tack, KJ; Wilcox, MH | 1 |
| Cercenado, E; Ruiz de Gopegui, E | 1 |
| Akinci, E; Balaban, N; Baran, G; Bodur, H; Cevik, MA; Erbay, A; Onguru, P | 1 |
| Bujanda, L; Cosme, A | 1 |
| Leclair, SJ; Scarano, FJ; Tang, Y | 1 |
| Cheong, HJ; Choi, WS; Heo, JY; Jo, YM; Kim, WJ; Noh, JY; Song, JY | 1 |
| Coffin, SE; Gerber, JS; Gross, K; McGowan, KL; Nolan, SM; Prasad, P; Reilly, AF; Rettig, S; Zaoutis, T | 1 |
| Acar, F; Burchiel, KJ; Miller, JP | 1 |
| Baker, T; De Cock, E; Duttagupta, S; Hardewig, J; Krueger, WA; Müller, E; Piecyk, A; Reisinger, E; Resch, A; Sorensen, S | 1 |
| Ascerić, M; Custović, A; Hadzić, S; Zulcić-Nakić, V | 1 |
| Johnson, S | 1 |
| Hammerman, WA; Hulten, KG; Kaplan, SL; Lamberth, LB; Mason, EO; Versalovic, J | 1 |
| Hoban, DJ; Karlowsky, JA; Nichol, K; Noreddin, AM; Voth, D; Zhanel, GG | 1 |
| Bou, G; Camba, V; Coque, TM; Pérez, S; Rodríguez-Baño, J; Torres, E; Villanueva, R; Vindel, A | 1 |
| Cadé, S; Enouf, V; Fabre, M; Foissaud, V; Mac Nab, C; Samson, T; Soler, C; Surcouf, C | 1 |
| Kaiser, GM; Mathe, Z; Paul, A; Rath, PM; Saner, FH; Treckmann, J; Vernadakis, S | 1 |
| Lesens, O | 1 |
| Cao-Huu, T; Chanet, P; Henard, S; Kessler, M; Loos-Ayav, C; Rabaud, C | 1 |
| Cao-Huu, T; Chanet, P; Diguio, N; Hartemann, P; Hautemanière, A; Kessler, M | 1 |
| Hutschala, D; Kinstner, C; Müller, M; Skhirdladze, K; Thalhammer, F; Tschernko, E | 1 |
| Dubberke, ER; Riddle, DJ | 1 |
| Aston, JL; Creech, CB; Dortch, MJ; Dossett, LA; May, AK | 1 |
| Niederman, MS | 1 |
| Harpe, S; Oinonen, M; Pakyz, A; Polk, R; Schmiedeskamp, M | 1 |
| Erstad, BL; Kopp, BJ; Nix, DE; Norris, CJ; Patanwala, AE | 1 |
| Arias, CA; Eliopoulos, GM; Galloway-Peña, JR; Murray, BE; Nallapareddy, SR | 1 |
| Hryniewicz, W; Kawalec, M; Konopka, L; Ozorowski, T; Zaleska, M | 1 |
| Blick, SK; Lyseng-Williamson, KA | 1 |
| Adam, HJ; Bryce, E; Gravel, D; Loeb, M; Louie, L; Matlow, A; McGeer, A; Mulvey, MR; Simor, AE; Watt, C | 1 |
| Alfandari, S; Arimane, O; Bonenfant, C; Cattoen, C; Descamps, D; Grandbastien, B; Hendricx, S; Levent, T; Taines, V | 1 |
| Mazer, MA; Ramsey, KM | 1 |
| Choi, IS; Chung, JW; Han, SY; Ho Choi, S; Hong, SB; Jung, YJ; Kim, MN; Kim, NJ; Kim, WD; Koh, Y; Lim, CM; Yun, SC | 1 |
| Stein, GE; Wells, EM | 1 |
| Aubert, G; Auboyer, C; Carricajo, A; Forgeot, A; Morel, J; Zeni, F | 1 |
| Boyeras Navarro, ID; Luna, CM | 1 |
| Fisher, K; Phillips, C | 1 |
| Gkrania-Klotsas, E; Nicholl, C; Parks, T; Wallis, S; Wilson, J | 1 |
| Becker, HK; Jones, RN; Moet, GJ; Sader, HS | 1 |
| Li Bassi, G; Saucedo, LM | 1 |
| Fontana, F; Gregori, D; Gullo, A; Milanese, M; Silvestri, L; Solidoro, A; Van Saene, HK | 1 |
| Leonard, SN; Rybak, MJ; Vidaillac, C | 1 |
| Poxton, IR | 1 |
| Launey, Y; Nesseler, N; Seguin, P | 1 |
| Bernard, L; Grima, D; Miller, M; Pepin, J; Thompson, M | 1 |
| Allen, M; Cano, E; Haque, NZ; Kett, DH; Lamerato, L; Mangino, JE; Moore, CL; Patel, S; Peterson, E; Peyrani, P; Ramirez, JA; Reyes, K; Wiemken, T; Zervos, MJ; Zuniga, LC | 1 |
| Carroll, NV; Harpe, SE; Oinonen, M; Pakyz, AL; Polk, RE | 1 |
| Kern, WV | 1 |
| Hermsen, ED; Kalil, AC; Murthy, MH; Neto, FK; Rupp, ME; Sun, J | 1 |
| Simor, AE | 1 |
| Hsueh, PR; Lai, CC; Lin, SH; Tan, CK | 1 |
| Doherty, JA; Kollef, MH; Micek, ST; Reichley, RM; Sarikonda, KV; Warren, D | 1 |
| Salkind, AR | 1 |
| Al Abdulmohsin, S; Al-Tawfiq, JA; Dib, JG; Jenden, PD; Mohammed, K | 1 |
| Aruj, P; Bruno, D; Luna, CM | 1 |
| Busscher, HJ; Engelsman, AF; Francis, KP; Nejadnik, MR; Ploeg, RJ; Saldarriaga-Fernandez, IC; van Dam, GM; van der Mei, HC | 1 |
| Ballard, SA; Grabsch, EA; Grayson, ML; Howden, BP; Johnson, PD; Seemann, T; Stinear, TP; Young, HL | 1 |
| Hewett, ML | 1 |
| Chong, Y; Kim, JJ; Kim, S; Koh, E; Lee, CH; Lee, J; Lee, K; Lee, MA; Roh, KH; Yong, D | 1 |
| Chu, CC; Hsueh, PR; Huang, YT; Lai, CC; Lee, PI; Lee, YL; Lu, CL; Tan, CK; Wang, CY | 1 |
| Bishara, J; Leibovici, L; Lev, B; Lishtzinsky, Y; Paul, M; Samra, Z; Talker, O; Zemer-Wassercug, N | 1 |
| Cattoir, V; Leclercq, R | 1 |
| Chaudhry, R; Das, I; Lambert, P; Lewis, T; Nightingale, P | 1 |
| Barriere, SL; Corey, GR; Fagon, JY; Friedland, HD; Genter, FC; Kanafani, ZA; Kitt, MM; Kollef, MH; Lalani, T; Lee, PC; Lentnek, AL; Luna, CM; Nannini, EC; Niederman, MS; Rahav, G; Rocha, MG; Rubinstein, E; Shorr, AF; Stryjewski, ME; Torres, A | 1 |
| Bruun, NE; Fowler, VG; Rasmussen, RV; Skov, R | 1 |
| Burkhardt, O; Pletz, MW; Welte, T | 1 |
| Jiménez-Mejías, ME; Márquez-Rivas, J; Neth, O; Rivero-Garvía, M; Rueda-Torres, AB | 1 |
| Albrecht, H | 1 |
| Chen, Q; Huang, P; Huang, YL; Lin, ZQ | 1 |
| Choi, EY; Choi, SH; Hong, SB; Huh, JW; Kim, MN; Kim, SH; Kim, YS; Koh, Y; Lim, CM | 1 |
| Boldrin, C; De Canale, E; Fallico, L; Franchin, E; Grossato, A; Manganelli, R; Palù, G; Parisi, SG; Tommasini, T | 1 |
| Fasih, N; Hasan, R; Jabeen, K; Khan, E; Zafar, A | 1 |
| Bourdon, N; Cattoir, V; Coignard, B; Fines-Guyon, M; Leclercq, R; Maugat, S; Thiolet, JM | 1 |
| Davey, PG; Marwick, CA; Nathwani, D | 1 |
| Cercenado, E | 1 |
| Hollis, SJ; Michalets, EL; Pounders, CL; Sutherland, S | 1 |
| Leung, W; Nguyen, GC; Weizman, AV | 1 |
| Bahr, MH; Behrman, SW; Dickson, PV; Zarzaur, BL | 1 |
| Tarchini, G | 1 |
| Dresser, LD; MacLean, RD; McGavin, MJ; Simor, AE; Tsuji, BT | 1 |
| Altunsoy, A; Aypak, C; Azap, A; Balık, I; Ergönül, Ö | 1 |
| Dobay, O; Dombrádi, V; Dombrádi, Z; Kozák, A; Nagy, K; Szabó, J | 1 |
| Fajardo Olivares, M; Hidalgo Orozco, R; Robles Marcos, M; Rodríguez Garrido, S; Rodríguez-Vidigal, FF; Vera Tomé, A | 1 |
| Karabekos, D; Karvouniaris, M; Makris, D; Zakynthinos, E | 1 |
| Avazashvili, N; Chikviladze, D; Gachechiladze, Kh; Metreveli, D; Mikeladze, M; Nozadze, T | 1 |
| Cobos, N; Fernandez, J; Martínez, JA; Mensa, J; Mohamad, AM; Morata, L; Soriano, A; Sterzik, H | 1 |
| Cocanour, CS | 1 |
| Abi-Haidar, Y; Gupta, K; Itani, KM; Strymish, J; Williams, SA | 2 |
| Azak, A; Duranay, M; Huddam, B; Işcan, G; Kocak, G | 1 |
| Liu, Y; Luo, EJ; Ma, XX; Wang, EH | 1 |
| Gorbach, S; Mullane, KM | 1 |
| Paterson, DL; van Hal, SJ | 1 |
| El-Amin, NM; Faidah, HS | 1 |
| Bookstaver, PB; Bosso, JA; Mauldin, PD; Nappi, J; Rudisill, C; Swindler, J; Wellein, M | 1 |
| Fujita, N; Ichiyama, S; Iinuma, Y; Ito, Y; Matsumura, Y; Matsushima, A; Nagao, M; Shimizu, T; Shirano, M; Takakura, S; Yamamoto, M | 1 |
| Gardner, E; Mancuso, P; Meghani, N; Thomson, A | 1 |
| Abdelali, S; Abdelouahid, DE; Azzaoui, H; Rahmoun, M; Rebiahi, SA | 1 |
| Malkan, AD; Scholand, SJ | 1 |
| Cesur, S; Demiröz, AP; Irmak, H; Karakoç, E; Kınıklı, S; Pelitli, TS | 1 |
| Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Vorob'eva, TIu | 1 |
| Bogomolova, NS; Bol'shakov, LV; Kuznetsova, SM; Oreshkina, TD | 1 |
| Gaddad, SM; Shivannavar, CT; Thati, V | 1 |
| Bellissimo-Rodrigues, F; Carlotti, AP; Carmona, F; Gaspar, GG; Martinez, R; Matsuno, AK; Prado, SI; Silva, MF | 1 |
| Cheong, HJ; Kee, SY; Kim, WJ; Kwon, YJ; Lee, JE; Park, CW; Pyo, HJ | 1 |
| Choi, SH; Chung, J; Hong, SB; Jang, HJ; Kim, JW; Koh, Y; Lim, CM | 1 |
| Kelly, CP | 1 |
| Arias, CA; Murray, BE | 1 |
| Hautala, T; Koskela, M; Luttinen, S; Rahkonen, M | 1 |
| Cai, Y; Chan, JP; Fisher, DA; Hsu, LY; Koh, TH; Krishnan, P; Kwa, AL; Tan, TY; Tee, NW | 1 |
| Donskey, CJ; Guerrero, DM; Jinno, S; Jury, LA; Kundrapu, S; Nerandzic, MM | 1 |
| Cadnum, JL; Donskey, CJ; Eckart, KE; Nerandzic, MM | 1 |
| Armbruster, S; Goldkind, L | 1 |
| Chung, DR; Ha, YE; Joo, EJ; Kang, CI; Kim, JM; Ko, KS; Peck, KR; Song, JH; Wi, YM | 1 |
| Agarwal, A; Jain, A | 1 |
| Cornely, OA; Fätkenheuer, G; Hallek, M; Liss, BJ; Seifert, H; Vehreschild, JJ; Vehreschild, MJ; Wisplinghoff, H | 1 |
| Baddley, JW; Chamot, E; Kunz, DF; McKinnell, JA; Miller, LG; Moser, SA; Pappas, PG; Patel, M; Shirley, RM | 1 |
| Balm, MN; Dancer, SJ; Fisher, DA; Jureen, R; Lin, RT; Teo, C; Yeoh, AE | 1 |
| Niki, Y | 1 |
| Chen, FJ; Chen, TC; Chen, YH; Lin, SY; Lin, YI; Lu, PL; Siu, LK | 1 |
| Aslantas, Ö; Demir, C; Erdem, Z; Türkyilmaz, S; Yilmaz, MA | 1 |
| Akpabie, A; Aubry, A; Barbut, F; Brossier, F; Brun-Buisson, C; Chedhomme, FX; Fortineau, N; Fournier, S; Gillaizeau, F; Jarlier, V; Kassis-Chikhani, N; Lucet, JC; Robert, J; Seytre, D; Simon, I; Vanjak, D; Zahar, JR | 1 |
| de Magalhaes Silverman, M; Gingrich, RD; Wudhikarn, K | 1 |
| Chang, SC; Chen, SY; Chen, WJ; Chiang, WC; Chie, WC; Hsueh, PR; Lai, MS; Liao, CH; Wang, JL | 1 |
| Alaniz, C; Pogue, JM | 1 |
| Gastmeier, P; Kola, A; Meyer, E; Schwab, F | 1 |
| Deshpande, LM; Farrell, DJ; Jones, RN; Mendes, RE; Shopsin, B; Smyth, DS | 1 |
| Corey, GR; Nannini, EC; Stryjewski, ME | 1 |
| Church, TJ; Segarra-Newnham, M | 1 |
| Abreu-Lanfranco, O; Boyce, JM; Fisher, A; Hung, WY; Karjoo, A; Pop, OF; Protopapas, Z; Thompson, B | 1 |
| Choi, SH; Chong, YP; Jeong, JY; Kim, ES; Kim, MN; Kim, SH; Kim, T; Kim, YS; Lee, SO; Park, KH; Park, SJ; Woo, JH | 1 |
| Harpe, SE; Inocencio, TJ; Oinonen, MJ; Pakyz, AL; Polk, RE | 1 |
| Almirante, B; Benito, N; Bereciartua, E; Camoez, M; Dominguez, MA; Espejo, E; Fernandez-Mazarrasa, C; Gasch, O; Goenaga, MA; Lopez-Medrano, F; Martinez, JA; Molina, J; Padilla, B; Pintado, V; Pujol, M; Rodriguez-Baño, J; Rodriguez-Lopez, F; Ruiz, E | 1 |
| Cuthbertson, BH; Daneman, N; Fowler, RA; Sarwar, S | 1 |
| Cekin, Y; Colak, D; Dönmez, L; Mutlu, D; Oğünç, D; Ongüt, G; Ozhak Baysan, B; Sepin Özen, N | 1 |
| Chien, CC; Lee, CH; Liu, JW | 1 |
| Bobin-Dubreux, S; Byl, B; Denis, O; Knoop, C; Nonhoff, C; Struelens, MJ | 1 |
| Shnayerson, M | 1 |
| Bismuth, R; Coriat, P; De Bels, D; Korinek, AM; Puybasset, L; Trystram, D | 1 |
| Malnick, SD; Zimhony, O | 1 |
| Cieslak, PR; Fleming, DW; Strausbaugh, LJ; Thomas, AR | 1 |
| Carias, L; Goossens, H; Huang, W; Klare, I; Konstabel, C; Murray, BE; Nallapareddy, SR; Rice, LB; Rudin, S; Vael, C | 1 |
| Chatzidimitriou, M; Katikaridou, E; Kollaras, P; Koumentaki, E; Metallidis, S; Nikolaidis, P; Tourkantonis, A; Tsona, A | 1 |
| Chang, KH; Chong, Y; Kim, JM; Kim, MS; Lee, K; Shin, JW; Yong, D | 1 |
| Igarashi, T; Usukura, Y | 1 |
| Tanaka, K; Watanabe, K | 1 |
| Lowy, FD | 1 |
| Gold, HS; Inglima, K; Pillai, SK; Press, RA; Rahim, S; Venkataraman, L | 1 |
| Avlamis, A; Demertzi, E; Pantazatou, A; Papanicolas, J; Papaparaskevas, J; Stefanou, I | 1 |
| Kauffman, CA | 1 |
| Christiansen, KJ; Douglas, CR; Heath, CH; Khinsoe, CH; Kosaras, FP; Lee, RC; Orrell, CT; Pearman, JW; Perry, PL; Peterson, AM | 1 |
| Cammarata, SK; Kollef, MH; Oliphant, TH; Wunderink, RG | 1 |
| Calfee, DP; Durbin, LJ; Farr, BM; Germanson, TP; Giannetta, ET | 1 |
| Adler, S; Bruss, JB; Deville, JG; Edge-Padbury, B; Kaplan, SL; Morfin, MR; Naberhuis-Stehouwer, S; Wu, E; Yogev, R | 1 |
| Arlet, V; Demers, AM; Labbé, AC; Moore, DL; Rodrigues, R; Tanguay, K | 1 |
| Almeida, SC; Bokermann, S; Brandileone, MC; Moreira, Mde F; Pignatari, AC; Salomão, R; Valdetaro, F; Villins, M; Vitório, F; Zanella, RC | 1 |
| Barefoot, L; Hansjosten, K; Martínez, JA; Ruthazer, R; Snydman, DR | 1 |
| LOURIA, DB | 1 |
| BETINOVA, M; NEMEC, P | 1 |
| PLATTNER, HC; SCHERER, J | 1 |
| Alcalá, MA; Alvarez Lerma, F; Blanco, A; Insausti, J; Olaechea, P; Palomar, M | 1 |
| Adler, S; Bruss, JB; Deville, J; Edge-Padbury, B; Jantausch, BA; Lopez, P; Morfin, MR; Naberhuis-Stehouwer, S | 1 |
| Karpov, OI; Sidorenko, SV; Zaĭtsev, AA | 1 |
| Bauer, TT | 1 |
| Cammarata, SK; Croos-Dabrera, RV; Kollef, MH; Rello, J; Wunderink, RG | 2 |
| Benjamin, WH; Chavers, LS; Chavers, P; Funkhouser, E; Moser, SA; Stamm, AM; Waites, KB | 1 |
| Cammarata, SK; Kuter, DJ; Le, VH; Nasraway, SA; O'Grady, N; Shorr, AF | 1 |
| Plumridge, N | 1 |
| Ioanas, M; Lode, H | 1 |
| Di, JH; Shen, XZ; Yang, YH | 1 |
| Cole, CA; Elhassan, NO; Gigliotti, F; Hardy, DJ; Sinkin, RA; Stevens, TP | 1 |
| Barrett, SP; de la Cal, MA; Petros, AJ; Silvestri, L; van Saene, HK; Weir, WI | 1 |
| Fisman, DN; Harris, AD; Lipsitch, M; Morris, JG; Perencevich, EN; Smith, DL | 1 |
| Farr, BM | 2 |
| Rollins, G | 1 |
| Bergeret, M; Boisset, S; Denis, F; Ducancelle, A; Garnier, F; Pineiro, A; Raymond, J | 1 |
| Benjamin, DK; Bloom, B; Clark, R; Powers, R; Sanchez, P; White, R | 1 |
| Buchanan, LV; Dailey, CF; Gibson, JK; Haas, JV; Pagano, PJ; Van Enk, RA | 1 |
| Kalil, AC; Puumala, SE; Stoner, J | 1 |
| Bartoloni, A; Benedetti, M; Dei, R; Goldstein, BP; Mantella, A; Paradisi, F; Sbaragli, S | 1 |
| Blazic, M; Fontana, F; Gregori, D; Milanese, M; Oblach, L; Piacente, N; Silvestri, L; van Saene, HK | 1 |
| Leneveu, M; Merrer, J; Pauthier, F; Pisica-Donose, G | 1 |
| Chou, YH; Chuang, YY; Huang, YC; Lee, CY; Lien, R; Lin, TY | 1 |
| Lin, D; Powers, JH; Ross, DB; Soreth, J | 1 |
| Cleveland, KO; Gelfand, MS | 1 |
| Wunderink, RG | 1 |
| Maki, DG; Marx, JA; Tambyah, PA | 1 |
| Baquero, F; Coque, TM; Novais, C; Peixe, L; Sousa, JC | 1 |
| Blum-Menezes, D; Bratfich, OJ; Duboc, GM; Levi, C; Levin, AS; Moretti, ML; Stucchi, RB; Vormittag, E | 1 |
| Palasuntheram, C; Perera, S | 1 |
| Alary, ME; Chouinard, D; Forget, K; Pelletier, A; Pépin, J; Pépin, K; Valiquette, L; Villemure, P | 1 |
| Hageman, JC; McDonald, LC | 1 |
| Li, DJ; Liu, WL; Sun, ZY; Zhu, XH | 1 |
| McFarland, LV | 1 |
| Humphreys, H; Smyth, EG | 1 |
| Wegner, DL | 1 |
| Aepfelbacher, M | 1 |
| Chihara, J; Fukui, R; Kayaba, H; Kobayashi, N; Kobayashi, Y; Saitoh, N; Sakurada, N; Tobita, M; Tomita, N; Ueki, S | 1 |
| Lehn, N; Naber, KG; Wagenlehner, FM; Witte, W | 1 |
| Marris, E | 1 |
| Alex, CP; Garland, JS; Henrickson, KJ; Maki, DG; McAuliffe, TL | 1 |
| Alonso, R; Bouza, E; Muñoz, P | 1 |
| Beekmann, SE; Diekema, DJ; Doern, GV | 1 |
| Bond, CA; Raehl, CL | 1 |
| Aslam, S; Hamill, RJ; Musher, DM | 1 |
| Blot, S | 1 |
| Emmanuel, R; Khudaier, BY; Rani, P; Sharma, M; Sharma, SK; Taneja, N; Tewari, R | 1 |
| Alshami, I; Asghar, AH; Burnie, JF; Matthews, RC; Momenah, AM | 1 |
| Arns, Cda C; Follador, W; Guerra, A; Machado, AR | 1 |
| Diallo, HM; Diop, BM; Hatim, B; Seydi, M; Soumaré, M; Sow, AI; Sow, PS; Tine, R | 1 |
| Carmeli, Y; Flores, EL; Lin, MY; Sreeramoju, P; Tolentino, J; Weber, SG; Zumsteg, J | 1 |
| Eliopoulos, GM; Moellering, RC; Sakoulas, G | 1 |
| Gordon, D; Ju, O; Woolley, M | 1 |
| Kollef, MH | 2 |
| Appelbaum, PC | 1 |
| Thompson, M | 1 |
| Almirante, B; Calleja, R; Fernandez-Hidalgo, N; Pahissa, A; Pigrau, C; Planes, AM; Rodriguez, D; Ruiz, I | 1 |
| Mortlock, S | 1 |
| Jackson, B; Jenkins, D; Nixon, M; Taylor, G; Varghese, P | 1 |
| Caltenco-Serrano, R; Mojica-Madera, JA; Nava-Ocampo, AA; Villanueva-García, D | 1 |
| Bertha, G; Grisold, A; Krause, R; Laferl, H; Smolle, KH; Szell, M; Wenisch, C | 1 |
| Baltopoulos, G; Dimopoulos, G; Koulenti, D; Myrianthefs, P | 1 |
| Koulenti, D; Rello, J | 1 |
| Borschel, DM; Chenoweth, CE; Collins, CD; Hyde, KV; Kaufman, SR; Raghunathan, TE; Saint, S; VanDerElzen, KA | 1 |
| Huang, J; Malczynski, M; Noskin, GA; Postelnick, MJ; Qi, C; Scheetz, MH; Warren, JR; Zembower, TR | 1 |
| Bhat, G; Hussain, A; Kamath, S | 1 |
| Dobbs, TE; Hoesley, CJ; Moser, SA; Patel, M; Stamm, AM; Waites, KB | 1 |
| Troelstra, A; van der Bruggen, T; Vlaminckx, BJ | 1 |
| Daniel Mullins, C; Kuznik, A; Levine, AR; Liu, LZ; Obeidat, NA; Shaya, FT; Wong, W | 1 |
| Camargo, IL; Darini, AL; Gilmore, MS | 1 |
| Bar, K; Bearman, GM; Edmond, MB; Wenzel, RP; Wisplinghoff, H | 1 |
| Mallol, J; Rello, J | 1 |
| Doherty, JA; Isakow, W; Jeffres, MN; Kollef, MH; McKinnon, PS; Micek, ST; Ritchie, DJ | 1 |
| Sen, MR; Tiwari, HK | 1 |
| Beyer, I; Byl, B; Cherifi, S; Delmee, M; Mascart, G; Van Broeck, J | 1 |
| Scheinfeld, N | 1 |
| Bodonaik, NC; Moonah, S | 1 |
| Bouza, E; Burillo, A; Muñoz, P | 1 |
| Chen, HZ; Han, YX; Huang, QS; Jiang, JD; Li, CR; Lou, RH; Wang, YM; Yang, XY; You, XF; Zhang, WX | 1 |
| Czaban, SL; Olszańska, D; Siemiatkowski, A | 1 |
| Talbot, TR | 1 |
| García-Rodríguez, JA; Muñoz Bellido, JL | 1 |
| Hall, RG; Maclayton, DO | 1 |
| Fisher, DA; Hsu, LY; Koh, TH; Koh, YL; Krishnan, P; Lin, RT; Loomba-Chlebicka, N; Tan, TY; Tee, NW | 1 |
| Chatterjee, I; Iredell, JR; Lipman, J; Woods, M | 1 |
| Hornillos Calvo, M; Pareja Sierra, T | 1 |
| Pea, F; Viale, P | 1 |
| de Bruin, MA; Riley, LW | 1 |
| Abella, A; Alía, I; Aranguren, A; Cerdá, E; de la Cal, MA; García-Hierro, P; Lorente, JA; van Saene, HK | 1 |
| Sunakawa, K | 1 |
| Marik, PE; Salerno, D; Vahid, B | 1 |
| Estes, L; Orenstein, R | 1 |
| Lyles, A | 1 |
| Fujita, N; Hashimoto, S; Kato, Y; Nomura, M; Okayama, Y; Shime, N; Yamagishi, M | 1 |
| Bauer, F; Benca, J; Beno, P; Huttova, M; Kisac, P; Kovac, M; Ondrusova, A; Rudinsky, B; Sramka, M | 1 |
| Blix, HS; Røed, J; Sti, MO | 1 |
| Fong, YT; Koh, D; Koh, TH; Kurup, A; Lee, HY; Lim, MK; Yang, KS | 1 |
| Estes, L; Orenstem, R | 1 |
| Pakyz, A | 1 |
| Camargo, LF; Correa, L; Junior, MS; Marra, AR; Pereira, CA | 1 |
| Doherty, JA; Isakow, W; Jeffres, MN; Kollef, MH; Micek, ST | 1 |
| Abrahamsen, TG; Anderson, AS; Flaegstad, T; Klingenberg, C; Otto, M; Rønnestad, A; Sollid, JE; Villaruz, A; Zorman, J | 1 |
| Adams-Huet, B; Hall, RG | 1 |
| Paterson, DL; Potoski, BA | 1 |
| Bédos, JP; Moine, P | 1 |
| Hwang, GY; Jang, IH; Kim, HY; Kwon, O; Uh, Y; Yoon, KJ | 1 |
| Linden, PK | 2 |
| Cataldo, MA; Tacconelli, E | 1 |
| Jayashree, M; Mathew, JL; Ray, P; Singhi, S | 1 |
| Le, J; Lieberman, JM; McKamy, S; Nguyen, T; Okamoto, M | 1 |
| Baysan, BO; Colak, D; Ergani-Ozcan, A; Inan, D; Naas, T; Nordmann, P; Ogunc, D | 1 |
| Ament, A; Broex, E; Deurenberg, RH; Gordts, B; Nulens, E; Scheres, J; Smeets, E; Stobberingh, EE; van Tiel, FH | 1 |
| Rehm, SJ | 1 |
| Halsey, J | 1 |
| Scheurer, D | 1 |
| Al-Nassir, WN; Donskey, CJ; Li, Y; Pultz, MJ; Riggs, MM; Sethi, AK | 1 |
| Aguilar, L; Barberán, J; Giménez, M; Prieto, J | 1 |
| Kollef, MH; Nathwani, D; Rubinstein, E | 1 |
| Booth, JM; Doyle, AE; Louis, WJ; McNeil, JJ; Morris, P; Proudfoot, AD; Tosolini, FA | 1 |
| Lamont, JT; Trnka, YM | 1 |
| Kucers, A | 1 |
| Bauchet, J; Faurisson, F; Garaud, JJ; Inglebert, F; Regnier, B; Vachon, F | 1 |
| Connolly, MG; Craven, DE; Hsieh, CR; Kollisch, NR; McCabe, WR | 1 |
| Limon, L; Norris, SM | 1 |
| Chew, WH; Lockman, DS; Rissing, JP | 1 |
| Campelli, A; Di Noto, C; Fabbri, A; Ferraris, R; Mantero, E; Nahum, M | 1 |
| Baumgart, S; Campos, JM; Hall, SE; Polin, RA | 1 |
| Brabyn, DG; Chance, GW; Han, VK; Sayed, H; Shaheed, WA | 1 |
| Linnemann, CC; Myers, JP | 1 |
| Brady, L; Harkness, JL; King, K; Thomson, M | 1 |
| Hurse, A; McDonald, M; Sim, KN | 1 |
| Harvey, K; McDonald, M; Ward, P | 1 |
| McDonald, PJ | 1 |
| Andrew, J; Asche, V; Carson, P; Collopy, B; Davidson, A; Douglas, D; Gilbert, G; Harvey, K; Hewstone, A; Pavillard, R; Spicer, J; Tosolini, F | 1 |
| Douglas, DK; Westwood, G | 1 |
| Brown, WJ; Cushing, RD; Jui, J; Levine, DP | 1 |
| Burdon, DW | 1 |
| Fekety, R; Kim, KH; Silva, J; Toshniwal, R | 1 |
| Lamer, C; LeGuillou, JL; Letournel, E; Letournel-Glomaud, C; Moulinié, JP | 1 |
| Bartholomew, WR; Goldstein, E; Parr, T; Vickers, MK | 1 |
| Hryniewicz, W; Trzciński, K; Tyski, S; Zareba, T | 1 |
| Betschel, S; Kreiswirth, B; Low, DE; Willey, BM | 1 |
| Casewell, MW | 1 |
| Arduino, MJ; Banerjee, S; Bland, LA; Jarvis, WR; Maloney, SA; Montecalvo, M; Shay, DK; Wormser, GP | 1 |
| Badoual, J; Bergeret, M; Bingen, E; Brahimi, N; Doit, C; Gendrel, D; Raymond, J | 1 |
| Cameron, SB; Dunn, DL; Ferrieri, P; Juni, BA; Mason, KR; Rhame, FS; Wells, CL | 1 |
| Dowling, TC; Hebden, JN; Jarvis, W; Johnson, JA; McCarter, RJ; Morris, JG; Perdue, BE; Polish, LB; Schwalbe, RS; Shay, DK | 1 |
| Edmond, MB; Hwang, T; Ober, JF; Pfaller, MA; Sanford, MD; Weinbaum, DL; Wenzel, RP | 1 |
| Gerding, DN; Lee, JT; Olson, MM; Shanholtzer, CJ | 1 |
| Isenberg, HD; Lam, S; Morthland, VH; Pfaller, MA; Singer, C; Tucci, V | 1 |
| Yokota, K | 1 |
| Aubertin, J; Brunet, F; Charbonneau, P; Domart, Y; Garaud, JJ; Harding, I | 1 |
| Bartlett, JG; Froggatt, JW | 1 |
| Demling, L; Stoll, R | 1 |
| Clem, JR | 1 |
| Borton, D | 1 |
| Deveney, CW; Deveney, KE; Grasley, A; Jobe, BA; Sheppard, BC | 1 |
| Goldmann, DA; Jarvis, WR; Shay, DK | 1 |
| Larsson, C | 1 |
| Bates, J; Griffiths, DT; Jordens, JZ | 1 |
| Ford, M; Gould, FK; Morgan, S; Morrison, D; Orr, KE; Perry, JD; Sisson, PR | 1 |
| Chadwick, PR; Oppenheim, BA | 1 |
| Cartmill, TD; Keith, E; McCann, DC; Nice, CN; Panigrahi, H; Worsley, MA | 1 |
| Paramore, CG; Turner, DA | 1 |
| Boyce, JM; Carias, LL; Fraimow, H; Giorgio, C; Green, M; Marshall, SH; Medeiros, AA; Mermel, LA; Thorisdottir, AS; Zervos, MJ | 1 |
| Boyce, JM; Chow, JW; Fortna, S; Medeiros, AA; Opal, SM; Potter-Bynoe, G; Romulo, RL; Sherman, CB; Zervos, MJ | 1 |
| Haney, PE; Hernandez, JM; Horner, JS | 1 |
| Cheong, I; Rahman, MZ; Tan, SC; Wong, YH; Zainudin, BM | 1 |
| Grota, P; Hernandez, J; Patterson, JE; Ross, KA; Sanchez, RO | 1 |
| Eisner, W; Faur, Y; Frieden, TR; Kreiswirth, B; Low, DE; Munsiff, SS; Warren, S; Willey, BM; Williams, G | 1 |
| Bates, J; Jordens, Z; Selkon, JB | 1 |
| Biavasco, F; De Sio, G; Maffei, C; Manso, E; Sambo, G; Varaldo, PE | 1 |
| Natori, H; Oizumi, K; Tanaka, K; Tokunaga, N | 1 |
| Can, G; Coban, A; Ince, Z; Ozgeneci, A; Uçsel, R | 1 |
| Swartz, MN | 1 |
| Cuadros, JA; Ena, J; Gómez-Herruz, P; González-Palacios, R; Romanyk, JP; Valls, V | 1 |
| Jacobs, NF | 1 |
| Wood, CA | 1 |
| Chow, JW; Green, M; Kuritza, A; Sahm, DF; Shlaes, DM; Zervos, MJ | 1 |
| Baillie, LW; Casewell, MW; Wade, JJ | 1 |
| Feldt, K; Williams, CO | 1 |
| Altarac, D; Handwerger, S; Marchione, S; Monka, J; Murray, BE; Raucher, B; Singh, KV; Walters, B; Wolff, J | 1 |
| Altirriba Valls, O; Andreu Duat, MD; Demestre Guasch, X; Farré Riba, R; Ginovart Galiana, G; Mangues Bafalluy, A; Raspall Torrent, F | 1 |
| Hayashi, K | 1 |
| Anglada, AM; Ceriani Cernadas, JM | 1 |
| Boyle, JF; Gianarkis, DG; Herrington, JA; Painter, BG; Rendo, A; Soumakis, SA; Thurberg, BE | 1 |
| Edmond, MB; Pasculle, AW; Wenzel, RP | 1 |
| Blackmore, TK; Gordon, DL; Heath, CH | 1 |
| Goossens, H; Gordts, B; Ieven, M; Van Landuyt, H; Vandamme, P | 1 |
| Boyce, JM; Giorgio, C; Medeiros, AA; Mermel, LA; Potter-Bynoe, G; Rice, LB; Zervos, MJ | 1 |
| Hagman, HM; Strausbaugh, LJ | 1 |
| Jarvis, WR; Maloney, SA; Montecalvo, MA; Patel, P; Shay, DK; Tacsa, L; Wormser, GP | 1 |
| Boyce, JM | 3 |
| Carraher, M; Chung, M; de Lencastre, H; Gedris, C; Montecalvo, MA; VanHorn, K; Wormser, GP | 1 |
| Dilmen, U; Gamberzade, S; Kaya, IS; Kitapci, F; Senses, DA; Toppare, MF | 1 |
| Burns, LA | 1 |
| Fraimow, HS; Shlaes, DM | 1 |
| Dembry, LM; Uzokwe, K; Zervos, MJ | 1 |
| Andremont, A; Barbier, N; Chachaty, E; Dumontier, S; Saulnier, P | 1 |
| Drgona, L; Krcmery, V; Kukuckova, E; Lacka, J; Oravcova, E; Trupl, J | 1 |
| Dembry, LM; Farrel, P; Tallapragada, S; Weinstein, JW | 1 |
| Kjerulf, A; Pallesen, L; Westh, H | 1 |
| Cox, TR | 1 |
| Franklin, C; Hayden, MK; Hu, TC; Matushek, M; Nathan, C; Rice, T; Slaughter, S; Van Voorhis, J; Weinstein, RA | 1 |
| Corey, GR; Roe, M; Sanders, L; Sexton, DJ; Thorpe, JJ; Towns, M; Weinstein, JW | 1 |
| Brunton, J; Campbell, I; Conly, J; Dedier, H; Garcia, M; Gillis, G; Hockin, J; Humar, A; Jolley, BA; Kennedy, C; Lior, L; Litt, M | 1 |
| Melhus, A; Tjernberg, I | 1 |
| Bandy, U | 1 |
| Ang, SW; Lee, ST; Seah, CS | 1 |
| Gedris, CA; Rodney, KM; van Horn, KG | 1 |
| Dobbin, KR; Dunworth, BA | 1 |
| French, GL; Issack, MI; Power, EG | 1 |
| Chadwick, PR; Elliot, J; Joseph, LA; Keaney, MG; Rowland, P | 1 |
| Barton, AL; Doern, GV | 1 |
| Barie, PS; Bohnen, JM; Davis, JM; Fichtl, RE; Gadaleta, D; Huycke, MM; Wells, CL | 1 |
| Gold, HS; Moellering, RC | 1 |
| Culver, D; Danzing, L; Edwards, J; Gaynes, R; Stroud, L | 1 |
| Goldmann, DA | 2 |
| Gielerak, P; Jarvis, WR; Jochimsen, EM; Singer, DA | 1 |
| Atwood, E; Burney, S; Ditore, V; Huang, W; Kreiswirth, B; Landman, D; Oydna, E; Patel, K; Quale, J; Saurina, G; Willey, BM; Zaman, M | 1 |
| Glatt, AE; Thakor, K | 1 |
| Emre, S; Lou, W; Mendelson, MH; Meyers, BR; Meyers, J; Miller, C; Papanicolaou, GA; Sheiner, P | 1 |
| Coque, TM; Murray, BE; Okhyusen, PC; Ricke, SC; Tomayko, JF | 1 |
| Chadwick, PR; Fox, A; Morgenstern, GR; Oppenheim, BA; Scarffe, JH; Woodford, N | 1 |
| Bradley, CR; Fraise, AP | 1 |
| Fraise, AP | 2 |
| Bonten, MJ; Hayden, MK; Matushek, M; Nathan, C; Rice, T; Slaughter, S; van Voorhis, J; Weinstein, RA | 1 |
| Goldmann, DA; Huskins, WC | 1 |
| Davis, JM; Hong, J | 1 |
| Lipsett, PA; Mainous, MR; O'Brien, M | 1 |
| Kolokithas, D; Ojo, F; Rao, GG | 1 |
| Keane, CT; Lavery, A; Morrison, D; Power, A; Rossney, AS | 1 |
| Wade, JJ | 1 |
| Archibald, L; Gaynes, R; McGowan, JE; Monnet, D; Phillips, L; Tenover, F | 1 |
| Rutala, WA; Weber, DJ | 1 |
| Landman, D; Quale, JM; Saurina, G | 1 |
| Biavasco, F; Lupidi, R; Manso, E; Miele, A; Varaldo, PE; Vignaroli, C | 1 |
| Bateman, AC; Cookson, B; Elliott, TS; Hastings, JG; Johnson, AP; Morrison, D; Woodford, N | 1 |
| de Lencastre, H; Mato, R; Roberts, RB; Tomasz, A | 1 |
| de Lencastre, H; Kreiswirth, BN; Roberts, RB; Severina, EP; Tomasz, A | 1 |
| Ford, DS; Hibberd, PL; Hooper, DC; Pegues, CF; Pegues, DA | 1 |
| Anglim, AM; Byers, KE; Farr, BM; Klym, B; Scheld, WM | 1 |
| Cooke, RP; Cookson, BD; Kaufmann, ME; Morrison, D; Stephenson, J | 1 |
| Hunter, MP; Richards, GA | 1 |
| Lai, KK | 1 |
| Bhat, KG; Bhat, MG; Paul, C | 1 |
| Gutmann, L; Michel, M | 1 |
| Chadwick, C; Molyneux, R | 1 |
| Fredlund, H; Myhre, EB; Sjöberg, L; Sundsfjord, A; Torell, E; Törnquist, E | 1 |
| Klare, I; Witte, W | 1 |
| Allerberger, F; Dierich, MP; Haas, G; Hirschl, AM; Klare, I; Lass-Flörl, C; Presterl, E; Witte, W | 1 |
| Genoni, M; Künzli, A; Niederhäuser, U; Turina, MI; Vogt, M; Vogt, P | 1 |
| Leaver, M | 1 |
| Leclercq, R | 1 |
| Cheadle, WG; Fabian, T; Fry, DE; Gardner, SA; Kesterson, L; Livingston, DH; Malangoni, MA; Polk, HC; Trachtenberg, LS | 1 |
| Braveny, I; Cremer, J; Elsner, E; Milatovic, D; Wallrauch, C | 1 |
| Haran, MA; Isenberg, HD; Tucci, V | 1 |
| Cetron, MS; Crane, GL; Finelli, L; Jarvis, WR; Paul, SM; Tokars, JI | 1 |
| Coffman, SL; Edmund, MB; Jones, RN; Marshall, SA; Pfaller, MA; Wenzel, RP; Wilke, WW | 1 |
| Morris, JG; Qaiyumi, S; Roghmann, MC; Schwalbe, R | 1 |
| Chadwick, PR; Cookson, BD; Morrison, D; Woodford, N | 1 |
| Nelson, RR | 2 |
| Carmeli, Y; Kawachi, C; Lichtenberg, D; Samore, M; Saubermann, L | 1 |
| Hirakata, Y; Izumikawa, K; Kaku, M; Kamihira, S; Koga, H; Kohno, S; Matsuda, J; Tomono, K; Yamada, Y; Yamaguchi, T | 1 |
| Baker, S; Fontecchio, SA; Kelley, AL; Lai, KK; Melvin, ZS | 1 |
| Hinkle, C; Porwancher, R; Remphrey, S; Sheth, A; Taylor, E; Zervos, M | 1 |
| Buiting, AG; Endtz, HP; Kluytmans, JA; Koeleman, JG; Spanjaard, L; van Belkum, A; van den Braak, N; van Duin, A; Vandenbroucke-Grauls, CM; Verbrugh, HA; Voss, A; Weersink, AJ | 1 |
| Bobrowska, M; Ramotar, K; Shymanski, J; Toye, B; Woods, W | 1 |
| Nordhaus-Bike, AM | 1 |
| Messick, CR; Pendland, SL | 1 |
| Warnick, F | 1 |
| Eliopoulos, GM | 1 |
| Cookson, B; Morrison, D; Woodford, N | 1 |
| Cran, M; Duff, Z; Gill-Morton, P; Main, S; Mercer, J; Robinson, K | 1 |
| Edmond, MB; Jones, RN; Marshall, SA; Pfaller, MA; Wenzel, RP | 1 |
| Jones, RN; Marshall, SA; Pfaller, MA | 1 |
| Breatnach, F; Butler, K; Byrne, C; Clarke, A; Kaufmann, M; Murphy, H; Nourse, C; O'Meara, A | 1 |
| Lloyd, S; Lundstrom, TS | 1 |
| China, C; Dever, LL; Eng, RH; Johanson, WG; O'Donovan, C | 1 |
| Sheff, B | 1 |
| Baier, RJ; Bocchini, JA; Brown, EG | 1 |
| Brown, AE; Chung, M; De Lencastre, H; McNeeley, DF; Noel, GJ | 1 |
| Appleton, D | 1 |
| Ananthakrishna, NC; Bhat, KG; Paul, C | 1 |
| Flexner, CW; Lechtzin, N; Lucas, GM; Moore, RD; Puryear, DW; Yau, LL | 1 |
| Adal, KA; Anglim, AM; Byers, KE; Durbin, LJ; Farr, BM; Simonton, BM | 1 |
| Ambergen, AW; Bonten, MJ; Hayden, MK; Nathan, C; Slaughter, S; van Voorhis, J; Weinstein, RA | 1 |
| Brooks, S; Friedeman, L; Griffith, J; Hameed, R; Khan, A; Mukherji, R; Schupf, N; Stoica, D | 1 |
| d'Halewyn, MA; Fortin, A; Guay, M; Leblanc, G; Milord, F; Vigeant, P | 1 |
| Iwen, PC; Olson, SB; Rupp, ME; Smith, TL | 1 |
| f1ossley, K | 1 |
| Edmond, MB; Wenzel, RP | 1 |
| French, GL | 1 |
| Fujita, N; Ike, Y; Komori, T; Yoshimura, M | 1 |
| Fleer, A; Krediet, TG | 1 |
| Chiorazzi, N; Farber, BF; Schiller, B | 1 |
| Brady, JP; Hasbargen, JA; Snyder, JW | 1 |
| Martone, WJ | 1 |
| Goossens, H | 1 |
| Alshab, D; Chow, JW; Clewell, DB; Dembry, L; Donabedian, S; Robinson-Dunn, B; Thal, L; Zervos, MJ | 1 |
| Hollis, RJ; Kruszynski, JA; Noskin, GA; Peterson, LR; Pfaller, MA; Savor, C | 1 |
| McGowan, JP | 1 |
| Belliveau, PP; Fontecchio, SA; Kelley, AL; Lai, KK; Melvin, ZS | 1 |
| Fisher, MC | 1 |
| Haase, G; Lütticken, R; Peltroche-Llacsahuanga, H | 1 |
| Easterbrook, PJ | 1 |
| Amyes, SG; Brown, AR; Miles, RS; Paton, R; Plant, WD; Stevenson, GM; Winney, RJ | 1 |
| Goodwin, CW; McManus, AT; Pruitt, BA | 1 |
| Thomas, JR | 1 |
| Altamirano-Dimas, M; Bryce, EA; Gribble, M; Isaac-Renton, JL; Noble, MA; Roberts, FJ; Roscoe, DL; Scharf, S; Walker, M; Walsh, A | 1 |
| Colvin, LG; Fuller, RE; Harrell, LJ; Meredith, FT; Sexton, DJ | 1 |
| Goetz, AM; Muder, RR; Rihs, JD; Wagener, MM | 1 |
| Christenson, JC; Daly, JA; Jenkins, E; Korgenski, EK | 1 |
| Cole, MF; Evans, MK; Pearce, CL; Peters, SM | 1 |
| Hayden, MK; Kim, WJ; Weinstein, RA | 1 |
| Digranes, A; Gaustad, P; Haarr, E; Harthug, S; Høiby, EA; Langeland, N; Natås, OB; Olsvik, O; Simonsen, GS; Sundsfjord, A; Svarva, PL | 1 |
| Conner-Kerr, TA; Franklin, ME; Gaillard, J; Jones, RM; Sullivan, PK | 1 |
| Bonten, MJ; Hayden, MK; Nathan, C; Slaughter, S; van Voorhis, J; Weinstein, RA | 1 |
| Joly-Guillou, ML | 1 |
| Igari, J; Nakamura, A; Oguri, T; Tabe, Y | 1 |
| Campos, JM; Patel, KM; Pikis, A; Singh-Naz, N; Sleemi, A | 1 |
| Bensoussan, R; Laverdiere, M; Weiss, K | 1 |
| Fleenor-Ford, A; Hayden, MK; Weinstein, RA | 1 |
| Corey, GR; Fowler, VG; Gottlieb, GS; Harrell, LJ; Kong, LK; Li, J; McClelland, RS; Roussakis, G; Ryan, T; Sanders, LL; Sexton, DJ | 1 |
| Bronk, M; Hellmann, A; Kur, J; Samet, A | 1 |
| Fontecchio, SA; Kelley, AL; Lai, KK; Melvin, ZS | 1 |
| Baker, R; Fish, L; Jarvis, WR; Jochimsen, EM; Manning, K; Singer, DA; Young, S | 1 |
| Andersen, BM; Digranes, A; Harthug, S; Jacobsen, T; Lingaas, E; Natås, OB; Olsvik, O; Ringertz, SH; Simonsen, GS; Skulberg, A; Sundsfjord, A; Syversen, G | 1 |
| Anderson, RM; Austin, DJ | 1 |
| Barrett, SP; Cookson, BD; Morrison, D; Sisson, P; Woodford, N | 1 |
| Fukayama, M | 1 |
| Garrett, DO; Hill, B; Jarvis, WR; Jochimsen, E; Johnston, J; McAllister, S; Murfitt, K; Nelson, P; Sall, RK; Spera, RV; Tenover, FC; Zimmer, B | 1 |
| Arduino, MJ; Carson, L; Jarvis, WR; Killum, E; Marston, B; Miller, ER; Rimland, D; Satake, S; Sinkowitz-Cochran, RL; Tenover, FC; Tokars, JI | 1 |
| Watson, T | 1 |
| Pugliese, G | 1 |
| Gorman, C | 1 |
| Simmons, J | 1 |
| Iakovlev, SV | 1 |
| Bertolatti, D; Coombs, GW; Grubb, WB; Kay, ID; Pearman, JW; Steven, RA | 1 |
| Carnevale, KA; Dweck, HS; Gedris, C; Levi, MH; Li, K; Malik, RK; Maw, M; Montecalvo, MA; Munoz, JL; Reale, MR; van Horn, K | 1 |
| Jayaratne, P; Rutherford, C | 1 |
| Armstrong-Evans, M; Blacklock, A; Cann, D; Gould, R; Liska, S; Litt, M; Low, DE; McArthur, MA; McGeer, A; Nusinowitz, S; Willey, B | 1 |
| Bilker, WB; Brennan, PJ; Lautenbach, E | 1 |
| Greenaway, CA; Miller, MA | 1 |
| Anderson, RM; Austin, DJ; Bonten, MJ; Slaughter, S; Weinstein, RA | 1 |
| Swanston, WH | 1 |
| Andrews, J; Ashby, J; Jevons, G; Lines, N; Wise, R | 1 |
| Kantzanou, M; Legakis, NJ; Tassios, PT; Tseleni-Kotsovili, A; Vatopoulos, AC | 1 |
| Bartlett, ST; Keay, S; McCarter, RJ; Morris, JG; Oldach, DW; Pfundstein, J; Qaiyumi, SQ; Roghmann, MC; Schwalbe, RS; Schweitzer, E | 1 |
| Evans, ME; Millheim, ET; Rapp, RP | 1 |
| Aguero, SM; Arduino, MJ; Banerjee, SN; Carson, LA; Hill, BC; Jarvis, WR; Kuehnert, MJ; Quirk, SB; Trick, WE | 1 |
| D'Agata, EM; DeGirolami, PC; Gold, HS; Ostrowsky, BE; Samore, MH; Venkataraman, L | 1 |
| Bauters, F; Courcol, RJ; Husson, MO; Savage, C; Trivier, D | 1 |
| Cho, SR; Lee, HK; Lee, WG | 1 |
| Filka, J; Huttova, M; Kralinsky, K; Krcmery, V; Sagat, T; Tuharsky, J | 1 |
| Armstrong, D; Brown, AE; Chung, M; de Lencastre, H; Tomasz, A | 1 |
| Culver, DH; Edwards, JR; Fridkin, SK; Gaynes, RP; McGowan, JE; Pichette, SC; Pryor, ER; Tenover, FC | 1 |
| Wenzel, RP; Wong, MT | 1 |
| Gedris, C; Horowitz, HW; Jarvis, WR; Montecalvo, MA; Petrullo, C; Rodney, K; Shay, DK; Uman, J; Wormser, GP | 1 |
| Bacci, S; Bosi, A; Fanci, R; Guidi, S; Laszlo, D; Rossi-Ferrini, P; Saccardi, R; Vannucchi, AM | 1 |
| Cieslak, PR; Fleming, DW; Ling, JM; Strausbaugh, LJ | 1 |
| Ferguson, JK | 1 |
| Abbott, M; Aberline, M; Grabsch, EA; Grayson, ML; Hogg, G; Johnson, PD; Kerr, PG; Li, HY; Olden, D | 1 |
| Coutlée, F; Faucher, MC; Forest, P; Roger, M; St-Antoine, P | 1 |
| Jacobson, AF; Winslow, EH | 1 |
| Gibbons, N; Krumins, I | 1 |
| Kolho, E; Salmenlinna, S; Suppola, JP; Tarkka, E; Vaara, M; Vuopio-Varkila, J | 1 |
| Armstrong-Evans, M; Capretta, G; Loeb, M; Olde, J; Salama, S | 1 |
| Delacour, JL; Elcadi, T; Floriot, C; Lancrenon, C; Tiberghien, F | 1 |
| Chang, SC; Chen, YC; Ho, SW; Hsueh, PR; Luh, KT; Pan, HJ; Teng, LJ; Wang, LH | 1 |
| D'Agata, EM; Green, K; Haas, DW; Schaffner, W; Schulman, G | 1 |
| Bordessoule, D; Denis, F; Gambarotto, K; Grélaud, C; Martin, C; Ploy, MC; Turlure, P | 1 |
| Carmeli, Y; Huskins, C; Samore, MH | 1 |
| Anholm, JD; Cheadle, WG; Fabian, TC; Fagon, J; Falcone, RE; Gibert, C; Haas, DW; Lilienthal, F; Paganin, F; Patrick, H; Torres, A | 1 |
| Barbarini, D; Carretto, E; Emmi, V; Marone, P; Marzani, FC; Poletti, F | 1 |
| Ballow, CH; Bhavnani, SM; Biedenbach, DJ; Deinhart, JA; Drake, JA; Forrest, A; Jones, RN | 1 |
| Orrett, FA | 1 |
| Roghmann, MC | 1 |
| Iacuzio, L; Sarnataro, C; Villari, P | 1 |
| Barrington, KJ; Craft, AP; Finer, NN | 1 |
| Chesneau, O; Morvan, A; Solh, NE | 1 |
| Arce, E; Gil, M; Lizama, V; Otth, L; Wilson, M; Zaror, A | 1 |
| Simmons, JC | 1 |
| Goldwirth, M; Krasin, E; Otremski, I | 1 |
| Fridkin, SK; Gaynes, RP; Hubert, SK; Lawton, R; McGowan, JE; Steward, CD; Tenover, FC; Wallace, D | 1 |
| Cross, JM; May, AK; McGwin, G; Melton, SM; Moser, SA; Rue, LW | 1 |
| Allouch, PY; Bedos, JP; Etienne, J; Marliere, C; Pina, P; Vandenesch, F | 1 |
| Buescher, ES; Karlowicz, MG; Surka, AE | 1 |
| D'Agata, EM; Green, WK; Li, H; Schaffner, W; Schulman, G; Tang, YW | 1 |
| Bouza, E; Graninger, W; Schaison, G | 1 |
| Basso, M; Costa, SF; Levin, AS; Newbaer, M; Santos, CR; Soares, I | 1 |
| Allum, AG; Digranes, A; Harthug, S; Hope, O; Kristiansen, BE; Langeland, N | 1 |
| Cammarata, S; Oliphant, T; Rubinstein, E; Wunderink, R | 1 |
| Dusé, AG; Ferraz, V; von Gottberg, A | 1 |
| Bonten, MJ; Gaillard, C; Homan, W; Manzioros, X; Mascini, EM; Top, J; Tribe, D; van Embden, JD; van Kregten, E; van Santen-Verheuvel, M; Vandenbroucke-Grauls, CM; Willems, RJ | 1 |
| Corpuz, M; Kamath, RP; Norkus, EP; Pitchumoni, CS; Poduval, RD | 1 |
| Goldmann, DA; Grohskopf, LA; Jarvis, WR; Maki, DG; Sinkowitz-Cochran, RL; Sohn, AH | 1 |
| Chitnis, D; Chitnis, V; Hemwani, N; Joshi, S; Verma, S | 1 |
| Ammendolia, MG; Baldassarri, L; Bertuccini, L; Creti, R; Gherardi, G | 1 |
| Gadba, R; Ofir, O; Samra, Z | 1 |
| Courval, JM; Edwards, JR; Fridkin, SK; Gaynes, RP; Hill, H; Lawton, R; McGowan, JE; Tenover, FC | 1 |
| Servais, H; Tulkens, PM | 1 |
| Embon, E; Katz, D; Levin, Y; Mishal, J; Sherer, Y | 1 |
| Peetermans, WE; Rijnders, BJ; Van Eldere, J; Van Wijngaerden, E | 1 |
| Gross, PA; Pujat, D | 1 |
| Cui, L; Dell'Aquila, AM; Gomes, MS; Hiramatsu, K; Levy, CE; Mamizuka, EM; Masiero, RL; Oliveira, GA | 1 |
| Horowitz, HW; Jarvis, WR; Montecalvo, MA; Petrullo, C; Shay, DK; Uman, J; Wormser, GP | 1 |
| Holmes, AH; Knox, KL | 1 |
| Blanco, MT; Gómez-García, AC; Hurtado, C; Morán, FJ; Pérez-Giraldo, C; Sánchez-Silos, RM | 1 |
| Jin, D; Wu, H; Wu, Z; Xu, J | 1 |
| Bonten, MJ; Weinstein, RA; Willems, R | 1 |
| Hachem, R; Hanna, H; Husni, R; Raad, I | 1 |
| Bonten, M; Mascini, E; Ridwan, B; van Der Reijden, N; Verhoef, J | 1 |
| Jog, SM; Patole, SK | 1 |
| Gottlieb, T; Leroi, MJ; Siarakas, S | 1 |
| Bouvet, A; Gerbal, R; Marie, JP; Ombandza-Moussa, E; Schlegel, L; Vekhoff, A | 1 |
| Chenoweth, CE; Dyke, DB; Malani, PN; Pagani, FD | 1 |
| Anglim, AM; Anneski, CJ; Byers, KE; Farr, BM | 1 |
| Arbuckle, RB; Hanna, HA; Osting, CA; Raad, II; Shaikh, ZH; Tarr, JJ | 1 |
| Bischoff, T; Climo, M; Edmond, MB; Ostrowsky, B; Tallent, SM; Wenzel, RP | 1 |
| Edwards, JR; Fridkin, SK; Gaynes, RP; Hill, HA; Lawton, RM; McGowan, JE; Volkova, NV | 1 |
| Edwards, JR; Fridkin, SK; Gaynes, RP; Lawton, R; McGowan, JE; Tenover, FC | 1 |
| Block, JB; Cusack, N; Fortner, CL; Greene, WH; Schimpff, SC; Wiernik, PH; Young, VM | 1 |
| Masuda, H; Nagahama, K; Nagamatsu, H; Negishi, T; Yamada, T | 1 |
| Cercenado, E; Eliopoulos, G; Isenberg, HD; Rubin, LG; Tucci, V | 1 |
| Bonadio, M; Maccanti, O | 1 |
| Watanabe, A | 1 |
| Bettin, KM; Clabots, CR; Gerding, DN; Homann, SR; Johnson, S; Peterson, LR; Quick, JN | 1 |
| Dai, L; Xiang, Y | 1 |
| Gortner, L; Möller, JC; Nachtrodt, G; Richter, A; Tegtmeyer, FK | 1 |
| Chen, HY; Hall, LM; Williams, RJ | 1 |
| Spencer, RC; Wilcox, MH | 1 |
| George, RC; Morris, KJ; Rao, GG; Woodford, N | 1 |
| Emmerson, AM; Garau, J | 1 |
| Acher, CW; Bohn, MJ; Kroncke, GM; Maki, DG; Myerowitz, PD; Stolz, SM | 1 |
| Matsumoto, K; Takahashi, A | 1 |
| Akutsu, M; Iwai, S; Kato, K; Kunimatsu, M; Sato, T; Tanaka, H; Tanaka, T | 1 |
| Alonso, T; Liñares, J; Pérez, JL | 1 |
| Gaynes, R; Hill, BC; Josephson, A; Karanfil, LV; Mandel, L; Murphy, M; Swenson, JM | 1 |
| Dias, S; Kaye, D; Levison, ME; Livornese, LL; May, P; Pitsakis, P; Romanowski, B; Samel, C; Taylor, S; Woods, G | 1 |
| Shimada, K | 1 |
| Garau, J; Lite, J; Ortega, L | 1 |
| Casewell, MW; Desai, N; Wade, JJ | 1 |
| Bingen, EH; Denamur, E; Elion, J; Lambert-Zechovsky, NY | 1 |
| Ish-Horowicz, MR; McIntyre, P; Nade, S | 1 |
| Luikart, SD; Morrison, VA; Weinshel, EL | 1 |
| Cafferkey, MT; Carroll, JD; Coleman, DC; Humphreys, H; Keane, CT; Pomeroy, HM | 1 |
| Coll, PP; O'Connor, PJ | 1 |
| Matsumoto, K; Nagatake, T | 1 |
| Kanno, H | 1 |
| Epstein, MF; Freeman, J; Goldmann, DA; Platt, R; Sidebottom, DG; Smith, NE | 1 |
| Riggs, D; Santeiro, M; Weathers, L; Weibley, RE | 1 |
| Joyce, FS; Szczepanski, KP | 1 |
| Collins, CH; Fitch, LE; George, RC; Gilfillan, AJ; Heptonstall, J; Johnson, AP; Morrison, D; Naidoo, J; Uttley, AH; Woodford, N | 1 |
| Berkowitz, I; Sacho, H; Strimling, MO | 1 |
| Berry, AJ; Ludlam, HA; Phillips, I; Young, AE | 1 |
| Bhana, RH; Coovadia, YM; Haffejee, I; Johnson, AP; Marples, RR | 1 |
| Fogarty, KA; McClain, WJ | 1 |
| Calver, GP; Hall, SM; Williams, M | 1 |
| Beattie, T; Cafferkey, MT; Fitzpatrick, DJ; Keane, CT; Toner, M | 1 |
| Cheng, AF; French, GL | 1 |
| John, JF; Levkoff, AH; Reboli, AC | 1 |
| Ehni, WF; Reller, LB | 1 |
| Kunihiro, M; Nakamura, I; Unoki, T | 1 |
| Cooper, GL; Gennery, BA | 1 |
| Banssillon, V; Carry, PY; Chomarat, M; Flandrois, JP; Grozel, JM; Lepape, A; Perdrix, JP | 1 |
| Cox, CE; Grad, C; McCabe, RE | 1 |
| Avesani, V; Delmée, M; Michaux, JL; Vandercam, B | 1 |
| Peacock, JE | 1 |
| Shanson, DC | 1 |
| Bitar, CM; Bradshaw, TJ; Dalton, HP; Lamb, VA; Mayhall, CG; Spadora, AC | 1 |
| Aldridge, KE | 1 |
| Arsura, EL; Fazio, RA; Wickremesinghe, PC | 1 |
| Henderson, IS; Leung, AC; McLay, A; Orange, G | 1 |
| Di Caprio, JM; McKee, WM; Roberts, CE; Sherris, JC | 1 |
| Benner, EJ; Kayser, FH | 1 |
| Koenig, MG | 1 |
| Wise, RI | 1 |
| Arditi, LI; Cobbs, CG; Johnson, WD; Kaye, D | 1 |
| Schoutens, E; Yourassowsky, E | 1 |
| Ross, S | 1 |
| Barrett, FF; Casey, JI; Finland, M; Wilcox, C | 1 |
| McKitrick, JC; Plotkin, SA | 1 |
151 review(s) available for vancomycin and Health Care Associated Infection
| Article | Year |
|---|---|
Vancomycin-Resistant Enterococci: Epidemiology, Infection Prevention, and Control.
Topics: Antimicrobial Stewardship; Child; Cross Infection; Drug Resistance, Multiple; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Pediatrics; Vancomycin; Vancomycin-Resistant Enterococci | 2021 |
Hospital-acquired infections caused by enterococci: a systematic review and meta-analysis, WHO European Region, 1 January 2010 to 4 February 2020.
Topics: Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacterial Infections; Hospitals; Humans; Vancomycin; Vancomycin-Resistant Enterococci; World Health Organization | 2021 |
The use of core genome multilocus sequence typing to determine the duration of vancomycin-resistant Enterococcus faecium outbreaks.
Topics: Cross Infection; Disease Outbreaks; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Multilocus Sequence Typing; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
A molecular study regarding the spread of vanA vancomycin-resistant Enterococcus faecium in a tertiary hospital in China.
Topics: Bacterial Proteins; Cross Infection; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Tertiary Care Centers; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
A 600 mg of fixed-dose linezolid in renally impaired patients versus 15 mg/kg intermittent dose-optimized vancomycin in renally non-impaired patients: A single centre retrospective analysis for adult patients with hospital-acquired pneumonia due to methic
Topics: Adult; Anti-Bacterial Agents; Creatinine; Cross Infection; Healthcare-Associated Pneumonia; Hospitals; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Vancomycin | 2023 |
Vancomycin-resistant Enterococcus faecium and the emergence of new sequence types associated with hospital infection.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis.
Topics: Adult; Africa; Americas; Anti-Bacterial Agents; Asia, Southeastern; Bacteremia; Child; Comorbidity; Cross Infection; Europe; Female; Humans; Male; Mediterranean Region; Methicillin-Resistant Staphylococcus aureus; Neoplasms; Observational Studies as Topic; Prevalence; Risk Factors; Staphylococcal Infections; Vancomycin | 2021 |
Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Ceftazidime; Child; Child, Preschool; Cross Infection; Gastrointestinal Tract; Gram-Positive Bacterial Infections; Hospitalization; Humans; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2017 |
Valvular Heart Disease in Adults: Infective Endocarditis.
Topics: Anti-Bacterial Agents; Blood Culture; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Echocardiography; Endocarditis; Endocarditis, Bacterial; Gentamicins; Heart Valve Prosthesis; Humans; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Vancomycin | 2017 |
Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection.
Topics: Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Fecal Microbiota Transplantation; Humans; Randomized Controlled Trials as Topic; Treatment Outcome; Vancomycin | 2017 |
Evidence-Based Practice in the Treatment for Antibiotic-Associated Diarrhea in the Intensive Care Unit.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Critical Care Nursing; Cross Infection; Diarrhea; Evidence-Based Practice; Humans; Intensive Care Units; Proton Pump Inhibitors; Risk Factors; Vancomycin | 2018 |
New and emerging therapies in treatment of Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Fecal Microbiota Transplantation; Humans; Metronidazole; Recurrence; Severity of Illness Index; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2018 |
Risk factors for hospitalized patients with resistant or multidrug-resistant
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Critical Care; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Risk Factors; Vancomycin | 2018 |
Prevention and Treatment of Clostridium difficile Enterocolitis.
Topics: Clostridioides difficile; Colectomy; Cross Infection; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Incidence; Male; Metronidazole; Risk Assessment; Severity of Illness Index; United States; Vancomycin | 2018 |
MRSA colonization status as a predictor of clinical infection: A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; Biomarkers; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Respiratory Tract Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Vancomycin | 2018 |
Antimicrobial-resistant CC17 Enterococcus faecium: The past, the present and the future.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Global Health; Gram-Positive Bacterial Infections; Humans; Vancomycin; Vancomycin Resistance | 2019 |
Clostridium difficile Infection in Children.
Topics: Age Factors; Anti-Infective Agents; Child; Child, Preschool; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Diarrhea; Female; Humans; Incidence; Male; Metronidazole; Prognosis; Risk Assessment; Sex Factors; United States; Vancomycin | 2019 |
Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia; Randomized Controlled Trials as Topic; Staphylococcal Infections; Teicoplanin; Vancomycin | 2013 |
[Antimicrobial therapy of Clostridium difficile infection. Systematic review and meta-analysis of the scientific evidence].
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Metronidazole; Treatment Outcome; Vancomycin | 2013 |
Staphylococcus aureus bacteremia, risk factors, complications, and management.
Topics: Age Distribution; Anti-Bacterial Agents; APACHE; Bacteremia; Community-Acquired Infections; Comorbidity; Contraindications; Cross Infection; Female; Humans; Immunocompromised Host; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mortality; Risk Factors; Sex Distribution; Staphylococcal Infections; Time Factors; Vancomycin; Vancomycin Resistance | 2013 |
[Clostridium difficile infection: epidemiology, disease burden and therapy].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Cost of Illness; Cross Infection; Diarrhea; Drug Costs; Enterocolitis, Pseudomembranous; Health Care Costs; Humans; Hungary; Metronidazole; Public Health; Recurrence; Seasons; Vancomycin | 2013 |
Trends and significance of VRE colonization in the ICU: a meta-analysis of published studies.
Topics: Bacterial Infections; Cross Infection; Enterococcus; Hospitalization; Humans; Intensive Care Units; Prevalence; Vancomycin; Vancomycin Resistance | 2013 |
Vancomycin-resistant enterococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2013 |
Control of the spread of vancomycin-resistant enterococci in hospitals: epidemiology and clinical relevance.
Topics: Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Germany; Gram-Positive Bacterial Infections; Humans; Hygiene; Incidence; Patient Isolation; Prevalence; Risk Factors; Survival Rate; Vancomycin | 2013 |
Clostridium difficile infection in the elderly.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Management; Humans; Metronidazole; Outcome Assessment, Health Care; Prevalence; Risk Factors; Severity of Illness Index; Vancomycin | 2014 |
Methicillin-resistant Staphylococcus aureus enterocolitis sequentially complicated with septic arthritis: a case report and review of the literature.
Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; Bacteremia; Bacterial Typing Techniques; Catheter-Related Infections; Catheters; Clone Cells; Community-Acquired Infections; Cross Infection; Diabetes Mellitus, Type 2; Diagnosis, Differential; Disease Susceptibility; Enterocolitis; Enterocolitis, Pseudomembranous; Equipment Contamination; Evolution, Molecular; Feces; Hip Joint; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Pneumococcal; Shock, Septic; Staphylococcal Infections; Synovial Fluid; Vancomycin | 2014 |
European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cross Infection; Disease Models, Animal; Europe; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Risk Factors; Vancomycin | 2014 |
Vancomycin-resistant enterococci colonization among dialysis patients: a meta-analysis of prevalence, risk factors, and significance.
Topics: Anti-Bacterial Agents; Colony Count, Microbial; Cross Infection; Cross-Sectional Studies; Hospitalization; Humans; Kidney Failure, Chronic; Prevalence; Renal Dialysis; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci | 2015 |
Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia; Randomized Controlled Trials as Topic; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2015 |
Augmented renal vancomycin clearance in cancer patients: a case report and review of the literature.
Topics: Adenocarcinoma; Bacteremia; Combined Modality Therapy; Cross Infection; Disease Progression; Dose-Response Relationship, Drug; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neoplasm Staging; Opportunistic Infections; Pancreatic Neoplasms; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2015 |
Staphylococcus aureus with reduced susceptibility to vancomycin in healthcare settings.
Topics: Anti-Bacterial Agents; Cross Infection; Daptomycin; Hand Hygiene; Humans; Infection Control; Methicillin-Resistant Staphylococcus aureus; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2014 |
The Surgical Management of Complicated Clostridium Difficile Infection: Alternatives to Colectomy.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colectomy; Combined Modality Therapy; Cross Infection; Enema; Humans; Ileostomy; Therapeutic Irrigation; Vancomycin | 2016 |
Treating Central Catheter-Associated Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Beyond Vancomycin.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Catheterization, Central Venous; Cross Infection; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Risk Assessment; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2016 |
Advances in prevention and treatment of vancomycin-resistant Enterococcus infection.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Vancomycin; Vancomycin Resistance | 2016 |
Multidrug-Resistant Enterococcal Infections: New Compounds, Novel Antimicrobial Therapies?
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cell Membrane; Cell Wall; Cross Infection; Depsipeptides; Drug Discovery; Drug Resistance, Multiple, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Models, Animal; Nisin; Vancomycin | 2017 |
Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence.
Topics: Animals; Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Teicoplanin; Vancomycin; Vancomycin Resistance; Virginiamycin | 2017 |
New approaches to prevention of staphylococcal infection in surgery.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Carrier State; Chemoprevention; Chlorhexidine; Cross Infection; Humans; Mupirocin; Patient Isolation; Staphylococcal Infections; Surgical Wound Infection; Vancomycin | 2008 |
Clostridium difficile: a reemerging pathogen.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colectomy; Communicable Diseases, Emerging; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Incidence; Infection Control; Metronidazole; Risk Factors; Vancomycin | 2008 |
[Community-acquired methicillin-resistant Staphylococcus aureus].
Topics: Adolescent; Anti-Bacterial Agents; Australia; Bacterial Proteins; Bacterial Toxins; Child; Combined Modality Therapy; Community-Acquired Infections; Cross Infection; Debridement; Drainage; Europe; Exotoxins; Genomic Islands; Humans; Leukocidins; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Penicillin-Binding Proteins; Species Specificity; Staphylococcal Infections; United States; Vancomycin; Young Adult | 2008 |
[Clostridium-difficile-associated diarrhea].
Topics: Aged; Anti-Bacterial Agents; Bacterial Toxins; Biological Therapy; Clostridioides difficile; Colectomy; Colonoscopy; Combined Modality Therapy; Cross Infection; Diarrhea; DNA, Bacterial; Enterocolitis, Pseudomembranous; Female; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Infant, Newborn; Male; Metronidazole; Probiotics; Recurrence; Risk Factors; Superinfection; Vancomycin | 2009 |
Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Risk Factors; Treatment Outcome; Vancomycin | 2009 |
Clostridium difficile infection in the intensive care unit.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Incidence; Intensive Care Units; Metronidazole; Vancomycin | 2009 |
Treatment options for nosocomial pneumonia due to MRSA.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Vancomycin | 2009 |
The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
Management of methicillin-resistant Staphylococcus aureus pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Humans; Incidence; Infusions, Intravenous; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin | 2010 |
Fidaxomicin: a new macrocyclic, RNA polymerase-inhibiting antibiotic for the treatment of Clostridium difficile infections.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Clinical Trials as Topic; Clostridioides difficile; Cross Infection; DNA-Directed RNA Polymerases; Enterocolitis, Pseudomembranous; Fidaxomicin; Humans; Secondary Prevention; Treatment Outcome; Vancomycin | 2010 |
Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges.
Topics: Anti-Bacterial Agents; Bacteremia; Cross Infection; Disease Management; Endocarditis, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2010 |
Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Education, Medical, Continuing; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Prospective Studies; Randomized Controlled Trials as Topic; Renal Insufficiency; Teicoplanin; Thrombocytopenia; Vancomycin | 2010 |
Diagnosis, management, and prevention of Clostridium difficile infection in long-term care facilities: a review.
Topics: Aged; Anti-Infective Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Equipment Contamination; Humans; Infection Control; Long-Term Care; Metronidazole; Risk Factors; Severity of Illness Index; Vancomycin | 2010 |
Clostridium difficile: an update for the primary care clinician.
Topics: Anti-Infective Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Hand Disinfection; Humans; Metronidazole; Patient Isolation; Primary Health Care; Probiotics; Recurrence; Severity of Illness Index; Vancomycin | 2010 |
Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Cross Infection; Endocarditis; Humans; Livestock; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2011 |
Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Bacterial; Vancomycin | 2010 |
[Linezolid versus vancomycin in the treatment of pneumonia caused by Gram-positive cocci: meta-analysis of randomised controlled trials].
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Gram-Positive Cocci; Humans; Linezolid; Oxazolidinones; Pneumonia, Pneumococcal; Randomized Controlled Trials as Topic; Vancomycin | 2010 |
MRSA: treating people with infection.
Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2010 |
[Update of antimicrobial resistance in Gram-positive microorganisms].
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Daptomycin; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterococcus; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; United States; Vancomycin | 2010 |
Nosocomial MRSA pneumonia: data from recent clinical trials.
Topics: Acetamides; Anti-Infective Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cross Infection; DNA, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Polymerase Chain Reaction; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Vancomycin | 2011 |
Best strategies in recurrent or persistent Clostridium difficile infection.
Topics: Anti-Infective Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Humans; Metronidazole; Probiotics; Secondary Prevention; Vancomycin | 2011 |
Fidaxomicin: first-in-class macrocyclic antibiotic.
Topics: Actinomycetales; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Clinical Trials, Phase III as Topic; Clostridioides difficile; Clostridium Infections; Cross Infection; DNA-Directed RNA Polymerases; Fidaxomicin; Gastrointestinal Tract; Humans; Microbial Sensitivity Tests; Nucleic Acid Synthesis Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome; Vancomycin | 2011 |
New Gram-positive antibiotics: better than vancomycin?
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gram-Positive Bacteria; Humans; Pneumonia; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2011 |
Current strategies for management of initial Clostridium difficile infection.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Intestines; Length of Stay; Metronidazole; Recurrence; Rehabilitation Centers; Risk Factors; Severity of Illness Index; Vancomycin | 2012 |
The rise of the Enterococcus: beyond vancomycin resistance.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enteritis; Enterococcus faecium; Gastrointestinal Tract; Gram-Positive Bacterial Infections; Humans; Microbial Interactions; Vancomycin; Vancomycin Resistance; Virulence Factors | 2012 |
[The cutting-edge of medicine anti-MRSA agents; how to select and how to use].
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Daptomycin; Dibekacin; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Vancomycin | 2012 |
Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat.
Topics: Anti-Bacterial Agents; Bacteremia; Colitis; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Graft vs Host Disease; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Iowa; Opportunistic Infections; Postoperative Complications; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2013 |
Telavancin for the treatment of hospital-acquired pneumonia: findings from the ATTAIN studies.
Topics: Aminoglycosides; Anti-Bacterial Agents; Creatinine; Cross Infection; Drug Administration Schedule; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2012 |
Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin | 2012 |
Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis.
Topics: Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents, Local; Cephalosporins; Clinical Trials as Topic; Cross Infection; Decontamination; Digestive System; Disease Transmission, Infectious; Drug Resistance, Bacterial; Enterobacteriaceae; Europe; Fluoroquinolones; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intensive Care Units; Methicillin-Resistant Staphylococcus aureus; Neomycin; Nystatin; Odds Ratio; Oropharynx; Polymyxins; Prevalence; Primary Prevention; Pseudomonas aeruginosa; Randomized Controlled Trials as Topic; South Africa; Tobramycin; United States; Vancomycin | 2013 |
Treatment of Clostridium difficile-associated diarrhea.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Drug Administration Schedule; Female; Humans; Infection Control; Metronidazole; Pregnancy; Severity of Illness Index; Vancomycin | 2002 |
[Pseudo-membranous colitis].
Topics: Bacterial Proteins; Bacterial Toxins; Biomarkers; Clostridioides difficile; Cross Infection; Diagnosis, Differential; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Humans; Vancomycin | 2003 |
Antimicrobial resistance: the example of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Humans; Penicillins; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Therapeutic and preventative options for the management of vancomycin-resistant enterococcal infections.
Topics: Anti-Bacterial Agents; Cross Infection; Depsipeptides; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Peptides, Cyclic; Vancomycin; Vancomycin Resistance | 2003 |
[Staphylococci and vancomycin--confrontation trends].
Topics: Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
[Progresses in molecular biologic studies on coagulase negative staphylococcus infection].
Topics: Bacteremia; Catheterization; Child; Coagulase; Cross Infection; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Methicillin; Quinolones; Staphylococcal Infections; Staphylococcus; Urinary Tract Infections; Vancomycin | 2004 |
MRSA--time for a more pragmatic approach?
Topics: Administration, Topical; Anti-Bacterial Agents; Antibiotic Prophylaxis; Carrier State; Cross Infection; Health Care Rationing; Humans; Infection Control; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2004 |
Prevention and treatment of nosocomial sepsis in the NICU.
Topics: Anti-Bacterial Agents; Blood-Borne Pathogens; Candidiasis; Cross Infection; Humans; Hygiene; Immunoglobulins, Intravenous; Infant, Newborn; Infection Control; Intensive Care Units, Neonatal; Process Assessment, Health Care; Sepsis; Vancomycin | 2004 |
[Stakes, treatment strategies and progression of MRSA nosocomial pneumonia, especially pneumonia due to mechanical ventilation].
Topics: Acute Disease; Anti-Bacterial Agents; Critical Care; Cross Infection; Disease Progression; Drug Monitoring; Hospital Mortality; Humans; Kidney Diseases; Methicillin Resistance; Microbial Sensitivity Tests; Patient Selection; Pneumonia, Bacterial; Prognosis; Respiration, Artificial; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Treatment Outcome; Vancomycin | 2004 |
Vancomycin intermediate and resistant Staphylococcus aureus. What the nephrologist needs to know.
Topics: Adult; Aged; Anti-Bacterial Agents; Communicable Diseases, Emerging; Cross Infection; Drug Utilization; Humans; Infection Control; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Nephrology; Renal Dialysis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; United States; Vancomycin; Vancomycin Resistance | 2004 |
Alternative treatments for Clostridium difficile disease: what really works?
Topics: Anti-Infective Agents; Carrier State; Clostridioides difficile; Clostridium Infections; Colitis; Complementary Therapies; Cross Infection; Humans; Metronidazole; Vancomycin | 2005 |
[Are we being threatened by multiresistant strains of Staphylococcus aureus?].
Topics: Aged; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fosfomycin; Humans; Immunosuppression Therapy; Microbial Sensitivity Tests; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Time Factors; Vancomycin | 2005 |
Clinical manifestations, treatment and control of infections caused by Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Infection Control; Metronidazole; Vancomycin | 2005 |
Treatment of Clostridium difficile-associated disease: old therapies and new strategies.
Topics: Anti-Infective Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Probiotics; Secondary Prevention; Vaccination; Vancomycin; Vancomycin Resistance | 2005 |
Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.
Topics: Adaptation, Biological; Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Genotype; Humans; Methicillin Resistance; Operon; Phenotype; Staphylococcal Infections; Staphylococcus aureus; Trans-Activators; Vancomycin; Vancomycin Resistance | 2006 |
Antibiotic management of ventilator-associated pneumonia due to antibiotic-resistant gram-positive bacterial infection.
Topics: Cross Infection; Drug Resistance, Bacterial; Equipment Contamination; Humans; Pneumonia, Pneumococcal; Pneumonia, Staphylococcal; Staphylococcus aureus; Streptococcus pneumoniae; Treatment Failure; Vancomycin; Ventilators, Mechanical; Virulence | 2005 |
The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Carrier State; Community-Acquired Infections; Cross Infection; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2006 |
Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care.
Topics: Acinetobacter Infections; Administration, Inhalation; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Methicillin Resistance; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Practice Guidelines as Topic; Pseudomonas Infections; Respiration, Artificial; Vancomycin | 2006 |
Dalbavancin: a review for dermatologists.
Topics: Acetamides; Adult; Animals; Catheterization; Clinical Trials, Phase III as Topic; Cross Infection; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Enterococcus; Female; Fever; Gram-Positive Bacterial Infections; Headache; Humans; Linezolid; Male; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rabbits; Randomized Controlled Trials as Topic; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Teicoplanin; Treatment Outcome; Vancomycin | 2006 |
Antimicrobial therapy of Clostridium difficile-associated diarrhea.
Topics: Aged; Anti-Infective Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Outbreaks; Feces; Humans; Infant; Megacolon, Toxic; Metronidazole; Nitro Compounds; Risk Factors; Secondary Prevention; Thiazoles; Vancomycin | 2006 |
Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; MEDLINE; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin | 2007 |
The implications of enterococci for the intensive care unit.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Clindamycin; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Infection Control; Intensive Care Units; Peritonitis; Risk Factors; Vancomycin | 2007 |
Does vancomycin prescribing intervention affect vancomycin-resistant enterococcus infection and colonization in hospitals? A systematic review.
Topics: Cross Infection; Drug Prescriptions; Drug Utilization; Enterococcus; Gram-Positive Bacterial Infections; Humans; Vancomycin; Vancomycin Resistance | 2007 |
Optimizing therapy for vancomycin-resistant enterococci (VRE).
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin | 2007 |
Vancomycin-resistant enterococci (VRE): transmission and control.
Topics: Communicable Disease Control; Cross Infection; Disinfection; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infectious Disease Transmission, Professional-to-Patient; Vancomycin; Vancomycin Resistance | 2008 |
Staphylococcus aureus: the new adventures of a legendary pathogen.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Community-Acquired Infections; Cross Infection; Endocarditis; Fasciitis, Necrotizing; Female; Humans; Methicillin Resistance; Middle Aged; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2008 |
Current and future treatment modalities for Clostridium difficile-associated disease.
Topics: Anti-Bacterial Agents; Bacterial Vaccines; Clostridioides difficile; Clostridium Infections; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Vancomycin | 2008 |
[Improvement of bactericide activity in hospital treatment of gram positive infections].
Topics: Anti-Bacterial Agents; Cross Infection; Daptomycin; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Hospitals; Humans; Vancomycin | 2008 |
Pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Clostridium difficile colitis.
Topics: Adult; Animals; Anti-Bacterial Agents; Carrier State; Child; Clostridium; Clostridium Infections; Colitis; Colitis, Ulcerative; Cricetinae; Crohn Disease; Cross Infection; Cytotoxins; Enterocolitis, Pseudomembranous; Enterotoxins; Feces; Humans; Infant; Infant, Newborn; Vancomycin | 1984 |
Vancomycin.
Topics: Clostridium; Cross Infection; Deafness; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Infusions, Parenteral; Vancomycin | 1984 |
Methicillin-resistant Staphylococcus aureus bacteraemia.
Topics: Catheterization; Cross Infection; Humans; Methicillin; Middle Aged; Neoplasms; Penicillin Resistance; Pneumonia; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1981 |
Enterococcis: pathogens of the 90s.
Topics: Abdominal Abscess; Aminoglycosides; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacterial Infections; Humans; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin | 1994 |
Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).
Topics: Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Infection Control; Societies, Hospital; United States; Vancomycin | 1995 |
Antibiotic resistance.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus; Humans; Penicillin Resistance; Staphylococcus; Streptococcus; Vancomycin | 1995 |
Recommendations for preventing the spread of vancomycin resistance.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Incidence; Infection Control; Vancomycin | 1995 |
Reducing the spread of antimicrobial-resistant microorganisms. Control of vancomycin-resistant enterococci.
Topics: Child; Cross Infection; Drug Resistance, Multiple; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Pediatrics; Vancomycin | 1995 |
[Treatment of cancer and counter-measures for MRSA infections].
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Cross Infection; Dibekacin; Disinfection; Female; Humans; Leukemia; Lymphoma; Male; Methicillin Resistance; Middle Aged; Patient Isolation; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
Hospital-acquired infections: diseases with increasingly limited therapies.
Topics: Candidiasis; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1994 |
Antibiotic-induced diarrhea and pseudomembranous colitis.
Topics: Administration, Oral; Anti-Bacterial Agents; Cluster Analysis; Cross Infection; Cytotoxins; Diarrhea; Enterocolitis, Pseudomembranous; Feces; Humans; Incidence; Infection Control; Metronidazole; Primary Prevention; Sensitivity and Specificity; Sigmoidoscopy; Vancomycin | 1994 |
Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control.
Topics: Clinical Protocols; Cross Infection; Drug Resistance, Microbial; Humans; Patient Care Planning; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1996 |
Emerging resistance in Enterococcus spp.
Topics: Anti-Bacterial Agents; Australia; Cross Infection; Drug Resistance, Microbial; Enterococcus; Humans; Streptococcal Infections; Vancomycin | 1996 |
Glycopeptide resistance in gram-positive pathogens.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Staphylococcus aureus; Vancomycin | 1995 |
First documented isolation of vancomycin-resistant Enterococcus faecium in Sweden.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Heart Valve Prosthesis; Humans; Microbial Sensitivity Tests; Middle Aged; Mitral Valve; Sweden; Vancomycin | 1996 |
Antimicrobial-drug resistance.
Topics: beta-Lactam Resistance; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Negative Bacteria; Humans; Penicillin Resistance; Streptococcus pneumoniae; Vancomycin | 1996 |
Vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Humans; Infection Control; Vancomycin | 1996 |
Nosocomial infections and nosocomial pneumonia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterocolitis, Pseudomembranous; Humans; Pneumonia, Bacterial; Surgical Wound Infection; Urinary Tract Infections; Vancomycin | 1996 |
Enterococcus faecium in hospitals.
Topics: Anti-Bacterial Agents; Carrier State; Cross Infection; Disease Outbreaks; Disease Transmission, Infectious; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1997 |
Role of environmental contamination in the transmission of vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Cross Infection; Disinfection; Drug Resistance, Microbial; Enterococcus; Environmental Exposure; Equipment Contamination; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1997 |
Vancomycin-resistant enterococcus. Detection, epidemiology, and control measures.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Transmission, Infectious; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Vancomycin | 1997 |
Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1997 |
Vancomycin-resistant enterococci: implications for infection control.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Incidence; Infection Control; Vancomycin | 1997 |
[Glycopeptide resistant enterococci. Occurrence, distribution, resistance transmission, significance].
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Species Specificity; Teicoplanin; Vancomycin | 1997 |
VRE in Australia: when antibiotics fail, what then?
Topics: Anti-Bacterial Agents; Australia; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Vancomycin | 1997 |
Antibiotic resistance in streptococci and enterococci. Where are we, where are we going? An opening lecture.
Topics: Animals; Cephalosporin Resistance; Community-Acquired Infections; Cross Infection; Disease Reservoirs; Drug Resistance, Multiple; Enterococcus; Gene Transfer Techniques; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Molecular Epidemiology; Penicillin Resistance; Pneumococcal Infections; Staphylococcus; Streptococcus; Streptococcus pneumoniae; Vancomycin | 1997 |
The epidemiology of fecal carriage of vancomycin-resistant enterococci.
Topics: Carrier State; Cross Infection; Drug Resistance, Microbial; Enterococcus; Feces; Hospitals, University; Humans; Massachusetts; Vancomycin | 1997 |
Vancomycin-resistant enterococci. Mechanism and clinical relevance.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Risk Factors; Vancomycin | 1997 |
Enterococci as emerging pathogens of humans.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; United Kingdom; Vancomycin | 1997 |
Guidelines for the prevention and control of vancomycin resistant enterococci (VRE) in long-term care facilities. Sioux Falls Task Force on Antimicrobial Resistance.
Topics: Anti-Bacterial Agents; Cross Infection; Disinfection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Health Education; Humans; Long-Term Care; Mass Screening; South Dakota; Vancomycin | 1998 |
Clinical implications of nosocomial gram-positive bacteremia and superimposed antimicrobial resistance.
Topics: Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Humans; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1998 |
Enterococci and vancomycin resistance.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1998 |
[Vancomycin resistant enterococci].
Topics: Animals; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Humans; Vancomycin | 1998 |
Spread of vancomycin-resistant enterococci: why did it happen in the United States?
Topics: Anti-Bacterial Agents; Carrier State; Cross Infection; Disease Reservoirs; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Hospitals; Humans; Infection Control; United States; Vancomycin | 1998 |
Aminoglycosides, vancomycin, and quinolones.
Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Cross Infection; Humans; Vancomycin | 1998 |
[Infections caused by multiresistant enterococci in Norway].
Topics: Anti-Bacterial Agents; Communicable Disease Control; Cross Infection; Drug Resistance, Multiple; Enterococcus; Humans; Infection Control; Norway; Vancomycin | 1998 |
Hospital wards spreading vancomycin-resistant enterococci to intensive care units: returning coals to Newcastle.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Hospital Units; Humans; Infection Control; Intensive Care Units; United States; Vancomycin | 1998 |
Vancomycin-resistant Enterococcus.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin | 1998 |
Vancomycin-resistant enterococci: implications for surgeons.
Topics: Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Resistance, Microbial; Enterococcus; Humans; Risk Factors; Surgical Procedures, Operative; Surgical Wound Infection; Vancomycin | 1999 |
[Methicillin resistant Staphylococcus aureus infection].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Dibekacin; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1999 |
[Teicoplanin. New treatment potentials for gram-positive infections in the hospital].
Topics: Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Teicoplanin; Vancomycin | 1999 |
Intrinsically vancomycin-resistant gram-positive organisms: clinical relevance and implications for infection control.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Genes, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infection Control; Vancomycin | 1999 |
The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bias; Case-Control Studies; Confounding Factors, Epidemiologic; Cross Infection; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Length of Stay; Male; Middle Aged; Odds Ratio; Publishing; Research Design; Risk; Vancomycin; Vancomycin Resistance | 1999 |
Vancomycin for prophylaxis against sepsis in preterm neonates.
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Sepsis; Staphylococcal Infections; Vancomycin | 2000 |
[Vancomycin therapy in bone and joint infections--looking into the future].
Topics: Anti-Bacterial Agents; Bacterial Infections; Bone Diseases, Infectious; Cross Infection; Humans; Joint Diseases; Staphylococcal Infections; Vancomycin | 2000 |
Teicoplanin in the treatment of serious infection.
Topics: Anti-Bacterial Agents; Bacteremia; Bone Diseases, Infectious; Child; Cross Infection; Drug Administration Schedule; Drug Resistance, Microbial; Endocarditis, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Home Care Services; Humans; Intensive Care Units; Joint Diseases; Neutropenia; Staphylococcal Infections; Teicoplanin; Vancomycin | 2000 |
Implementing practice guidelines for appropriate antimicrobial usage: a systematic review.
Topics: Adult; Algorithms; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Female; HIV Infections; Humans; Infant, Newborn; Multicenter Studies as Topic; Otitis Media; Peer Review, Health Care; Pharyngitis; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Sinusitis; Surgical Wound Infection; Therapy, Computer-Assisted; Time Factors; Urinary Tract Infections; Vancomycin | 2001 |
Vancomycin-resistant enterococci: why are they here, and where do they come from?
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Disease Outbreaks; Enterococcus; Enterococcus faecium; Europe; Gram-Positive Bacterial Infections; Humans; Infection Control; Membrane Proteins; North America; Vancomycin; Vancomycin Resistance | 2001 |
What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals?
Topics: Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus; Humans; Infection Control; Netherlands; Streptococcal Infections; Vancomycin | 2002 |
Clostridium difficile infection: responses, relapses and re-infections.
Topics: Clinical Trials as Topic; Cross Infection; Disease Outbreaks; Enterocolitis, Pseudomembranous; Humans; Infection Control; Metronidazole; Recurrence; Vancomycin | 1992 |
[Enterococci: acquired antibiotic resistance].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Incidence; Urinary Tract Infections; Vancomycin | 1992 |
[Bacteremia caused by vancomycin-resistant Enterococcus faecalis. Report of 2 cases].
Topics: Aged; Bacteremia; Cross Infection; Daptomycin; Drug Resistance, Microbial; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Peptides; Pneumonia; Postoperative Complications; Retrospective Studies; Urinary Tract Infections; Vancomycin | 1991 |
Vancomycin: current perspectives and guidelines for use in the NICU.
Topics: Cross Infection; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1989 |
Therapeutic approach to methicillin-resistant Staphylococcus aureus (MRSA) infections: vancomycin update.
Topics: Cross Infection; Humans; Methicillin; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1988 |
Staphylococcal infections--treatment and control.
Topics: Carrier State; Cephalosporins; Cross Infection; Hospitalization; Humans; Infant, Newborn; Infant, Newborn, Diseases; Lysostaphin; Osteomyelitis; Penicillins; Staphylococcal Infections; Staphylococcal Toxoid; Staphylococcal Vaccines; Staphylococcus; Staphylococcus Phages; Vancomycin; Wound Infection | 1968 |
Modern management of severe staphylococcal disease.
Topics: Anti-Bacterial Agents; Carbon Dioxide; Carbon Isotopes; Cephalosporins; Cross Infection; Europe; Hospitals, Teaching; Humans; Israel; Penicillin Resistance; Penicillins; Protein Binding; Staphylococcal Infections; Staphylococcus; Time Factors; United States; Vancomycin | 1973 |
55 trial(s) available for vancomycin and Health Care Associated Infection
| Article | Year |
|---|---|
Stopping Hospital Infections With Environmental Services (SHINE): A Cluster-randomized Trial of Intensive Monitoring Methods for Terminal Room Cleaning on Rates of Multidrug-resistant Organisms in the Intensive Care Unit.
Topics: Adenosine Triphosphate; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Intensive Care Units; Methicillin-Resistant Staphylococcus aureus; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
A Phase 3, Randomized, Investigator-blinded Trial Comparing Ceftobiprole With a Standard-of-care Cephalosporin, With or Without Vancomycin, for the Treatment of Pneumonia in Pediatric Patients.
Topics: Adolescent; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cross Infection; Female; Hospitalization; Humans; Infant; Infusions, Intravenous; Male; Pneumonia, Bacterial; Treatment Outcome; Vancomycin | 2021 |
Clinical outcomes of linezolid and vancomycin in patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus stratified by baseline renal function: a retrospective, cohort analysis.
Topics: Aged; Anti-Bacterial Agents; Cohort Studies; Cross Infection; Female; Humans; Kidney Diseases; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2017 |
A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive Pathogens.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Pneumonia; Pyrimidines; Treatment Outcome; Vancomycin | 2017 |
Antibiotic use practice and predictors of hospital outcome among patients with systemic bacterial infection: Identifying targets for antibiotic and health care resource stewardship.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Female; Health Resources; Humans; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Sepsis; Vancomycin | 2019 |
Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Body Weight; Cross Infection; Dose-Response Relationship, Drug; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin | 2013 |
[Challenges of Clostridium difficile infection].
Topics: Aminoglycosides; Biodiversity; Cause of Death; Colonoscopy; Cross Infection; Disinfection; Enterocolitis, Pseudomembranous; Feces; Fidaxomicin; Hospital Mortality; Humans; Metronidazole; Patient Readmission; Prognosis; Recurrence; Tomography, X-Ray Computed; Transplantation; Vancomycin | 2013 |
The ZEPHyR study: a randomized comparison of linezolid and vancomycin for MRSA pneumonia.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Humans; Kidney Diseases; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Prospective Studies; Survival Analysis; Treatment Outcome; Vancomycin | 2013 |
A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Cross Infection; Demography; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Ventilator-Associated; Retrospective Studies; Risk Factors; Vancomycin | 2013 |
The ATTAIN trials: efficacy and safety of telavancin compared with vancomycin for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Female; Humans; Lipoglycopeptides; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Treatment Outcome; Vancomycin | 2014 |
Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies.
Topics: Aged; Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Humans; Middle Aged; Pneumonia, Staphylococcal; Retrospective Studies; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2014 |
Clinical outcome of neonates with nosocomial suspected sepsis treated with cefazolin or vancomycin: a non-inferiority, randomized, controlled trial.
Topics: Anti-Bacterial Agents; Cefazolin; Cross Infection; Humans; Infant, Newborn; Prospective Studies; Sepsis; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2014 |
[A prospective randomized controlled trial on effect of norvancomycin tube sealing for prevention of central venous catheter-related infection in critical patients].
Topics: Adult; Aged; Catheter-Related Infections; Cross Infection; Female; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Vancomycin; Young Adult | 2014 |
Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Double-Blind Method; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Models, Economic; Oxazolidinones; Pneumonia, Staphylococcal; Prospective Studies; Vancomycin | 2014 |
Health economic evaluation of patients treated for nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: secondary analysis of a multicenter randomized clinical trial of vancomycin and linezolid.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Double-Blind Method; Drug Costs; Female; Health Resources; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Renal Dialysis; Renal Insufficiency; Treatment Outcome; Vancomycin | 2014 |
Cytotoxic Virulence Predicts Mortality in Nosocomial Pneumonia Due to Methicillin-Resistant Staphylococcus aureus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Toxins; Cell Line; Cell Survival; Cross Infection; Culture Media; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Neutrophils; Pneumonia, Staphylococcal; Vancomycin; Virulence; Virulence Factors; Young Adult | 2015 |
Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Environmental Microbiology; Female; Fidaxomicin; Hospitalization; Humans; Male; Metronidazole; Vancomycin | 2015 |
Fecal microbiota transplantation restores dysbiosis in patients with methicillin resistant Staphylococcus aureus enterocolitis.
Topics: Adult; Child; Combined Modality Therapy; Cross Infection; Dysbiosis; Enterocolitis; Fecal Microbiota Transplantation; Feces; Female; Gastrointestinal Microbiome; Humans; Male; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Vancomycin; Young Adult | 2015 |
Predictors of Clinical Success in the Treatment of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Nosocomial Pneumonia (NP).
Topics: Adult; Aged; Aged, 80 and over; Cross Infection; Double-Blind Method; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Vancomycin | 2015 |
Linezolid Versus Vancomycin in the Empiric Treatment of Nosocomial Pneumonia: A Cost-Utility Analysis Incorporating Results from the ZEPHyR Trial.
Topics: Anti-Bacterial Agents; Computer Simulation; Cost Savings; Cost-Benefit Analysis; Cross Infection; Decision Support Techniques; Drug Costs; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Models, Economic; Monte Carlo Method; Pneumonia, Staphylococcal; Probability; Prospective Studies; Quality-Adjusted Life Years; Treatment Outcome; Uncertainty; Vancomycin | 2015 |
Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Coinfection; Cross Infection; Double-Blind Method; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Lipoglycopeptides; Male; Middle Aged; Pneumonia, Ventilator-Associated; Time Factors; Treatment Outcome; Vancomycin; Young Adult | 2015 |
Economic evaluation among Chinese patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus and treated with linezolid or vancomycin: a secondary, post-hoc analysis based on a Phase 4 clinical trial study.
Topics: Adult; Aged; Anti-Bacterial Agents; China; Comorbidity; Cost-Benefit Analysis; Cross Infection; Double-Blind Method; Female; Health Services; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Models, Econometric; Pneumonia, Bacterial; Renal Insufficiency; Severity of Illness Index; Socioeconomic Factors; Staphylococcal Infections; Vancomycin | 2016 |
Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Cerebrospinal Fluid Shunts; Cross Infection; Female; Hospitals; Humans; Male; Methicillin Resistance; Middle Aged; Prevalence; Prospective Studies; Random Allocation; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Vancomycin | 2008 |
Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
Topics: Acetamides; Adolescent; Adult; Aged; Anti-Bacterial Agents; China; Cross Infection; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 2008 |
Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2008 |
Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Cross Infection; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Skin Diseases, Bacterial; Vancomycin | 2009 |
Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Follow-Up Studies; Hospital Mortality; Humans; Intensive Care Units; Korea; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Probability; Prospective Studies; Rifampin; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Survival Analysis; Treatment Outcome; Vancomycin | 2010 |
Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Female; Humans; Lipoglycopeptides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Treatment Outcome; Vancomycin | 2011 |
Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Creatinine; Cross Infection; Female; Hospitals; Humans; Incidence; Kidney Diseases; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Prospective Studies; South Carolina; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2011 |
Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial.
Topics: Aged; Anti-Infective Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Cross Infection; Drug Combinations; Female; Hospital Mortality; Humans; Imipenem; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Time Factors; Treatment Outcome; Vancomycin | 2012 |
Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia.
Topics: Acetamides; Anti-Bacterial Agents; Cluster Analysis; Cross Infection; DNA, Bacterial; Double-Blind Method; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Oxazolidinones; Pneumonia, Staphylococcal; Prospective Studies; Staphylococcal Protein A; United States; Vancomycin | 2012 |
Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Vancomycin | 2003 |
Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.
Topics: Acetamides; Bacteremia; Child; Child, Preschool; Confidence Intervals; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple; Female; Follow-Up Studies; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Latin America; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Probability; Severity of Illness Index; Treatment Outcome; United States; Vancomycin | 2003 |
Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Female; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Linezolid; Male; Oxazolidinones; Pneumonia, Bacterial; Treatment Outcome; Vancomycin | 2003 |
Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Double-Blind Method; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Prospective Studies; Thrombocytopenia; Vancomycin | 2003 |
Prevention of MRSA pneumonia by oral vancomycin decontamination: a randomised trial.
Topics: Administration, Oral; Administration, Topical; Aged; Carrier State; Cross Infection; Female; Humans; Intensive Care Units; Male; Methicillin Resistance; Middle Aged; Pneumonia, Bacterial; Respiration, Artificial; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2004 |
A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
Topics: Anti-Bacterial Agents; Anticoagulants; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Critical Illness; Cross Infection; Double-Blind Method; Heparin; Humans; Hypoglycemia; Infant, Newborn; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2005 |
Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Anticoagulants; Bacteremia; Blood; Catheterization, Central Venous; Catheters, Indwelling; Ciprofloxacin; Colony Count, Microbial; Cross Infection; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Heparin; Humans; Male; Middle Aged; Vancomycin | 2006 |
Effects of controlled perioperative antimicrobial prophylaxis on infectious outcomes in pediatric cardiac surgery.
Topics: Adolescent; Antibiotic Prophylaxis; Cardiac Surgical Procedures; Child; Child, Preschool; Cross Infection; Drug Administration Schedule; Drug Costs; Female; Humans; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Male; Methicillin Resistance; Risk Assessment; Staphylococcal Infections; Teicoplanin; Vancomycin | 2007 |
Teicoplanin: a well-tolerated and easily administered alternative to vancomycin for gram-positive infections in intensive care patients.
Topics: Adult; Aged; Aged, 80 and over; Critical Care; Cross Infection; Drug Monitoring; Drug Therapy, Combination; Female; Gram-Positive Bacterial Infections; Humans; Kidney Diseases; Male; Middle Aged; Netilmicin; Prospective Studies; Teicoplanin; Vancomycin | 1994 |
Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium.
Topics: Adult; Aged; Aged, 80 and over; Cross Infection; Culture Media; DNA Fingerprinting; Drug Resistance, Microbial; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Restriction Mapping; United Kingdom; Vancomycin | 1994 |
Comparison of rectal and perirectal swabs for detection of colonization with vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Cross Infection; Disease Reservoirs; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Rectum; Reproducibility of Results; Sensitivity and Specificity; Vancomycin | 1996 |
A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit.
Topics: Adult; Aged; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Gloves, Surgical; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests; Middle Aged; Protective Clothing; Vancomycin | 1996 |
Cardiac surgery in a high-risk group of patients: is prolonged postoperative antibiotic prophylaxis effective?
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Cardiac Output, Low; Cardiac Surgical Procedures; Catheters, Indwelling; Clavulanic Acid; Clavulanic Acids; Cross Infection; Drug Therapy, Combination; Heart Diseases; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Penicillins; Postoperative Care; Postoperative Complications; Prospective Studies; Ticarcillin; Vancomycin | 1997 |
Treatment of pneumonia in mechanically ventilated trauma patients. Results of a prospective trial.
Topics: Aztreonam; Bronchoalveolar Lavage Fluid; Cilastatin; Cross Infection; Drug Therapy, Combination; HLA-DR Antigens; Humans; Imipenem; Pneumonia; Prospective Studies; Respiration, Artificial; Vancomycin; Wounds and Injuries | 1997 |
Selective use of vancomycin to prevent coagulase-negative staphylococcal nosocomial bacteremia in high risk very low birth weight infants.
Topics: Anti-Bacterial Agents; Bacteremia; Cross Infection; Double-Blind Method; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Parenteral Nutrition; Regression Analysis; Risk; Staphylococcal Infections; Statistics, Nonparametric; Vancomycin | 1998 |
A randomized trial of surgical antimicrobial prophylaxis with and without vancomycin in organ transplant patients.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Ceftriaxone; Cephalosporins; Chi-Square Distribution; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Kidney Transplantation; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Pancreas Transplantation; Postoperative Complications; Risk Factors; Statistics, Nonparametric; Treatment Outcome; Vancomycin | 1999 |
An open evaluation of triple antibiotic therapy including vancomycin for febrile bone marrow transplant recipients with severe neutropenia.
Topics: Adolescent; Adult; Amikacin; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Child; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Prospective Studies; Treatment Outcome; Vancomycin | 1999 |
Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.
Topics: Adult; Aged; Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Pneumococcal; Pneumonia, Staphylococcal; Prospective Studies; Treatment Outcome; Vancomycin; Virginiamycin | 2000 |
Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Cross Infection; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Positive Bacteria; Hospitalization; Humans; Linezolid; Male; Middle Aged; Monobactams; Oxazolidinones; Pneumonia; Safety; Time Factors; Treatment Outcome; Vancomycin | 2001 |
Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Air Conditioning; Air Microbiology; Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Environment, Controlled; Female; Gentamicins; Hospital Units; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Male; Middle Aged; Nystatin; Patient Isolators; Remission, Spontaneous; Urinary Tract Infections; Vancomycin; Ventilation; Virus Diseases | 1975 |
Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial.
Topics: Aged; Bacterial Typing Techniques; Carrier State; Clostridioides difficile; Clostridium Infections; Cross Infection; DNA Restriction Enzymes; Enterocolitis, Pseudomembranous; Feces; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Prohibitins; Vancomycin | 1992 |
Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations. A double-blind randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Cardiac Surgical Procedures; Cefamandole; Cefazolin; Cross Infection; Double-Blind Method; Female; Humans; Male; Methicillin Resistance; Middle Aged; Staphylococcus; Surgical Wound Infection; Treatment Outcome; Vancomycin; Vascular Surgical Procedures | 1992 |
A double-blind comparative study of prophylactic antibiotic therapy in open heart surgery: penicillin G versus vancomycin.
Topics: Adult; Bacteriuria; Cardiac Surgical Procedures; Clinical Trials as Topic; Cross Infection; Double-Blind Method; Endocarditis, Bacterial; Humans; Penicillin G; Penicillin Resistance; Postoperative Complications; Staphylococcal Infections; Staphylococcus; Trachea; Vancomycin; Wound Infection | 1986 |
Oral norfloxacin versus parenteral treatment of nosocomial urinary tract infection.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clinical Trials as Topic; Cross Infection; Female; Humans; Lactams; Male; Middle Aged; Norfloxacin; Opportunistic Infections; Random Allocation; Urinary Tract Infections; Vancomycin | 1987 |
783 other study(ies) available for vancomycin and Health Care Associated Infection
| Article | Year |
|---|---|
In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cross Infection; Drug Synergism; Drug Therapy, Combination; Gram-Positive Cocci; Microbial Sensitivity Tests | 2007 |
Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.
Topics: Aged; Anti-Bacterial Agents; Canada; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Infections; Staphylococcus aureus | 2007 |
In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.
Topics: Anti-Infective Agents; Bacteria; Community-Acquired Infections; Cross Infection; Enterococcus; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Respiratory System; Staphylococcus; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 2008 |
Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Disease Models, Animal; Drug Resistance, Bacterial; Female; Humans; Methicillin Resistance; Mice; Mice, Inbred BALB C; Phenotype; Pneumonia, Staphylococcal; Staphylococcus aureus | 2008 |
Activities of ceftobiprole, linezolid, vancomycin, and daptomycin against community-associated and hospital-associated methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Hospitalization; Humans; Incidence; Male; Middle Aged; Prognosis; Quebec; Ribotyping; Risk Factors | 2008 |
Improved antimicrobial activity of linezolid against vancomycin-intermediate Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance | 2008 |
In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Glycosides; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 2008 |
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Bacteriocins; Blotting, Southern; Conjugation, Genetic; Cross Infection; Culture Media; DNA Nucleotidyltransferases; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Erythromycin; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Perforin; Pheromones; Plasmids; Vancomycin Resistance | 2009 |
In vitro activity of the quinolone WCK 771 against recent U.S. hospital and community-acquired Staphylococcus aureus pathogens with various resistance types.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Fluoroquinolones; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Quinolones; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin Resistance | 2009 |
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
Topics: Bacterial Proteins; China; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Hospitals, Teaching; Humans; Leukocidins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Staphylococcal Infections | 2009 |
Exploring 5-nitrofuran derivatives against nosocomial pathogens: synthesis, antimicrobial activity and chemometric analysis.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cross Infection; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Nitrofurans; Principal Component Analysis; Structure-Activity Relationship | 2014 |
Synthesis and biological evaluation of novel peptide BF2 as an antibacterial agent against clinical isolates of vancomycin-resistant enterococci.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cross Infection; Drug Synergism; Enterococcus faecalis; Enterococcus faecium; Erythrocytes; HEK293 Cells; Humans; Oligopeptides; Rats, Wistar; Vancomycin-Resistant Enterococci | 2014 |
Nosocomial Native Valve Endocarditis due to Methicillin-Susceptible Staphylococcus aureus in a Patient with Psoriatic Arthritis.
Topics: Aged, 80 and over; Arthritis, Psoriatic; Ceftriaxone; Central Venous Catheters; Cerebral Infarction; Cross Infection; Endocarditis, Bacterial; Fatal Outcome; Humans; Magnetic Resonance Imaging; Male; Mitral Valve; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2021 |
Bacteriophage Rescue Therapy of a Vancomycin-Resistant
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Female; Genome, Bacterial; Gram-Positive Bacterial Infections; Humans; Infant; Liver Transplantation; Microbial Sensitivity Tests; Phage Therapy; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci; Whole Genome Sequencing | 2021 |
Long-read sequencing-based in silico phage typing of vancomycin-resistant Enterococcus faecium.
Topics: Bacteriophage Typing; Computer Simulation; Cross Infection; Disease Outbreaks; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Multilocus Sequence Typing; Vancomycin; Vancomycin-Resistant Enterococci | 2021 |
A vanA vancomycin-resistant Enterococcus faecium ST80 outbreak resulting from a single importation event.
Topics: Australia; Bacterial Proteins; Cross Infection; Disease Outbreaks; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Phylogeny; Vancomycin; Vancomycin-Resistant Enterococci | 2021 |
Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse genetic lineages in Ireland.
Topics: Cross Infection; Enterococcus faecium; Genomics; Gram-Positive Bacterial Infections; Humans; Ireland; Multilocus Sequence Typing; Plasmids; Prevalence; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Cerebrospinal Fluid Penetration of Vancomycin During Continuous Infusion Therapy in Patients With Nosocomial Ventriculitis.
Topics: Anti-Bacterial Agents; Cerebral Ventriculitis; Cross Infection; Humans; Intensive Care Units; Vancomycin | 2021 |
Impact of discontinuing contact precautions and enforcement of basic hygiene measures on nosocomial vancomycin-resistant Enterococcus faecium transmission.
Topics: Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Hygiene; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Spatiotemporal prediction of vancomycin-resistant Enterococcus colonisation.
Topics: Cross Infection; Gram-Positive Bacterial Infections; Humans; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2022 |
Association between prevalence of laboratory-identified
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Hospitals; Humans; Prevalence; Vancomycin | 2022 |
Optimising genomic approaches for identifying vancomycin-resistant Enterococcus faecium transmission in healthcare settings.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Carbon-Oxygen Ligases; Cross Infection; Delivery of Health Care; Disease Outbreaks; Enterococcus faecium; Genome, Bacterial; Genomics; Gram-Positive Bacterial Infections; Humans; Multilocus Sequence Typing; Phylogeny; Vancomycin; Vancomycin-Resistant Enterococci; Whole Genome Sequencing | 2022 |
Are There Bad ICU Rooms? Temporal Relationship between Patient and ICU Room Microbiome, and Influence on Vancomycin-Resistant
Topics: Adult; Cross Infection; Gastrointestinal Microbiome; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Prospective Studies; RNA, Ribosomal, 16S; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2022 |
Trends of Antimicrobial Susceptibility in Clinically Significant Coagulase-Negative Staphylococci Isolated from Cerebrospinal Fluid Cultures in Neurosurgical Adults: a Nine-Year Analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Cerebral Ventriculitis; Cerebrospinal Fluid; Coagulase; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Linezolid; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Staphylococcus; Vancomycin; Young Adult | 2022 |
Vancomycin-resistant
Topics: Canada; Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Multilocus Sequence Typing; Retrospective Studies; Sepsis; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2023 |
Persistence and multi-ward dissemination of vancomycin-resistant Enterococcus faecium ST17 clone in hospital settings in Slovakia 2017-2020.
Topics: Bacterial Proteins; Clone Cells; Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Phylogeny; Plasmids; Slovakia; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
A pilot observational study of CSF vancomycin therapeutic drug monitoring during the treatment of nosocomial ventriculitis.
Topics: Anti-Bacterial Agents; Cerebral Ventriculitis; Cross Infection; Drug Monitoring; Encephalitis; Humans; Vancomycin | 2022 |
Synergistic effects of length of stay and prior MDRO carriage on the colonization and co-colonization of methicillin-resistant
Topics: Anti-Bacterial Agents; Cross Infection; Cross-Sectional Studies; Gram-Negative Bacteria; Humans; Length of Stay; Male; Methicillin-Resistant Staphylococcus aureus; Prevalence; Risk Factors; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Vancomycin MIC creep progresses in methicillin-resistant Staphylococcus aureus despite the national antimicrobial stewardship campaign: Single facility data in Japan.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Cross Infection; Humans; Japan; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2022 |
Survival of hospital- and community-associated Enterococcus faecium following exposure to in-use concentrations of the biocide sodium dichloroisocyanurate (NaDCC).
Topics: Chlorine; Cross Infection; Disinfectants; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Triazines; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Antimicrobial therapy, resistance, and appropriateness in healthcare-associated and community-associated infections; a point prevalence survey.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Delivery of Health Care; Humans; Prevalence; Vancomycin | 2022 |
Pharmacokinetic variability of vancomycin in patients with nosocomial meningitis.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Monitoring; Female; Humans; Meningitis, Bacterial; Vancomycin | 2022 |
First report of nosocomial outbreak of vancomycin-resistant Enterococcus faecium infection among COVID-19 patients hospitalized in a non-intensive care unit ward in Slovakia.
Topics: Anti-Bacterial Agents; COVID-19; Cross Infection; Disease Outbreaks; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Multilocus Sequence Typing; SARS-CoV-2; Slovakia; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Rapid in vivo development of resistance to daptomycin in vancomycin-resistant Enterococcus faecium due to genomic alterations.
Topics: Anti-Bacterial Agents; Cross Infection; Daptomycin; Enterococcus faecium; Genomics; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Ecological effects of selective oral decontamination on multidrug-resistance bacteria acquired in the intensive care unit: a case-control study over 5 years.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Case-Control Studies; Cross Infection; Decontamination; Humans; Intensive Care Units; Pneumonia, Ventilator-Associated; Vancomycin | 2022 |
Trend in healthcare-associated infections due to vancomycin-resistant Enterococcus at a hospital in the era of COVID-19: More than hand hygiene is needed.
Topics: COVID-19; Cross Infection; Delivery of Health Care; Gram-Positive Bacterial Infections; Hand Hygiene; Hospitals; Humans; Methicillin-Resistant Staphylococcus aureus; Pandemics; Staphylococcal Infections; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
HEALTHCARE-ASSOCIATED TUBO-OVARIAN INFECTIONS IN UKRAINE: RESULTS OF A MULTICENTER STUDY (2020-2022).
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cohort Studies; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Methicillin; Pseudomonas aeruginosa; Staphylococcus aureus; Ukraine; Vancomycin | 2022 |
Antibiotic Abuse and Antimicrobial Resistance in Hospital Environment: A Retrospective Observational Comparative Study.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Hospitals; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nitrofurantoin; Retrospective Studies; Staphylococcus aureus; Vancomycin | 2022 |
Vancomycin-resistant Enterococcus outbreak in a pre- and post-cardiothoracic transplant population: Impact of discontinuing multidrug-resistant organism surveillance during the coronavirus disease 2019 pandemic.
Topics: Anti-Bacterial Agents; COVID-19; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Pandemics; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Impact of a change in universal gloving protocol on rates of central line-related bloodstream infection, Clostridioides difficile, and vancomycin-resistant Enterococcus.
Topics: Adult; Clostridioides; Clostridium Infections; Cross Infection; Humans; Infection Control; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Vancomycin-resistant Enterococcus faecium: admission prevalence, sequence types and risk factors-a cross-sectional study in seven German university hospitals from 2014 to 2018.
Topics: Animals; Antacids; Anti-Bacterial Agents; Cross Infection; Cross-Sectional Studies; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, University; Prevalence; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Effectiveness of patient and staff cohorting to reduce the risk of vancomycin-resistant enterococcus (VRE) acquisition: a retrospective cohort study during a VRE outbreak in Japan.
Topics: Cross Infection; Disease Outbreaks; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Japan; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Nosocomial outbreak of vancomycin-resistant
Topics: Cross Infection; Disease Outbreaks; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Switzerland; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Nosocomial meningitis caused by Staphylococcus haemolyticus in a child with neutropenia in the absence of intracranial devices: a case report.
Topics: Adolescent; Anti-Bacterial Agents; Child; Coagulase; Cross Infection; Hospitals; Humans; Linezolid; Male; Meningitis, Bacterial; Neutropenia; Rifampin; Staphylococcal Infections; Staphylococcus; Staphylococcus haemolyticus; Vancomycin | 2023 |
A case-control study of Clostridioides difficile symptomatic infections in a pediatric cancer hospital.
Topics: Anti-Bacterial Agents; Asparaginase; Busulfan; Cancer Care Facilities; Carboplatin; Case-Control Studies; Cefepime; Child; Clostridioides difficile; Clostridium Infections; Cross Infection; Humans; Melphalan; Meropenem; Neoplasms; Retrospective Studies; Risk Factors; Vancomycin | 2023 |
Using Genomics To Investigate an Outbreak of Vancomycin-Resistant Enterococcus faecium ST78 at a Large Tertiary Hospital in Queensland.
Topics: Australia; Cross Infection; Disease Outbreaks; Enterococcus faecium; Genomics; Gram-Positive Bacterial Infections; Humans; Phylogeny; Queensland; Tertiary Care Centers; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Vancomycin-sensitive
Topics: Bacteremia; Bacterial Proteins; Cross Infection; Denmark; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Multilocus Sequence Typing; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Impact of a new hospital with close to 100% single-occupancy rooms on environmental contamination and incidence of vancomycin-resistant Enterococcus faecium colonization or infection: a genomic surveillance study.
Topics: Cross Infection; Enterococcus faecium; Genomics; Gram-Positive Bacterial Infections; Hospitals; Humans; Incidence; Prospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2023 |
Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control study.
Topics: Case-Control Studies; Cross Infection; Gram-Positive Bacterial Infections; Hospitals; Humans; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2023 |
Investigating the relationship between vancomycin-resistant Enterococcus control practices and the incidence of health care-associated Clostridioides difficile infections in Ontario.
Topics: Clostridioides; Clostridium Infections; Cross Infection; Delivery of Health Care; Gram-Positive Bacterial Infections; Health Facilities; Hospitals; Humans; Incidence; Infection Control; Ontario; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Daily practice and prognostic factors for pneumonia caused by methicillin-resistant Staphylococcus aureus in Japan: A multicenter prospective observational cohort study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Cross Infection; Drug Monitoring; Female; Humans; Japan; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Prognosis; Prospective Studies; Risk Factors; Teicoplanin; Treatment Outcome; Vancomycin | 2020 |
Risk factors for vancomycin-resistant enterococcus acquisition during a large outbreak in patients aged 65 years and older.
Topics: Aged; Aged, 80 and over; Aging; Anti-Bacterial Agents; Cohort Studies; Cross Infection; Disease Outbreaks; Female; France; Gram-Positive Bacterial Infections; Humans; Male; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2019 |
Discontinuing Contact Precautions for Vancomycin-Resistant Enterococcus (VRE) Is Associated With Rising VRE Bloodstream Infection Rates in Ontario Hospitals, 2009-2018: A Quasi-experimental Study.
Topics: Cross Infection; Gram-Positive Bacterial Infections; Hospitals; Humans; Infection Control; Ontario; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Enterococcal Bacteremia in Children With Malignancies and Following Hematopoietic Stem Cell Transplantation: A 15-Year Single-Center Experience.
Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Bacteremia; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Infant, Newborn; Retrospective Studies; Tertiary Care Centers; Time Factors; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Ten-year resistance trends in pathogens causing healthcare-associated infections; reflection of infection control interventions at a multi-hospital healthcare system in Saudi Arabia, 2007-2016.
Topics: Acinetobacter; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Health Facilities; Hospitals; Humans; Klebsiella; Methicillin-Resistant Staphylococcus aureus; Prevalence; Prospective Studies; Pseudomonas; Saudi Arabia; Vancomycin | 2020 |
Can vancomycin lock therapy extend the retention time of infected long-term catheters?
Topics: Anti-Bacterial Agents; Anticoagulants; Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Cross Infection; Female; Humans; Male; Middle Aged; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2020 |
Whole-genome analysis of vancomycin-resistant Enterococcus faecium causing nosocomial outbreaks suggests the occurrence of few endemic clonal lineages in Bavaria, Germany.
Topics: Bacterial Proteins; Cross Infection; Disease Outbreaks; Enterococcus faecium; Genotype; Germany; Gram-Positive Bacterial Infections; Hospitals; Humans; Multilocus Sequence Typing; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Methicillin and vancomycin resistance in coagulase-negative Staphylococci isolated from the nostrils of hospitalized patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Coagulase; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Hospitalization; Humans; Jordan; Male; Methicillin; Microbial Sensitivity Tests; Nose; Staphylococcal Infections; Staphylococcus; Vancomycin | 2020 |
Association between vancomycin-resistant Enterococcus faecium colonization and subsequent infection: a retrospective WGS study.
Topics: Bacterial Proteins; Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Multilocus Sequence Typing; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Whole Genome Sequence Analysis of the First Vancomycin-Resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterococcus; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Libya; Multilocus Sequence Typing; Vancomycin; Vancomycin-Resistant Enterococci; Whole Genome Sequencing | 2020 |
A new use of
Topics: Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Lacticaseibacillus rhamnosus; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Genomic Epidemiology of Vancomycin-Resistant Enterococcus faecium (VREfm) in Latin America: Revisiting The Global VRE Population Structure.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Enterococcus faecium; Genomics; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Phylogeny; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Characteristics of Clostridium difficile isolates and the burden of hospital-acquired Clostridium difficile infection in a tertiary teaching hospital in Chongqing, Southwest China.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; China; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Female; Hospitals, Teaching; Humans; Incidence; Male; Metronidazole; Middle Aged; Multilocus Sequence Typing; Polymerase Chain Reaction; Ribotyping; Risk Factors; Tertiary Care Centers; Vancomycin | 2020 |
Repurposing a platelet aggregation inhibitor ticagrelor as an antimicrobial against Clostridioides difficile.
Topics: Anti-Bacterial Agents; Biofilms; Cell Membrane; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Evaluation, Preclinical; Drug Repositioning; Drug Resistance, Bacterial; Drug Synergism; Humans; Metronidazole; Microbial Sensitivity Tests; Microscopy, Electron; Spores, Bacterial; Ticagrelor; Vancomycin | 2020 |
Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection.
Topics: Animals; Anti-Bacterial Agents; Arthritis, Rheumatoid; Auranofin; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Repositioning; Fidaxomicin; Gastrointestinal Tract; Humans; Mice; Microbial Sensitivity Tests; Recurrence; Vancomycin | 2020 |
Challenges in interpretation of WGS and epidemiological data to investigate nosocomial transmission of vancomycin-resistant Enterococcus faecium in an endemic region: incorporation of patient movement network and admission screening.
Topics: Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Comprehensive integrated NGS-based surveillance and contact-network modeling unravels transmission dynamics of vancomycin-resistant enterococci in a high-risk population within a tertiary care hospital.
Topics: Algorithms; Anti-Bacterial Agents; Contact Tracing; Cross Infection; Enterococcus faecium; Germany; Gram-Positive Bacterial Infections; High-Throughput Nucleotide Sequencing; Humans; Infection Control; Models, Theoretical; Phylogeny; Population Dynamics; Population Surveillance; Retrospective Studies; Tertiary Care Centers; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Increase of vancomycin-resistant Enterococcus faecium strain type ST117 CT71 at Charité - Universitätsmedizin Berlin, 2008 to 2018.
Topics: Aged; Anti-Bacterial Agents; Bacterial Typing Techniques; Berlin; Cross Infection; Female; Genome, Bacterial; Genotype; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci; Virulence; Virulence Factors; Whole Genome Sequencing | 2020 |
Vancomycin-resistant Enterococcus faecium colonizing patients on hospital admission in Germany: prevalence and molecular epidemiology.
Topics: Adult; Cross Infection; Enterococcus faecium; Genotype; Germany; Gram-Positive Bacterial Infections; Hospitals; Humans; Molecular Epidemiology; Multilocus Sequence Typing; Prevalence; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Increasing proportion of vancomycin-resistance among enterococcal bacteraemias in Switzerland: a 6-year nation-wide surveillance, 2013 to 2018.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cross Infection; Enterococcus faecalis; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Retrospective Studies; Switzerland; Vancomycin; Vancomycin Resistance | 2020 |
Chlorhexidine bathing to prevent healthcare-associated vancomycin-resistant Enterococcus infections: A cluster quasi-experimental controlled study at intensive care units.
Topics: Anti-Infective Agents, Local; Chlorhexidine; Cross Infection; Delivery of Health Care; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Prospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2021 |
Phylogeny of hospital acquired MRSA, and its comparative phenotypic clinico-epidemiology with vancomycin resistant S. aureus (VRSA).
Topics: Animals; Anti-Bacterial Agents; Cross Infection; Hospitals; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phylogeny; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin-Resistant Staphylococcus aureus | 2020 |
Comparison of solithromycin with erythromycin in Enterococcus faecalis and Enterococcus faecium from China: antibacterial activity, clonality, resistance mechanism, and inhibition of biofilm formation.
Topics: Anti-Bacterial Agents; Biofilms; China; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Linezolid; Macrolides; Microbial Sensitivity Tests; Triazoles; Vancomycin | 2021 |
Quantifying acquisition and transmission of Enterococcus faecium using genomic surveillance.
Topics: Adult; Aged; Aged, 80 and over; Alcohols; Anti-Bacterial Agents; Chlorhexidine; Cross Infection; Disease Outbreaks; Disinfectants; Enterococcus faecium; Genome, Bacterial; Gram-Positive Bacterial Infections; Humans; Infection Control; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Vancomycin; Vancomycin-Resistant Enterococci; Whole Genome Sequencing; Young Adult | 2021 |
Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Bacteremia; Cross Infection; Daptomycin; Enterococcus faecium; Febrile Neutropenia; Female; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Linezolid; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sex Factors; Soft Tissue Infections; Turkey; Urinary Tract Infections; Vancomycin; Vancomycin Resistance | 2020 |
An Update to Enterococcal Bacteremia: Epidemiology, Resistance, and Outcome.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cross Infection; Cross-Sectional Studies; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
Gut Microbiota Predict
Topics: Anti-Bacterial Agents; Bacterial Physiological Phenomena; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecium; Feces; Female; Gastrointestinal Microbiome; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Middle Aged; RNA, Ribosomal, 16S; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Risk factors and outcomes associated with the carriage of tigecycline- and vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Risk Factors; Tigecycline; Vancomycin | 2021 |
Correlation between Nosocomial Carriage of Vancomycin-Resistant Enterococci and Antimicrobial Use in Taiwan.
Topics: Anti-Infective Agents; Carrier State; Cross Infection; Enterococcus; Gram-Positive Bacterial Infections; Humans; Taiwan; Vancomycin; Vancomycin Resistance | 2020 |
A preliminary study of bowel rest strategy in the management of Clostridioides difficile infection.
Topics: Aged; Aged, 80 and over; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease-Free Survival; Female; Humans; Male; Metronidazole; Retrospective Studies; Survival Rate; Vancomycin | 2020 |
Epidemiology and Outcomes of Vancomycin-Resistant Enterococcus Infections in the U.S. Military Health System.
Topics: Anti-Bacterial Agents; Cross Infection; Enterococcus; Gram-Positive Bacterial Infections; Humans; Military Health Services; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2021 |
Vancomycin-resistant Enterococcus faecium in Algeria: phenotypic and genotypic characterization of clinical isolates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algeria; Anti-Bacterial Agents; Child; Child, Preschool; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Female; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Teicoplanin; Tigecycline; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Virulence Factors; Young Adult | 2021 |
Successful containment of two vancomycin-resistant Enterococcus faecium (VRE) outbreaks in a Dutch teaching hospital using environmental sampling and whole-genome sequencing.
Topics: Cross Infection; Disease Outbreaks; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Multilocus Sequence Typing; Netherlands; Vancomycin; Vancomycin-Resistant Enterococci | 2021 |
Occurrence of multidrug-resistant Enterococcus faecium isolated from environmental samples.
Topics: Aminoglycosides; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Environmental Microbiology; Fluoroquinolones; Gram-Positive Bacterial Infections; Linezolid; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Vancomycin; Virulence; Virulence Factors | 2021 |
The impact of vancomycin-resistant
Topics: Bacteremia; Cross Infection; Delivery of Health Care; Gram-Positive Bacterial Infections; Humans; Incidence; Policy; Vancomycin; Vancomycin-Resistant Enterococci | 2022 |
A Japanese traditional medicine Hochuekkito promotes negative conversion of vancomycin-resistant Enterococci.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Drugs, Chinese Herbal; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Japan; Male; Medicine, Chinese Traditional; Medicine, East Asian Traditional; Medicine, Kampo; Middle Aged; Probiotics; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2021 |
Antimicrobial susceptibility of gram-positive and gram-negative bacteria: a 5-year retrospective analysis at a multi-hospital healthcare system in Saudi Arabia.
Topics: Adult; Anti-Bacterial Agents; Colistin; Cross Infection; Delivery of Health Care; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Saudi Arabia; Sensitivity and Specificity; Tigecycline; Vancomycin | 2021 |
Nosocomial infections caused by vancomycin-resistant Enterococcus in a Japanese general hospital and molecular genetic analysis.
Topics: Anti-Bacterial Agents; Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, General; Humans; Japan; Molecular Epidemiology; Multilocus Sequence Typing; Vancomycin | 2021 |
Evaluation of copper alloys for reducing infection by methicillin resistant Staphylococcus aureus and vancomycin resistant Enterococcus faecium in intensive care unit and in vitro.
Topics: Alloys; Copper; Cross Infection; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2021 |
Fitness cost of vancomycin-resistant Enterococcus faecium plasmids associated with hospital infection outbreaks.
Topics: Bacterial Proteins; Cross Infection; Disease Outbreaks; DNA Transposable Elements; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Plasmids; Vancomycin | 2021 |
A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Febrile Neutropenia; Guidelines as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam; Teicoplanin; Tertiary Care Centers; Treatment Outcome; Turkey; Vancomycin | 2017 |
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals.
Topics: Anti-Bacterial Agents; Asian People; Clostridioides difficile; Clostridium Infections; Cross Infection; Daptomycin; Diarrhea; Electrophoresis, Gel, Pulsed-Field; Feces; Genes, Bacterial; Hospitals; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Reproducibility of Results; Republic of Korea; Ribotyping; Vancomycin | 2017 |
Linezolid versus vancomycin in Methicillin Resistant Staphylococcus aureus nosocomial pneumonia in the elderly.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin | 2017 |
Genotyping, antimicrobial resistance and virulence factor gene profiles of vancomycin resistance Enterococcus faecalis isolated from blood culture.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Blood Culture; Carbon-Oxygen Ligases; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Peptide Synthases; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Virulence; Virulence Factors | 2017 |
A Discrete Event Simulation Model of Patient Flow in a General Hospital Incorporating Infection Control Policy for Methicillin-Resistant Staphylococcus Aureus (MRSA) and Vancomycin-Resistant Enterococcus (VRE).
Topics: Anti-Bacterial Agents; Cross Infection; Enterococcus; Female; Hospitals, General; Humans; Infection Control; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Models, Theoretical; Organizational Policy; Patient Transfer; Vancomycin | 2018 |
Enterococci in orthopaedic infections: Who is at risk getting infected?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cohort Studies; Cross Infection; Daptomycin; Enterococcus; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Intraoperative Period; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Orthopedic Procedures; Perioperative Period; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2017 |
Clinical Outcome and Antimicrobial Therapeutic Drug Monitoring for the Treatment of Infections in Acute Burn Patients.
Topics: Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Burns; Child; Child, Preschool; Cross Infection; Drug Monitoring; Female; Humans; Imipenem; Infant; Intensive Care Units; Male; Meropenem; Middle Aged; Piperacillin; Pneumonia; Prognosis; Tertiary Care Centers; Thienamycins; Urinary Tract Infections; Vancomycin; Young Adult | 2017 |
Decrease in Vancomycin-Resistant Enterococcus Colonization After Extensive Renovation of a Unit Dedicated to the Treatment of Hematologic Malignancies and Hematopoietic Stem-Cell Transplantation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Equipment Contamination; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hospital Design and Construction; Humans; Infection Control; Leukemia, Myeloid, Acute; Male; Middle Aged; Molecular Typing; Patients' Rooms; Proportional Hazards Models; Retrospective Studies; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Young Adult | 2017 |
Decreased mortality in patients prescribed vancomycin after implementation of antimicrobial stewardship program.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; Cross Infection; Hospital Mortality; Hospitals, Veterans; Humans; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2017 |
Post-hospitalization Treatment Regimen and Readmission for C. difficile Colitis in Medicare Beneficiaries.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Colitis; Cross Infection; Drug Therapy, Combination; Female; Hospitalization; Humans; Male; Medicare; Metronidazole; Patient Readmission; Recurrence; Retrospective Studies; United States; Vancomycin | 2018 |
Vancomycin-resistant Enterococcus faecium ST17 outbreak in a Neonatal Unit.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Vancomycin; Vancomycin-Resistant Enterococci | 2018 |
Treating Clostridium difficile infection in patients presenting with hematological malignancies: Are current guidelines applicable?
Topics: Adult; Clostridioides difficile; Clostridium Infections; Cross Infection; Disease Management; Female; Hematologic Neoplasms; Hospital Units; Hospitals, Teaching; Humans; Immunocompromised Host; Male; Medication Adherence; Metronidazole; Middle Aged; Practice Guidelines as Topic; Recurrence; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vancomycin | 2017 |
Comparative evaluation of VITEK® 2 and three commercial gradient strip assays for daptomycin susceptibility testing of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Automation, Laboratory; Cross Infection; Daptomycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Reagent Kits, Diagnostic; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2017 |
Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study.
Topics: Anti-Bacterial Agents; Bacteremia; Blood Culture; Cohort Studies; Cross Infection; Female; Humans; Latin America; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Prospective Studies; Staphylococcal Infections; Vancomycin | 2018 |
Controlling for endogeneity in attributable costs of vancomycin-resistant enterococci from a Canadian hospital.
Topics: Aged; Anti-Bacterial Agents; Canada; Cross Infection; Female; Gram-Positive Bacterial Infections; Health Care Costs; Hospital Costs; Hospitals, Urban; Humans; Linear Models; Male; Retrospective Studies; Vancomycin; Vancomycin-Resistant Enterococci | 2017 |
Characterization of SCCmec and spa types of methicillin-resistant Staphylococcus aureus isolates from health-care and community-acquired infections in Kerman, Iran.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Child; Community-Acquired Infections; Cross Infection; Female; Humans; Infant; Iran; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Penicillin-Binding Proteins; Staphylococcal Infections; Vancomycin; Young Adult | 2017 |
Susceptibility of vancomycin-resistant and -sensitive Enterococcus faecium obtained from Danish hospitals to benzalkonium chloride, chlorhexidine and hydrogen peroxide biocides.
Topics: Benzalkonium Compounds; Chlorhexidine; Cross Infection; Denmark; Disinfectants; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Hospitals; Humans; Hydrogen Peroxide; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2017 |
The Impact of a Reported Penicillin Allergy on Surgical Site Infection Risk.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Clindamycin; Cross Infection; Drug Hypersensitivity; Female; Humans; Male; Massachusetts; Middle Aged; Odds Ratio; Penicillins; Retrospective Studies; Risk Factors; Surgical Wound Infection; Vancomycin | 2018 |
The outcome of patients with severe and severe-complicated Clostridium difficile infection treated with tigecycline combination therapy: a retrospective observational study.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anti-Bacterial Agents; Australia; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Minocycline; Retrospective Studies; Tigecycline; Treatment Outcome; Vancomycin | 2018 |
Spread of Vancomycin-Resistant Enterococcus faecium Isolates Despite Validated Infection Control Measures in an Italian Hospital: Antibiotic Resistance and Genotypic Characterization of the Endemic Strain.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Bacterial Typing Techniques; Cross Infection; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Infection Control; Italy; Microbial Sensitivity Tests; Vancomycin; Vancomycin-Resistant Enterococci | 2018 |
The Role of Negative Methicillin-Resistant Staphylococcus aureus Nasal Surveillance Swabs in Predicting the Need for Empiric Vancomycin Therapy in Intensive Care Unit Patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Baltimore; Case-Control Studies; Cross Infection; Female; Humans; Intensive Care Units; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Nasal Mucosa; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Staphylococcal Infections; Tertiary Care Centers; Vancomycin | 2018 |
Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Carbon-Oxygen Ligases; Child; Child, Preschool; Cross Infection; Exotoxins; Female; Hospitals, Teaching; Humans; Infant; Iran; Leukocidins; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Penicillin-Binding Proteins; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance; Young Adult | 2018 |
Effective Antimicrobial Stewardship Strategies for Cost-effective Utilization of Telavancin for the Treatment of Patients With Hospital-acquired Bacterial Pneumonia Caused by Staphylococcus aureus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antimicrobial Stewardship; Cost-Benefit Analysis; Cross Infection; Drug Costs; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin | 2018 |
Transferable vancomycin resistance in clade B commensal-type Enterococcus faecium.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Enterococcus faecium; Feces; Genome, Bacterial; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Operon; Phylogeny; Plasmids; Symbiosis; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2018 |
Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Disease Models, Animal; Feces; Female; Fidaxomicin; Gastrointestinal Microbiome; Mice; Mice, Inbred C57BL; RNA, Ribosomal, 16S; Vancomycin | 2018 |
Duration of exposure to multiple antibiotics is associated with increased risk of VRE bacteraemia: a nested case-control study.
Topics: Adult; Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; Case-Control Studies; Cross Infection; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Time Factors; United Kingdom; Vancomycin; Vancomycin Resistance | 2018 |
Relentless spread and adaptation of non-typeable vanA vancomycin-resistant Enterococcus faecium: a genome-wide investigation.
Topics: Anti-Bacterial Agents; Australia; Bacterial Proteins; Bacterial Typing Techniques; Cross Infection; Disease Outbreaks; Enterococcus faecium; Genome, Bacterial; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; New South Wales; Polymerase Chain Reaction; Vancomycin; Vancomycin-Resistant Enterococci; Whole Genome Sequencing | 2018 |
Vancomycin-resistant
Topics: Australia; Bacterial Proteins; Cross Infection; Enterococcus faecium; Epidemics; Gram-Positive Bacterial Infections; Hospitals; Humans; Infection Control; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Molecular Epidemiology; New Zealand; Phylogeny; Vancomycin; Vancomycin-Resistant Enterococci; Whole Genome Sequencing | 2018 |
Evidence-based Care Bundles for Preventing Surgical Site Infections in Spinal Instrumentation Surgery.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Cross Infection; Evidence-Based Medicine; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Orthopedic Procedures; Patient Care Bundles; Povidone-Iodine; Retrospective Studies; Spinal Diseases; Staphylococcal Infections; Surgical Wound Infection; Vancomycin | 2018 |
The 'ins and outs' of faecal microbiota transplant for recurrent Clostridium difficile diarrhoea at Wits Donald Gordon Medical Centre, Johannesburg, South Africa.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Drug Resistance, Bacterial; Fecal Microbiota Transplantation; Female; Humans; Intubation, Gastrointestinal; Male; Metronidazole; Middle Aged; Outcome and Process Assessment, Health Care; Recurrence; South Africa; Vancomycin | 2018 |
Association of bacterial genotypes and epidemiological features with treatment failure in hemodialysis patients with methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Female; Genotype; Humans; Kidney Failure, Chronic; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Renal Dialysis; Retrospective Studies; Staphylococcal Infections; Treatment Failure; Vancomycin | 2018 |
The evolving epidemiology of
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Canada; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome; Vancomycin; Young Adult | 2018 |
The local hospital milieu and healthcare-associated vancomycin-resistant enterococcus acquisition.
Topics: Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Disease Transmission, Infectious; Drug Utilization; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Middle Aged; Prevalence; Rectum; Retrospective Studies; United States; Vancomycin; Vancomycin-Resistant Enterococci; Young Adult | 2019 |
Outbreak report: a nosocomial outbreak of vancomycin resistant
Topics: Adolescent; Aged; Anti-Bacterial Agents; Austria; Child; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Organ Transplantation; Phylogeny; Postoperative Complications; Retrospective Studies; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Young Adult | 2018 |
Outbreak of vancomycin-resistant
Topics: Adult; Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Switzerland; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Whole Genome Sequencing | 2018 |
Emergence of a vancomycin-variable Enterococcus faecium ST1421 strain containing a deletion in vanX.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Enterococcus faecium; Gene Deletion; Humans; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Serine-Type D-Ala-D-Ala Carboxypeptidase; Vancomycin; Vancomycin Resistance | 2018 |
Use of telavancin in adolescent patients with cystic fibrosis and prior intolerance to vancomycin: A case series.
Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Child; Cross Infection; Cystic Fibrosis; Drug Hypersensitivity; Female; Humans; Lipoglycopeptides; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2018 |
Methicillin-resistant
Topics: Aged, 80 and over; Anti-Bacterial Agents; Blood Culture; Cross Infection; Diagnosis, Differential; Fatal Outcome; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Needs Assessment; Nursing Homes; Patient Selection; Pneumonia, Staphylococcal; Prognosis; Risk Factors; Time-to-Treatment; Vancomycin | 2019 |
A multicenter-based study on epidemiology, antibiotic susceptibility and risk factors of toxigenic Clostridium difficile in hospitalized patients in southwestern Iran.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Clostridioides difficile; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Hospitals, Teaching; Humans; Iran; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Vancomycin; Young Adult | 2018 |
Evolution of Daptomycin Resistance in Coagulase-Negative Staphylococci Involves Mutations of the Essential Two-Component Regulator WalKR.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Cross Infection; Daptomycin; Drug Resistance, Bacterial; Histidine Kinase; Humans; Microbial Sensitivity Tests; Polymorphism, Single Nucleotide; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus capitis; Staphylococcus epidermidis; Tertiary Care Centers; Vancomycin | 2019 |
Vancomycin use in surrounding patients during critical illness and risk for persistent colonization with vancomycin-resistant Enterococcus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carrier State; Cross Infection; Drug Utilization; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Prevalence; Retrospective Studies; Risk Assessment; Vancomycin; Vancomycin-Resistant Enterococci; Young Adult | 2019 |
Utilizing genomic analyses to investigate the first outbreak of vanA vancomycin-resistant Enterococcus in Australia with emergence of daptomycin non-susceptibility.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Australia; Bacteremia; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Daptomycin; Disease Outbreaks; Enterococcus faecium; Female; Genomics; Genotype; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Oncology Service, Hospital; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci; Whole Genome Sequencing | 2019 |
Catheter related recurrent blood stream infection caused by linezolid-resistant, methicillin resistant Staphylococcus haemolyticus; an emerging super bug.
Topics: Anti-Bacterial Agents; Baths; Catheter-Related Infections; Chlorhexidine; Cross Infection; Humans; Injections; Linezolid; Male; Methicillin Resistance; Middle Aged; Secondary Prevention; Sepsis; Staphylococcal Infections; Staphylococcus haemolyticus; Vancomycin | 2019 |
Association Between Antibiotic Use and Hospital-onset Clostridioides difficile Infection in US Acute Care Hospitals, 2006-2012: An Ecologic Analysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Clostridioides difficile; Clostridium Infections; Cross Infection; Cross-Sectional Studies; Drug Prescriptions; Ecological and Environmental Phenomena; Female; Fluoroquinolones; Hospitalization; Hospitals; Humans; Interrupted Time Series Analysis; Male; Metronidazole; Middle Aged; United States; Vancomycin | 2020 |
Epidemiological linkage of vancomycin-resistant Enterococcus faecium from different sources in Ahwaz, Iran.
Topics: Cross Infection; Enterococcus faecium; Genetic Linkage; Gram-Positive Bacterial Infections; Hospitals; Humans; Iran; Microbial Sensitivity Tests; Multilocus Sequence Typing; Vancomycin; Vancomycin Resistance | 2019 |
Characterization and risk factors for recurrence of Clostridioides (Clostridium) difficile infection in Japan: A nationwide real-world analysis using a large hospital-based administrative dataset.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitals; Humans; Inpatients; Japan; Logistic Models; Male; Metronidazole; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Vancomycin | 2019 |
Phenotypic and genotypic characterization of glycopeptide, aminoglycoside and macrolide resistance among clinical isolates of Enterococcus faecalis: a multicenter based study.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Erythromycin; Female; Genes, Bacterial; Genotype; Gentamicins; Gram-Positive Bacterial Infections; Humans; Iran; Male; Microbial Sensitivity Tests; Phenotype; Vancomycin | 2019 |
Emergence of an Australian-like pstS-null vancomycin resistant Enterococcus faecium clone in Scotland.
Topics: Anti-Bacterial Agents; Australia; Cross Infection; Disease Outbreaks; England; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Scotland; Vancomycin; Vancomycin-Resistant Enterococci | 2019 |
Antimicrobial consumption in three pediatric and neonatal intensive care units in Saudi Arabia: 33-month surveillance study.
Topics: Adolescent; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Cephalosporins; Child; Child, Preschool; Cross Infection; Epidemiological Monitoring; Female; Humans; Infant; Intensive Care Units, Neonatal; Male; Pediatrics; Prospective Studies; Saudi Arabia; Vancomycin | 2019 |
Detection of Nosocomial Outbreaks: Genomic Surveillance Takes the Lead.
Topics: Cross Infection; Disease Outbreaks; Enterococcus faecium; Genomics; Humans; Radiology, Interventional; Vancomycin | 2020 |
Outbreak of Vancomycin-resistant Enterococcus faecium in Interventional Radiology: Detection Through Whole-genome Sequencing-based Surveillance.
Topics: Cross Infection; Disease Outbreaks; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Radiology, Interventional; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
The discontinuation of contact precautions for methicillin-resistant
Topics: Cross Infection; Gram-Positive Bacterial Infections; Hospitals; Humans; Infection Control; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin-Resistant Enterococci | 2020 |
Linezolid versus vancomycin cost in the treatment of staphylococcal pneumonia.
Topics: Aged; Costs and Cost Analysis; Cross Infection; Diagnosis-Related Groups; Drug Costs; Economics, Nursing; Female; France; Hospitalization; Hospitals, Urban; Humans; Infusions, Intravenous; Length of Stay; Linezolid; Male; Middle Aged; Pneumonia, Staphylococcal; Retrospective Studies; Staphylococcus aureus; Vancomycin | 2020 |
Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Enterocolitis, Pseudomembranous; Europe; Fidaxomicin; Humans; Metronidazole; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymerase Chain Reaction; Ribotyping; Thiazoles; Treatment Outcome; Vancomycin | 2013 |
Impact of preoperative MRSA screening and decolonization on hospital-acquired MRSA burden.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Chi-Square Distribution; Chlorhexidine; Community-Acquired Infections; Cross Infection; Elective Surgical Procedures; Hospitals, University; Humans; Incidence; Infection Control; Mass Screening; Medication Adherence; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Nasal Mucosa; Orthopedic Procedures; Patient Admission; Prevalence; Program Evaluation; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin | 2013 |
Evaluation of compliance in control and prevention study of vancomycin resistant enterococcus outbreak.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Enterococcus; Female; Guideline Adherence; Hospitals, Pediatric; Humans; Infection Control; Male; Microbial Sensitivity Tests; Urinary Tract Infections; Vancomycin; Vancomycin Resistance | 2013 |
Sccmec type II gene is common among clinical isolates of methicillin-resistant Staphylococcus aureus in Jakarta, Indonesia.
Topics: Acetamides; Amikacin; Clindamycin; Community-Acquired Infections; Cross Infection; DNA Primers; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Indonesia; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Plasmids; Polymerase Chain Reaction; Species Specificity; Teicoplanin; Tigecycline; Time Factors; Vancomycin | 2013 |
Adjuvant vancomycin for antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Clostridioides difficile; Coronary Artery Bypass; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Propensity Score; Proportional Hazards Models; Risk Assessment; Risk Factors; Surgical Wound Infection; Time Factors; Treatment Outcome; United States; Vancomycin | 2013 |
Identification of vancomycin-resistant enterococci clones and inter-hospital spread during an outbreak in Taiwan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Taiwan; Tertiary Care Centers; Vancomycin; Vancomycin Resistance | 2013 |
Epidemiological investigation of a nosocomial outbreak of multidrug-resistant Corynebacterium striatum at one Belgian university hospital.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; Belgium; Corynebacterium; Corynebacterium Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Hospitals, University; Humans; Male; Middle Aged; Risk Factors; RNA, Bacterial; RNA, Ribosomal, 16S; Sequence Analysis, RNA; Vancomycin | 2014 |
[Clostridium difficile infections - still a major challenge].
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Colectomy; Combined Modality Therapy; Cross Infection; Disease Notification; Enterocolitis, Pseudomembranous; Fidaxomicin; Metronidazole; Probiotics; Vancomycin; Virulence | 2013 |
Drug resistance & virulence determinants in clinical isolates of Enterococcus species.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Humans; Vancomycin; Vancomycin Resistance; Virulence | 2013 |
In vitro susceptibility of Staphylococci and Enterococci to vancomycin and teicoplanin.
Topics: Anti-Bacterial Agents; Bacterial Infections; Critical Care; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus; Glycopeptides; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus; Teicoplanin; Vancomycin | 2013 |
Outcomes associated with a thrice-weekly antimicrobial stewardship programme in a 253-bed community hospital.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Fluoroquinolones; Hospitals, Community; Humans; Retrospective Studies; Vancomycin | 2013 |
Population structure and characterisation of Staphylococcus aureus from bacteraemia at multiple hospitals in China: association between antimicrobial resistance, toxin genes and genotypes.
Topics: Bacteremia; Bacterial Toxins; Bacterial Typing Techniques; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterotoxins; Genotype; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Multilocus Sequence Typing; Oxacillin; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2013 |
Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cross Infection; Humans; Lipoglycopeptides; Pneumonia, Bacterial; Treatment Outcome; Vancomycin | 2013 |
Modeling the regional spread and control of vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; California; Computer Simulation; Cross Infection; Enterococcus; Gram-Positive Bacterial Infections; Hospitals; Humans; Infection Control; Prevalence; Vancomycin; Vancomycin Resistance | 2013 |
Genomic insights to control the emergence of vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Chromosome Mapping; Cross Infection; Disease Outbreaks; DNA Transposable Elements; DNA, Bacterial; Enterococcus faecium; Genome, Bacterial; Gram-Positive Bacterial Infections; Hospitals; Humans; Molecular Epidemiology; Molecular Sequence Data; Phylogeny; Sequence Analysis, DNA; Vancomycin; Vancomycin Resistance | 2013 |
Pharmacodynamics of vancomycin in elderly patients aged 75 years or older with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Female; Humans; Japan; Male; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2013 |
Lack of association between genotypes and haematogenous seeding infections in a large cohort of patients with methicillin-resistant Staphylococcus aureus bacteraemia from 21 Spanish hospitals.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cross Infection; Female; Genotype; Hospitals; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Prospective Studies; Spain; Staphylococcal Infections; Survival Analysis; Treatment Outcome; Vancomycin; Young Adult | 2014 |
The influence of severe hypoalbuminemia on the half-life of vancomycin in elderly patients with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Female; Half-Life; Humans; Hypoalbuminemia; Japan; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Retrospective Studies; Severity of Illness Index; Vancomycin | 2013 |
Monte Carlo simulation analysis of ceftobiprole, dalbavancin, daptomycin, tigecycline, linezolid and vancomycin pharmacodynamics against intensive care unit-isolated methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Computer Simulation; Cross Infection; Daptomycin; Dose-Response Relationship, Drug; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Minocycline; Models, Biological; Monte Carlo Method; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin | 2014 |
Predictors of first recurrence in Clostridium difficile-associated disease. A study of 306 patients hospitalized in a Romanian tertiary referral center.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Community-Acquired Infections; Cross Infection; Enterocolitis, Pseudomembranous; Female; Hospitalization; Hospitals, Teaching; Humans; Kaplan-Meier Estimate; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Risk Factors; Romania; Tertiary Care Centers; Time Factors; Treatment Outcome; Vancomycin; Young Adult | 2013 |
Telavancin for hospital-acquired pneumonia: clinical response and 28-day survival.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Female; Humans; Lipoglycopeptides; Male; Middle Aged; Pneumonia; Staphylococcus aureus; United States; Vancomycin | 2014 |
Phenotypic & genotypic characterization of vancomycin resistant Enterococcus isolates from clinical specimens.
Topics: Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Drug Resistance, Bacterial; Genotype; Humans; India; Microbial Sensitivity Tests; Peptide Synthases; Phenotype; Teicoplanin; Vancomycin; Vancomycin-Resistant Enterococci | 2013 |
Emergence of vanA vancomycin-resistant Enterococcus faecium in a hospital in Porto Alegre, South Brazil.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Brazil; Carbon-Oxygen Ligases; Cross Infection; Cross-Sectional Studies; Disease Outbreaks; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2014 |
Trend of vancomycin susceptibility of staphylococci at a level 1 trauma centre of India.
Topics: Cross Infection; Humans; India; Microbial Sensitivity Tests; Staphylococcus aureus; Trauma Centers; Vancomycin | 2013 |
Which antibiotic for hospital acquired pneumonia caused by MRSA?
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pneumonia, Staphylococcal; Tigecycline; Vancomycin; Virginiamycin | 2014 |
A promising approach to provide appropriate colon target drug delivery systems of vancomycin HCL: pharmaceutical and microbiological studies.
Topics: Administration, Oral; Chemistry, Pharmaceutical; Colon; Cross Infection; Drug Delivery Systems; Galactans; Humans; Mannans; Plant Gums; Staphylococcus aureus; Vancomycin | 2014 |
Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Blood; Cross Infection; Echocardiography; Female; Hospital Mortality; Humans; Infectious Disease Medicine; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Organizational Policy; Practice Guidelines as Topic; Referral and Consultation; Retrospective Studies; Soft Tissue Infections; Staphylococcal Skin Infections; Vancomycin | 2014 |
Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Sanprasitthiprasong Hospital.
Topics: Anti-Bacterial Agents; Cross Infection; Hospitals, Teaching; Humans; Methicillin-Resistant Staphylococcus aureus; Public Health Surveillance; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2014 |
Evaluation of vancomycin-resistant enterococci (VRE)-associated morbidity following relaxation of VRE screening and isolation precautions in a tertiary care hospital.
Topics: Bacteremia; Cross Infection; Databases, Factual; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Infection Control; Patient Isolation; Polymerase Chain Reaction; Quebec; Retrospective Studies; Tertiary Care Centers; Vancomycin; Vancomycin-Resistant Enterococci | 2014 |
[Epidemiology of Clostridium difficile-associated disease (CDAD) in Salamanca].
Topics: Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Clostridioides difficile; Clostridium Infections; Comorbidity; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hospitals, University; Humans; Incidence; Male; Metronidazole; Middle Aged; Neoplasms; Postoperative Complications; Recurrence; Spain; Surveys and Questionnaires; Vancomycin | 2014 |
Transcriptional response to vancomycin in a highly vancomycin-resistant Streptomyces coelicolor mutant.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Wall; Cross Infection; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Mutation; Phosphates; Sigma Factor; Streptomyces coelicolor; Stress, Physiological; Transcription Factors; Transcription, Genetic; Vancomycin; Vancomycin Resistance | 2014 |
Trend in vancomycin susceptibility and correlation with molecular characteristics of methicillin-resistant Staphylococcus aureus causing invasive infections in Taiwan: results from the Tigecycline in vitro Surveillance in Taiwan (TIST) study, 2006-2010.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; DNA, Bacterial; Genes, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Typing; Polymerase Chain Reaction; Prevalence; Staphylococcal Infections; Taiwan; Vancomycin; Vancomycin Resistance | 2014 |
Healthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, Texas.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitals, University; Humans; Length of Stay; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence; Texas; Vancomycin | 2014 |
Linezolid and vancomycin-resistant Enterococcus faecium peritonitis in a child after liver transplantation.
Topics: Biliary Atresia; Child, Preschool; Coinfection; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Liver Transplantation; Male; Peritonitis; Portoenterostomy, Hepatic; Postoperative Complications; Pseudomonas Infections; RNA, Bacterial; RNA, Ribosomal, 23S; Vancomycin | 2015 |
An agent-based simulation model for Clostridium difficile infection control.
Topics: Anti-Bacterial Agents; Biometry; Clostridioides difficile; Computer Simulation; Cross Infection; Enterocolitis, Pseudomembranous; Hospitals; Humans; Infection Control; Markov Chains; Risk Assessment; Vancomycin; Wisconsin | 2015 |
Nosocomial infection caused by vancomycin-susceptible multidrug-resistant Enterococcus faecalis over a long period in a university hospital in Japan.
Topics: Anti-Bacterial Agents; Conjugation, Genetic; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Genotype; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Japan; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Plasmids; Retrospective Studies; Vancomycin | 2014 |
The occurrence and dissemination of methicillin and vancomycin-resistant Staphylococcus in samples from patients and health professionals of a university hospital in Recife, State of Pernambuco, Brazil.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Brazil; Cross Infection; Female; Health Personnel; Hospitals, University; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Nasal Cavity; Oxacillin; Penicillin-Binding Proteins; Polymerase Chain Reaction; Ribotyping; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2014 |
Reconsidering isolation precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
Topics: Cross Infection; Drug Resistance, Bacterial; Endemic Diseases; Enterococcus; Gram-Positive Bacterial Infections; Hand Hygiene; Humans; Infection Control; Methicillin-Resistant Staphylococcus aureus; Patient Isolation; Protective Clothing; Staphylococcal Infections; Vancomycin | 2014 |
Reduced susceptibility to vancomycin and biofilm formation in methicillin-resistant Staphylococcus epidermidis isolated from blood cultures.
Topics: Adult; Agar; Aged; Biofilms; Cross Infection; Culture Media; Female; Humans; Infant; Infant, Newborn; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Operon; Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus epidermidis; Tertiary Care Centers; Vancomycin; Vancomycin Resistance | 2014 |
[Clostridium difficile in visceral surgery].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Cohort Studies; Cross Infection; Cross-Sectional Studies; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Fidaxomicin; Germany; Hospital Mortality; Humans; Incidence; Intensive Care Units; Male; Metronidazole; Middle Aged; Minocycline; Patient Readmission; Retrospective Studies; Survival Rate; Tigecycline; Vancomycin; Young Adult | 2015 |
Multidrug-resistant organisms within the dialysis population: a potentially preventable perfect storm.
Topics: Cross Infection; Humans; Kidney Failure, Chronic; Renal Dialysis; Vancomycin; Vancomycin-Resistant Enterococci | 2015 |
Different VanA Elements in E. faecalis and in E. faecium Suggest at Least Two Origins of Tn1546 Among VRE in a Brazilian Hospital.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Brazil; Carbon-Oxygen Ligases; Clone Cells; Cross Infection; DNA Mutational Analysis; DNA Transposable Elements; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Enterococcus faecium; Gene Expression Regulation, Bacterial; Genetic Variation; Gram-Positive Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Penicillins; Phylogeny; Plasmids; Vancomycin; Vancomycin Resistance | 2015 |
Life-threatening haematuria caused by vancomycin-induced thrombocytopenia.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cross Infection; Hematuria; Humans; Iatrogenic Disease; Immunoglobulins, Intravenous; Immunologic Factors; Male; Methylprednisolone; Platelet Count; Pneumonia; Replantation; Thrombocytopenia; Treatment Outcome; Ureter; Urologic Surgical Procedures; Vancomycin | 2015 |
Risk factors for gyrA and parC mutations in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Case-Control Studies; Cross Infection; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Female; Humans; Levofloxacin; Male; Middle Aged; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Vancomycin | 2015 |
Vancomycin tolerant, methicillin-resistant Staphylococcus aureus reveals the effects of vancomycin on cell wall thickening.
Topics: Adaptation, Physiological; Cell Wall; Child; Cross Infection; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genotype; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phenotype; Phylogeny; Polymorphism, Genetic; Vancomycin | 2015 |
Vancomycin-resistant enterococci colonization in patients with hematological malignancies: screening and its cost-effectiveness.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Colony Count, Microbial; Cost-Benefit Analysis; Cross Infection; Female; Fever; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Incidence; Male; Mass Screening; Middle Aged; Neutropenia; Retrospective Studies; Turkey; Vancomycin; Vancomycin-Resistant Enterococci; Young Adult | 2014 |
Rifampicin resistance among multi-resistant MRSA clinical isolates from Chennai, India, and their molecular characterization.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Humans; India; Methicillin-Resistant Staphylococcus aureus; Molecular Sequence Data; Mutation; Phylogeny; Rifampin; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid; Staphylococcal Infections; Vancomycin | 2015 |
Treatment of Clostridium difficile infection in a French university hospital.
Topics: Adult; Aged; Clostridioides difficile; Cohort Studies; Cross Infection; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; France; Hospitals, University; Humans; Incidence; Male; Metronidazole; Middle Aged; Prospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vancomycin | 2015 |
Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Vancomycin | 2015 |
MRSA infection in patients hospitalized at Sanglah Hospital: a case series.
Topics: Adult; Aged; Anti-Bacterial Agents; Child; Child, Preschool; Cross Infection; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Staphylococcal Infections; Vancomycin | 2015 |
Characteristics and Antibiotic Use Associated With Short-Term Risk of Clostridium difficile Infection Among Hospitalized Patients.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Female; Humans; Inpatients; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Vancomycin | 2015 |
Survival of vancomycin-intermediate Staphylococcus aureus on hospital surfaces.
Topics: Bacterial Proteins; Cross Infection; Endocarditis, Bacterial; Equipment and Supplies, Hospital; Equipment Contamination; Hospitals; Humans; Hydrophobic and Hydrophilic Interactions; Methicillin-Resistant Staphylococcus aureus; Staphylococcus aureus; Survival; Vancomycin; Vancomycin Resistance | 2015 |
Methicillin-resistant Staphylococcus aureus in North-east Croatia.
Topics: Anti-Bacterial Agents; Croatia; Cross Infection; Drug Resistance, Bacterial; Humans; Incidence; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Public Health; Sentinel Surveillance; Staphylococcal Infections; Teicoplanin; Vancomycin | 2015 |
Continuous vs. intermittent vancomycin therapy for Gram-positive infections not caused by methicillin-resistant Staphylococcus aureus.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Female; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Prospective Studies; Sepsis; Vancomycin | 2016 |
Environmental survival of vancomycin-sensitive ampicillin-resistant Enterococcus faecium (AREfm).
Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Vancomycin | 2015 |
Could ceftaroline be an alternative therapy for linezolid resistant Staphylococcus epidermidis infections in Intensive Care Medicine?
Topics: Anti-Bacterial Agents; Bacteremia; Body Fluids; Catheter-Related Infections; Ceftaroline; Cephalosporins; Critical Care; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Exudates and Transudates; Humans; Linezolid; Methicillin; Minocycline; Staphylococcal Infections; Staphylococcus epidermidis; Tigecycline; Vancomycin | 2015 |
Performance of processes of care and outcomes in patients with Staphylococcus aureus bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cross Infection; Echocardiography; Female; Florida; Hospital Mortality; Hospitals, Teaching; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2016 |
Comparative-effectiveness of vancomycin and linezolid as part of guideline-recommended empiric therapy for healthcare-associated pneumonia.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Female; Humans; Linezolid; Male; Pneumonia, Bacterial; Practice Guidelines as Topic; Retrospective Studies; United States; United States Department of Veterans Affairs; Vancomycin | 2015 |
Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection.
Topics: Aged; Anti-Infective Agents; Bacteremia; Candida; Candidiasis; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Coinfection; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Metronidazole; Multivariate Analysis; Odds Ratio; Risk Factors; Survival Analysis; Treatment Outcome; Vancomycin | 2016 |
Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Comorbidity; Cross Infection; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Prospective Studies; Renal Dialysis; Spain; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2015 |
Evaluation of a Clostridium difficile infection management policy with clinical pharmacy and medical microbiology involvement at a major Canadian teaching hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Canada; Clostridioides difficile; Clostridium Infections; Cross Infection; Disease Management; Female; Hospitals, Teaching; Humans; Length of Stay; Male; Microbiology; Middle Aged; Pharmacy Service, Hospital; Prospective Studies; Retrospective Studies; Severity of Illness Index; Vancomycin; Young Adult | 2015 |
Antimicrobial susceptibility and molecular characteristics of methicillin-resistant Staphylococcus aureus in a Japanese secondary care facility.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cross Infection; Daptomycin; Dibekacin; Exotoxins; Humans; Japan; Leukocidins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Open Reading Frames; Recombinases; Secondary Care Centers; Skin; Soft Tissue Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virulence Factors | 2016 |
Healthcare-associated Staphylococcus aureus Bacteremia in Children: Evidence for Reverse Vancomycin Creep and Impact of Vancomycin Trough Values on Outcome.
Topics: Anti-Bacterial Agents; Bacteremia; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Texas; Vancomycin | 2016 |
Prevalence of Diverse Clones of Vancomycin-Resistant Enterococcus faecium ST78 in a Chinese Hospital.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Carbon-Oxygen Ligases; China; Clone Cells; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Gene Expression; Gene Transfer, Horizontal; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Male; Plasmids; Prevalence; Sequence Analysis, DNA; Vancomycin; Vancomycin-Resistant Enterococci; Virulence Factors | 2016 |
Is Vancomycin-only Prophylaxis for Patients With Penicillin Allergy Associated With Increased Risk of Infection After Arthroplasty?
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement; Cefazolin; Cross Infection; Drug Administration Schedule; Drug Hypersensitivity; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; North Carolina; Odds Ratio; Penicillins; Philadelphia; Protective Factors; Retrospective Studies; Risk Assessment; Risk Factors; Surgical Wound Infection; Time Factors; Treatment Outcome; Vancomycin | 2016 |
[Analysis of pathogen spectrum and resistance of clinical common organisms causing bloodstream infections, hospital-acquired pneumonia and intra-abdominal infections from thirteen teaching hospitals in 2013].
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefepime; Cephalosporins; China; Cross Infection; Hospitals, Teaching; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Minocycline; Pneumonia; Tigecycline; Vancomycin | 2015 |
High frequency of multidrug-resistant Staphylococcus aureus with SCCmec type III and Spa types t037 and t631 isolated from burn patients in southwest of Iran.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Burns; Cross Infection; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Humans; Iran; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2016 |
Enterococcus faecalis as multidrug resistance strains in clinical isolates in Imam Reza Hospital in Kermanshah, Iran.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Erythromycin; Gram-Positive Bacterial Infections; Hospitals; Humans; Iran; Microbial Sensitivity Tests; Polymerase Chain Reaction; Vancomycin; Vancomycin-Resistant Enterococci | 2015 |
Vancomycin-resistant enterococci colonization in a neonatal intensive care unit: who will be infected?
Topics: Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Female; Gram-Positive Bacterial Infections; Humans; Incidence; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Length of Stay; Male; Prospective Studies; Rectum; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin-Resistant Enterococci | 2016 |
Determinants of Outcome in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: Results From National Surveillance in Canada, 2008-2012.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Canada; Child; Child, Preschool; Cross Infection; Female; Hospitals; Humans; Infant; Infant, Newborn; Intensive Care Units; Kaplan-Meier Estimate; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multivariate Analysis; Patient Transfer; Population Surveillance; Prospective Studies; Staphylococcal Infections; Vancomycin; Young Adult | 2016 |
Population structure and acquisition of the vanB resistance determinant in German clinical isolates of Enterococcus faecium ST192.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Chromosome Mapping; Conjugation, Genetic; Cross Infection; Disease Outbreaks; DNA Transposable Elements; Enterococcus faecium; Gene Expression Regulation, Bacterial; Genome, Bacterial; Germany; Gram-Positive Bacterial Infections; High-Throughput Nucleotide Sequencing; Humans; Phylogeny; Vancomycin; Vancomycin Resistance | 2016 |
Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infections.
Topics: Aged; Anti-Bacterial Agents; Critical Care; Cross Infection; Drug Resistance, Microbial; Female; Humans; Intensive Care Units; Intraabdominal Infections; Male; Middle Aged; Time Factors; Treatment Outcome; Vancomycin | 2016 |
Nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus treated with linezolid or vancomycin: A secondary economic analysis of resource use from a Spanish perspective.
Topics: Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Health Care Costs; Humans; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Randomized Controlled Trials as Topic; Treatment Outcome; Vancomycin | 2016 |
Are vancomycin-resistant enterococci a problem in Polish hospitals?
Topics: Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacterial Infections; Humans; Length of Stay; Poland; Prevalence; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2015 |
Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Bayes Theorem; Cross Infection; Female; Hospitalization; Humans; Japan; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pneumonia, Bacterial; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2016 |
Identification of subclinical transmission of vancomycin-resistant enterococcus within an intensive care unit in Taiwan.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Intensive Care Units; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Multilocus Sequence Typing; Taiwan; Tigecycline; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2016 |
Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Communicable Diseases, Emerging; Costa Rica; Cross Infection; Diarrhea; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterocolitis, Pseudomembranous; Fluoroquinolones; Genes, Bacterial; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Typing; Moxifloxacin; Ribotyping; Time Factors; Vancomycin | 2016 |
Emergence of vanA gene among vancomycin-resistant enterococci in a tertiary care hospital of North - East India.
Topics: Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Drug Resistance, Multiple; Enterococcus faecalis; Humans; India; Microbial Sensitivity Tests; Tertiary Care Centers; Vancomycin; Vancomycin-Resistant Enterococci | 2016 |
Antibiotic susceptibility and genomic variations in Staphylococcus aureus associated with Skin and Soft Tissue Infection (SSTI) disease groups.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Toxins; Catheter-Related Infections; Clindamycin; Community-Acquired Infections; Cross Infection; Erythromycin; Exfoliatins; Exotoxins; Female; Genotype; Humans; Leukocidins; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Superantigens; Taiwan; Teicoplanin; Vancomycin; Virulence Factors | 2016 |
Room contamination, patient colonization pressure, and the risk of vancomycin-resistant Enterococcus colonization on a unit dedicated to the treatment of hematologic malignancies and hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Enterococcus; Environmental Microbiology; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Intensive Care Units; Male; Middle Aged; Patients' Rooms; Vancomycin; Vancomycin Resistance; Young Adult | 2016 |
Successful control of emerging vancomycin-resistant enterococci by territory-wide implementation of directly observed hand hygiene in patients in Hong Kong.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Gram-Positive Bacterial Infections; Hand Hygiene; Hong Kong; Hospitals; Humans; Incidence; Infection Control; Prospective Studies; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2016 |
Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Resistance, Bacterial; Feces; Female; Hospitalization; Hospitals; Humans; Immunoassay; Inflammation; Israel; Leukocyte L1 Antigen Complex; Leukocytosis; Male; Metronidazole; Middle Aged; Recurrence; Ribotyping; Severity of Illness Index; Vancomycin; Young Adult | 2016 |
Assessment of free fatty acids and cholesteryl esters delivered in liposomes as novel class of antibiotic.
Topics: Animals; Anti-Bacterial Agents; Cholesterol Esters; Cross Infection; DNA, Bacterial; Drug Combinations; Drug Compounding; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterococcus faecalis; Erythrocytes; Fatty Acids, Nonesterified; Fluorescent Dyes; Hemolysis; Hep G2 Cells; Humans; Liposomes; Microbial Sensitivity Tests; Organic Chemicals; Pseudomonas aeruginosa; Sheep; Staphylococcus epidermidis; Vancomycin | 2016 |
Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Cross Infection; Female; Hospital Mortality; Hospitals, University; Humans; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Propensity Score; Prospective Studies; Republic of Korea; Risk Factors; Sepsis; Vancomycin | 2016 |
Prevalence and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus isolated from clinical samples at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Child; Child, Preschool; Clindamycin; Coagulase; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethiopia; Female; Hospitals; Humans; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Young Adult | 2016 |
Factors associated with 12 week case-fatality in Staphylococcus aureus bacteraemia: a prospective cohort study.
Topics: Aged; Bacteremia; Cross Infection; Female; France; Humans; Male; Middle Aged; Penicillins; Prognosis; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Tertiary Care Centers; Vancomycin | 2016 |
Cost of nosocomial pneumonia: the example of vancomycin versus linezolid-shorter stay or fewer complications?
Topics: Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Hospitalization; Humans; Length of Stay; Linezolid; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Quality of Life; Renal Insufficiency; Vancomycin | 2016 |
Molecular types and antimicrobial susceptibility patterns of Clostridium difficile isolates in different epidemiological settings in a tertiary care center in Israel.
Topics: Adult; Anti-Bacterial Agents; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Genotype; Humans; Israel; Metronidazole; Prospective Studies; Tertiary Care Centers; Vancomycin | 2016 |
ECCMID 2016: addressing the burden of recurrent Clostridium difficile infections.
Topics: Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Congresses as Topic; Cost of Illness; Cross Infection; Enterotoxins; Europe; Gastrointestinal Microbiome; Humans; Netherlands; Vancomycin | 2016 |
Characteristic of Enterococcus faecium clinical isolates with quinupristin/dalfopristin resistance in China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; China; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Prevalence; RNA, Ribosomal, 16S; Vancomycin; Virginiamycin | 2016 |
Linezolid versus vancomycin for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus in the elderly: A retrospective cohort analysis: Effectiveness of linezolid in the elderly.
Topics: Aged; Analysis of Variance; Anti-Bacterial Agents; Body Mass Index; Comorbidity; Cross Infection; Female; Hospital Mortality; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Organ Dysfunction Scores; Outcome Assessment, Health Care; Pneumonia, Staphylococcal; Retrospective Studies; Vancomycin | 2017 |
The Risk Factors, Costs, and Survival Analysis of Invasive VRE Infections at a Medical Center in Eastern Taiwan.
Topics: Adolescent; Anti-Bacterial Agents; Case-Control Studies; Child; Child, Preschool; Cross Infection; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Infant; Length of Stay; Male; Risk Factors; Survival Analysis; Taiwan; Vancomycin; Vancomycin Resistance | 2017 |
Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci.
Topics: Anti-Bacterial Agents; Cross Infection; Enterococcus; Enterococcus faecalis; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2017 |
Is First-Line Vancomycin Still the Best Option to Treat Staphylococcus Health Care-Associated Meningitis?
Topics: Adult; Anti-Bacterial Agents; Catheter-Related Infections; Cerebrospinal Fluid Shunts; Cross Infection; Female; Humans; Infusions, Intravenous; Male; Meningitis, Bacterial; Middle Aged; Retrospective Studies; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin | 2017 |
Prospective study analyzing risk factors and characteristics of healthcare-associated infections in a Urology ward.
Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catheters, Indwelling; Cross Infection; Cystectomy; Drug Resistance, Microbial; Enterococcus; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Hospital Units; Humans; Immunosuppression Therapy; Incidence; Klebsiella; Klebsiella Infections; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Surgical Wound Infection; Urinary Catheters; Urinary Tract Infections; Urology; Vancomycin | 2017 |
Measures to Prevent and Control Vancomycin-Resistant Enterococci: Do They Really Matter?
Topics: Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacterial Infections; Humans; United States; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2017 |
Sphygmomanometers and thermometers as potential fomites of Staphylococcus haemolyticus: biofilm formation in the presence of antibiotics.
Topics: Anti-Bacterial Agents; Biofilms; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fomites; Humans; Microbial Sensitivity Tests; Oxacillin; Sphygmomanometers; Staphylococcal Infections; Staphylococcus haemolyticus; Thermometers; Vancomycin | 2017 |
Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.
Topics: Adult; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endocarditis, Bacterial; Gene Expression; Humans; Male; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Staphylococcal Infections; Vancomycin | 2017 |
Real-Time Electronic Tracking of Diarrheal Episodes and Laxative Therapy Enables Verification of Clostridium difficile Clinical Testing Criteria and Reduction of Clostridium difficile Infection Rates.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Electronic Data Processing; Enterocolitis, Pseudomembranous; Evidence-Based Medicine; Female; Hospital Information Systems; Humans; Laxatives; Male; Metronidazole; Middle Aged; Vancomycin | 2017 |
Variability in vancomycin use in newborn intensive care units determined from data in an electronic medical record.
Topics: Anti-Bacterial Agents; Cross Infection; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Male; Medical Records Systems, Computerized; Nafcillin; Oxacillin; Vancomycin | 2008 |
Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Endocarditis; Female; Hospitals; Humans; Male; Methicillin Resistance; Middle Aged; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Taiwan; Teicoplanin; Treatment Outcome; Vancomycin | 2008 |
First report of clinical and epidemiological characterisation of vancomycin-resistant enterococci from mainland China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Case-Control Studies; China; Cross Infection; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Length of Stay; Multivariate Analysis; Risk Factors; Vancomycin; Vancomycin Resistance | 2008 |
Characterization of glycopeptides, aminoglycosides and macrolide resistance among Enterococcus faecalis and Enterococcus faecium isolates from hospitals in Tehran.
Topics: Acetyltransferases; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Genes, Bacterial; Gentamicins; Humans; Iran; Kanamycin Kinase; Methyltransferases; Phosphotransferases (Alcohol Group Acceptor); Vancomycin; Vancomycin Resistance | 2008 |
Nosocomial outbreak of Enteroccocus gallinarum: untaming of rare species of enterococci.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Child; Child, Preschool; Colombia; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Species Specificity; Vancomycin; Vancomycin Resistance; Young Adult | 2008 |
Frequency of mecA gene and borderline oxacillin resistant Staphylococcus aureus in nosocomial acquired methicillin resistance Staphylococcus aureus infections.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Humans; Infectious Disease Transmission, Professional-to-Patient; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Penicillin-Binding Proteins; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Mortality and time to extubation in severe hospital-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Cross Infection; Female; Hospitals; Humans; Intensive Care Units; Intubation, Intratracheal; Male; Middle Aged; Pneumonia; Risk Factors; Time Factors; Vancomycin | 2009 |
Emergence of the vanA genotype among Enterococcus gallinarum isolates colonising the intestinal tract of patients in a university hospital in Rio de Janeiro, Brazil.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Brazil; Carbon-Oxygen Ligases; Carrier State; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Gastrointestinal Tract; Genotype; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Microbial Sensitivity Tests; Peptide Synthases; Teicoplanin; Vancomycin; Vancomycin Resistance; Young Adult | 2009 |
Methicillin-resistant Staphylococcus aureus bacteraemia and mortality in a teaching hospital.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Community-Acquired Infections; Cross Infection; Female; Hospitals, Teaching; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Staphylococcal Infections; United Kingdom; Vancomycin; Young Adult | 2009 |
Imipenem-resistant Pseudomonas aeruginosa: risk factors for nosocomial infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Vancomycin | 2008 |
Septicemic arthritis with antibiotic resistance: a case study.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Arthritis, Infectious; Arthritis, Rheumatoid; Bacteremia; beta-Lactam Resistance; Cross Infection; Escherichia coli; Escherichia coli Infections; Fatal Outcome; Humans; Leukopenia; Male; Middle Aged; Nafcillin; Prednisone; Staphylococcal Infections; Vancomycin | 2008 |
Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carrier State; Cross Infection; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Korea; Male; Middle Aged; Prevalence; Prospective Studies; Rectum; Risk Factors; Vancomycin; Vancomycin Resistance | 2009 |
Outbreak of vancomycin-resistant enterococcus colonization among pediatric oncology patients.
Topics: Adolescent; Anti-Bacterial Agents; Case-Control Studies; Child; Child, Preschool; Cross Infection; Disease Outbreaks; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, Pediatric; Humans; Infection Control; Male; Oncology Service, Hospital; Philadelphia; Prevalence; Risk Factors; Vancomycin; Vancomycin Resistance | 2009 |
Significant reduction in stereotactic and functional neurosurgical hardware infection after local neomycin/polymyxin application.
Topics: Administration, Topical; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Cross Infection; Cross-Sectional Studies; Deep Brain Stimulation; Drug Therapy, Combination; Electric Stimulation; Female; Humans; Incidence; Infusion Pumps, Implantable; Infusions, Intravenous; Male; Middle Aged; Neomycin; Polymyxin B; Prostheses and Implants; Retrospective Studies; Risk Factors; Staphylococcal Infections; Stereotaxic Techniques; Surgical Wound Infection; Vancomycin | 2009 |
Cost-effectiveness of linezolid vs vancomycin in suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Decision Support Techniques; Drug Costs; Female; Germany; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Models, Economic; Oxazolidinones; Pneumonia, Staphylococcal; Retrospective Studies; Vancomycin | 2009 |
Surveillance of intrahospital infections at the clinic for gynaecology and obstetrics.
Topics: Anti-Bacterial Agents; Bosnia and Herzegovina; Cefepime; Cephalosporins; Cross Infection; Female; Humans; Imipenem; Klebsiella pneumoniae; Obstetrics and Gynecology Department, Hospital; Population Surveillance; Prevalence; Prospective Studies; Proteus mirabilis; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus; Surgical Wound Infection; Urinary Tract Infections; Vancomycin | 2009 |
Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2009 |
Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model
Topics: Anti-Bacterial Agents; Cephalosporins; Colony Count, Microbial; Community-Acquired Infections; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
[Glycopeptide-resistant Enterococcus faecium in a hospital in northern Spain. Molecular characterization and clinical epidemiology].
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Genes, Bacterial; Glycopeptides; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors; Spain; Vancomycin; Virulence | 2009 |
[Glycopeptide-resistant enterococci carriage: Are actual isolation and identification techniques sufficient?].
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; Carbon-Oxygen Ligases; Carrier State; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus; Feces; Female; France; Glycopeptides; Gram-Positive Bacterial Infections; Hospital Units; Humans; Male; Mass Screening; Middle Aged; Peptide Synthases; Reagent Kits, Diagnostic; Rectum; Species Specificity; Vancomycin; Vancomycin Resistance; Young Adult | 2011 |
Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Cross Infection; Daptomycin; Endocarditis, Bacterial; Humans; Linezolid; Liver Transplantation; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Salvage Therapy; Staphylococcal Infections; Treatment Failure; Treatment Outcome; Vancomycin | 2009 |
[Vancomycin resistant Enterococci (VRE)].
Topics: Anti-Bacterial Agents; Cross Infection; Enterococcus faecium; Europe; France; Gram-Positive Bacterial Infections; Humans; Immunocompromised Host; Infection Control; Vancomycin; Vancomycin Resistance | 2009 |
[Interventions implemented to control an outbreak of vancomycin-resistant enterococci in a university hospital].
Topics: Anti-Bacterial Agents; Carrier State; Cross Infection; Disease Outbreaks; Enterococcus faecium; France; Gram-Positive Bacterial Infections; Hand Disinfection; Hospitals, University; Humans; Infection Control; Practice Guidelines as Topic; Protective Clothing; Urinary Tract Infections; Vancomycin; Vancomycin Resistance | 2009 |
[Control measures for a VRE outbreak in a haemodialysis unit].
Topics: Anti-Bacterial Agents; Carrier State; Cross Infection; Disease Outbreaks; Disinfection; Enterococcus faecium; Equipment Contamination; France; Gram-Positive Bacterial Infections; Hemodialysis Units, Hospital; Humans; Patient Isolation; Protective Clothing; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2009 |
Influence of vancomycin on renal function in critically ill patients after cardiac surgery: continuous versus intermittent infusion.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; C-Reactive Protein; Cardiac Surgical Procedures; Creatinine; Critical Care; Critical Illness; Cross Infection; Female; Hemofiltration; Humans; Infusions, Intravenous; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Vancomycin; Young Adult | 2009 |
Risk factors for treatment failure in patients receiving vancomycin for hospital-acquired methicillin-resistant Staphylococcus aureus pneumonia.
Topics: Aged; Animals; Anti-Bacterial Agents; Critical Care; Cross Infection; Drug Utilization; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Retrospective Studies; Risk Factors; Treatment Failure; Vancomycin | 2010 |
Use of International Classification of Diseases, Ninth Revision, Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Cross-Sectional Studies; Female; Humans; International Classification of Diseases; Male; Medical Records Systems, Computerized; Metronidazole; Middle Aged; Predictive Value of Tests; Sensitivity and Specificity; United States; United States Dept. of Health and Human Services; Vancomycin | 2009 |
Vancomycin dosing for pneumonia in critically ill trauma patients.
Topics: Adult; Anti-Bacterial Agents; Comorbidity; Critical Illness; Cross Infection; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Vancomycin; Wounds and Injuries | 2009 |
Analysis of clonality and antibiotic resistance among early clinical isolates of Enterococcus faecium in the United States.
Topics: Ampicillin Resistance; Bacterial Typing Techniques; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Sequence Analysis, DNA; United States; Vancomycin; Virulence | 2009 |
The effect of an antibiotic policy on the control of vancomycin-resistant enterococci outbreak and on the resistance patterns of bacteria isolated from the blood of patients in a hematology unit.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Enterococcus faecium; Follow-Up Studies; Gram-Positive Bacterial Infections; Guideline Adherence; Hematologic Diseases; Humans; Infection Control; Inpatients; Poland; Practice Guidelines as Topic; Vancomycin; Vancomycin Resistance | 2009 |
Telavancin.
Topics: Adult; Aminoglycosides; Animals; Anti-Bacterial Agents; Cross Infection; Disease Models, Animal; Drug Administration Schedule; Drug Interactions; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; Humans; Lipoglycopeptides; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Skin Diseases, Infectious; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2009 |
Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006.
Topics: Anti-Bacterial Agents; Canada; Cross Infection; Drug Resistance, Multiple, Bacterial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2010 |
Evaluation of glycopeptide use in nine French hospitals.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Dose-Response Relationship, Drug; Drug Monitoring; Drug Prescriptions; Drug Resistance, Microbial; Drug Utilization Review; France; Guideline Adherence; Hospitals; Hospitals, Private; Hospitals, Public; Hospitals, University; Humans; Infusions, Intravenous; Prospective Studies; Teicoplanin; Vancomycin; Vancomycin Resistance | 2010 |
Addition of rifampin to vancomycin for the treatment of pneumonias due to methicillin-resistant Staphylococcus aureus: caveat emptor.
Topics: Critical Care; Cross Infection; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Prognosis; Rifampin; Severity of Illness Index; Survival Rate; Treatment Outcome; Vancomycin | 2010 |
[Dosage adjustment of vancomycin in continuous infusion in critically ill-patients].
Topics: Anti-Bacterial Agents; Clinical Protocols; Critical Care; Critical Illness; Cross Infection; Dose-Response Relationship, Drug; Drug Monitoring; Hospitals, University; Humans; Infusions, Intravenous; Methicillin-Resistant Staphylococcus aureus; Recovery Room; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Vancomycin | 2010 |
In vitro inhibition of vancomycin-susceptible and vancomycin-resistant Enterococcus faecium and E. faecalis in the presence of citrus essential oils.
Topics: Anti-Bacterial Agents; Citrus; Cross Infection; Drug Combinations; Enterococcus faecalis; Enterococcus faecium; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Oils, Volatile; Plant Oils; Temperature; Vancomycin; Vancomycin Resistance | 2009 |
Continuing diarrhoea after ten days of oral metronidazole or oral vancomycin for presumed, hospital-acquired Clostridium difficile colitis in elderly hospital patients.
Topics: Aged, 80 and over; Albumins; Anti-Bacterial Agents; C-Reactive Protein; Clostridioides difficile; Clostridium Infections; Creatinine; Cross Infection; Diarrhea; Female; Hospitals; Humans; Leukocyte Count; Male; Metronidazole; Time Factors; United Kingdom; Vancomycin | 2010 |
Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008).
Topics: Anti-Bacterial Agents; Colony Count, Microbial; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Europe; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin | 2010 |
The use of prophylactic vancomycin to prevent MRSA colonization: does this double-edged sword promote future vancomycin resistance or is it a safe preventative strategy that should be used in all patients in the context of MRSA endemicity?
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2010 |
Topical oropharyngeal vancomycin to control methicillin-resistant Staphylococcus aureus lower airway infection in ventilated patients.
Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Carrier State; Critical Care; Cross Infection; Endpoint Determination; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oropharynx; Respiration, Artificial; Respiratory Tract Infections; Staphylococcal Infections; Vancomycin; Young Adult | 2010 |
In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates.
Topics: Acetamides; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Drug Synergism; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Tobramycin; Vancomycin | 2010 |
Nosocomial bacterial meningitis.
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Infusions, Intravenous; Meningitis, Bacterial; Vancomycin | 2010 |
Lack of increased colonization with vancomycin-resistant enterococci during preferential use of vancomycin for treatment during an outbreak of healthcare-associated Clostridium difficile infection.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Disease Outbreaks; Enterococcus; Enterocolitis, Pseudomembranous; Female; Hospitals, University; Humans; Incidence; Male; Quebec; Vancomycin; Vancomycin Resistance | 2010 |
Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Cause of Death; Cross Infection; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hospital Mortality; Humans; Intensive Care Units; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Staphylococcal Infections; Survival Analysis; Treatment Outcome; Vancomycin | 2010 |
Increase in use of vancomycin for Clostridium difficile infection in US hospitals.
Topics: Academic Medical Centers; Adult; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; United States; Vancomycin; Young Adult | 2010 |
Vancomycin plus rifampicin for methicillin-resistant Staphylococcus aureus pneumonia benefits only those who have no development of rifampicin resistance during treatment.
Topics: Critical Care; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intensive Care Units; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Rifampin; Risk Assessment; Treatment Outcome; Vancomycin | 2010 |
Methicillin-resistant Staphylococcus aureus nasal colonization is a poor predictor of intensive care unit-acquired methicillin-resistant Staphylococcus aureus infections requiring antibiotic treatment.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Female; Humans; Intensive Care Units; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Nasal Cavity; Predictive Value of Tests; Prospective Studies; ROC Curve; Sensitivity and Specificity; Staphylococcal Infections; Vancomycin; Young Adult | 2010 |
Improvement in vancomycin utilization in adults in a Saudi Arabian Medical Center using the Hospital Infection Control Practices Advisory Committee guidelines and simple educational activity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Utilization; Education, Medical, Continuing; Female; Guideline Adherence; Humans; Infection Control; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Practice Guidelines as Topic; Saudi Arabia; Staphylococcal Infections; United States; Vancomycin | 2009 |
Vancomycin, unbeatable for methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia? Really?
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Staphylococcal Infections; Vancomycin | 2010 |
The risk of biomaterial-associated infection after revision surgery due to an experimental primary implant infection.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Biofilms; Cross Infection; Equipment Contamination; Implants, Experimental; Mice; Prosthesis-Related Infections; Reoperation; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2010 |
A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E. faecium sequence type 203.
Topics: Anti-Bacterial Agents; Australia; Bacteremia; Bacterial Proteins; Bacterial Typing Techniques; Communicable Diseases, Emerging; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Genomics; Gram-Positive Bacterial Infections; Humans; Incidence; Meropenem; Microbial Sensitivity Tests; Phylogeny; Thienamycins; Vancomycin; Vancomycin Resistance | 2010 |
What is MRSA?
Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Staphylococcal Infections; Vancomycin | 2010 |
Increase of ceftazidime- and fluoroquinolone-resistant Klebsiella pneumoniae and imipenem-resistant Acinetobacter spp. in Korea: analysis of KONSAR study data from 2005 and 2007.
Topics: Acinetobacter; Bacterial Infections; Ceftazidime; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Pseudomonas aeruginosa; Republic of Korea; Vancomycin | 2010 |
Correlation between antimicrobial consumption and resistance among Staphylococcus aureus and enterococci causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Enterococcus; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Staphylococcus aureus; Taiwan; Teicoplanin; Vancomycin | 2011 |
Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?
Topics: Aged; Aged, 80 and over; Bacteremia; beta-Lactamases; beta-Lactams; Cross Infection; Drug Combinations; Drug Evaluation; Female; Humans; Logistic Models; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2011 |
[Enterococci resistant to glycopeptides].
Topics: Chromosomes, Bacterial; Community-Acquired Infections; Cross Infection; Dipeptides; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecium; Europe; France; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Vancomycin | 2010 |
Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Resistance, Bacterial; England; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2011 |
Reduction in external ventricular drain infection rate. Impact of a minimal handling protocol and antibiotic-impregnated catheters.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Catheters, Indwelling; Cerebrospinal Fluid; Cerebrospinal Fluid Shunts; Clindamycin; Coated Materials, Biocompatible; Cross Infection; Equipment Contamination; Humans; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Surgical Wound Infection; Vancomycin | 2011 |
Vancomycin treatment vs comparator drugs.
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Pneumonia, Ventilator-Associated; Staphylococcal Infections; Vancomycin | 2011 |
Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia.
Topics: Aged; Anti-Bacterial Agents; APACHE; Cohort Studies; Cross Infection; Dose-Response Relationship, Drug; Female; Humans; Male; Medical Audit; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Staphylococcal; Republic of Korea; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2011 |
Molecular epidemiology of Enterococcus faecium isolates from an Italian hospital.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Cluster Analysis; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Italy; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Vancomycin | 2011 |
Clonal dissemination of vanA positive Enterococcus species in tertiary care hospitals in Karachi, Pakistan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Cross-Sectional Studies; DNA Fingerprinting; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Genotype; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Pakistan; Polymerase Chain Reaction; Prevalence; Vancomycin; Vancomycin Resistance | 2010 |
Changing trends in vancomycin-resistant enterococci in French hospitals, 2001-08.
Topics: Bacterial Proteins; Bacterial Typing Techniques; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterococcus; France; Genotype; Gram-Positive Bacterial Infections; Hospitals; Humans; Membrane Proteins; Microbial Sensitivity Tests; Molecular Typing; Multilocus Sequence Typing; Vancomycin; Vancomycin Resistance | 2011 |
Outcomes associated with AUC24/MIC nomogram dosing of vancomycin.
Topics: Anti-Bacterial Agents; Area Under Curve; Cohort Studies; Cross Infection; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nomograms; Pneumonia; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2011 |
Increased risk of vancomycin-resistant enterococcus (VRE) infection among patients hospitalized for inflammatory bowel disease in the United States.
Topics: Adult; Case-Control Studies; Chi-Square Distribution; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospital Costs; Hospitalization; Humans; Inflammatory Bowel Diseases; Length of Stay; Logistic Models; Male; Middle Aged; Odds Ratio; Prevalence; Risk Factors; United States; Vancomycin | 2011 |
The microbiology of secondary and postoperative pancreatic infections: implications for antimicrobial management.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Bacterial Infections; Cross Infection; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Male; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Mycoses; Pancreatectomy; Pancreatic Pseudocyst; Pancreatitis; Pancreatitis, Acute Necrotizing; Reoperation; Retrospective Studies; Risk Factors; Sepsis; Surgical Wound Infection; Tennessee; Vancomycin; Vancomycin Resistance | 2011 |
On a different level: telavancin versus vancomycin for hospital-acquired pneumonia.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Pneumonia, Bacterial; Treatment Outcome; Vancomycin | 2011 |
Impact of accessory gene regulator (agr) dysfunction on vancomycin pharmacodynamics among Canadian community and health-care associated methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Canada; Community-Acquired Infections; Cross Infection; Hemolysin Proteins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Trans-Activators; Vancomycin | 2011 |
The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Cost Savings; Cross Infection; Drug Costs; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization; Escherichia; Health Policy; Hospitals; Humans; Imipenem; Klebsiella; Meropenem; Methicillin Resistance; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Staphylococcus aureus; Teicoplanin; Thienamycins; Turkey; Vancomycin | 2011 |
Prevalence of vanC vancomycin-resistant enterococci in the teaching hospitals of the University of Debrecen, Hungary.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Genes, Bacterial; Gentamicins; Hospitals, Teaching; Humans; Hungary; Longitudinal Studies; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Phylogeny; Prevalence; Vancomycin; Vancomycin Resistance | 2012 |
Activity of vancomycin, ciprofloxacin, daptomycin, and linezolid against coagulase-negative staphylococci bacteremia.
Topics: Acetamides; Bacteremia; Catheter-Related Infections; Ciprofloxacin; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Hospital Departments; Hospitals, University; Humans; Length of Stay; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Spain; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Staphylococcus hominis; Vancomycin | 2011 |
[Microbial spectrum of nosocomial pneumonia in traumatological patients].
Topics: Acetamides; Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bacteria; Carbapenems; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Female; Hospitals; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin; Wounds and Injuries | 2011 |
Is linezolid a risk factor for Gram-negative bacillus infections in intensive care unit patients? A comparative study with vancomycin.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Comorbidity; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Length of Stay; Linezolid; Male; Middle Aged; Oxazolidinones; Renal Insufficiency; Retrospective Studies; Risk Factors; Vancomycin | 2011 |
Preoperative nasal methicillin-resistant Staphylococcus aureus status, surgical prophylaxis, and risk-adjusted postoperative outcomes in veterans.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Boston; Cohort Studies; Cross Infection; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multivariate Analysis; Nasal Mucosa; Poisson Distribution; Retrospective Studies; Risk Adjustment; Risk Factors; Staphylococcal Infections; Surgical Wound Infection; Treatment Outcome; Vancomycin; Veterans Health | 2011 |
An unusual cause of continuous ambulatory peritoneal dialysis-associated outpatient peritonitis: Stenotrophomonas maltophilia.
Topics: Anti-Bacterial Agents; Ceftazidime; Cross Infection; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Middle Aged; Outpatients; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Stenotrophomonas maltophilia; Vancomycin | 2011 |
Antibiotic susceptibility of coagulase-negative staphylococci (CoNS): emergence of teicoplanin-non-susceptible CoNS strains with inducible resistance to vancomycin.
Topics: Anti-Bacterial Agents; Chi-Square Distribution; China; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Agar Gel; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Retrospective Studies; Staphylococcal Infections; Staphylococcus; Teicoplanin; Vancomycin | 2011 |
Vancomycin-resistant Enterococci. Prevalence and risk factors for fecal carriage in patients at tertiary care hospitals.
Topics: Academic Medical Centers; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Feces; Gram-Positive Bacterial Infections; Humans; Prevalence; Risk Factors; Saudi Arabia; Vancomycin | 2011 |
Regional spread and control of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Kyoto, Japan.
Topics: Anti-Bacterial Agents; Carrier State; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Enterococcus faecium; Feces; Genotype; Gram-Positive Bacterial Infections; Humans; Infection Control; Japan; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance | 2012 |
Recognizing metronidazole resistant C. difficile.
Topics: Anti-Infective Agents; Clostridioides difficile; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Humans; Metronidazole; Middle Aged; Opportunistic Infections; Probiotics; Recurrence; Vancomycin | 2011 |
Emergence of vancomycin-resistant Staphylococcus aureus identified in the Tlemcen university hospital (North-West Algeria).
Topics: Adult; Aged; Algeria; Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Female; Fosfomycin; Gentamicins; Hospitals, University; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Rifampin; Staphylococcal Infections; Surgical Wound Infection; Vancomycin; Vancomycin Resistance | 2011 |
Preventing downstream Clostridium difficile infections with upstream antibiotic management.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Humans; Metronidazole; Risk Factors; Secondary Prevention; Vancomycin | 2012 |
[Evaluation of vancomycin, teicoplanin, linezolide and tigecycline susceptibilities of nosocomial methicillin-resistant Staphylococcus strains by E-test].
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Turkey; Vancomycin | 2011 |
Factors associated with post-operative conversion to methicillin-resistant Staphylococcus aureus positivity or infection in initially MRSA-negative patients.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Chlorhexidine; Cross Infection; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Nasopharyngeal Diseases; Postoperative Complications; Risk Assessment; Risk Factors; Staphylococcal Infections; Vancomycin | 2011 |
[Antibiotic susceptibility of isolates from blood of patients in intensive care units of emergency medical service].
Topics: Acetamides; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Candida; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infection Control; Intensive Care Units; Linezolid; Meropenem; Moscow; Oxazolidinones; Sepsis; Thienamycins; Vancomycin | 2011 |
[Antibiotic resistance dynamics and isolation rate of staphylococci and enterococci from patients of reconstructive surgery units].
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Cefoxitin; Cross Infection; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Fusidic Acid; Gram-Positive Bacterial Infections; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Moscow; Oxacillin; Oxazolidinones; Rifampin; Surgery, Plastic; Vancomycin | 2011 |
Vancomycin resistance among methicillin resistant Staphylococcus aureus isolates from intensive care units of tertiary care hospitals in Hyderabad.
Topics: Anti-Infective Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; India; Intensive Care Units; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2011 |
Vancomycin-resistant enterococcus outbreak in a pediatric intensive care unit: report of successful interventions for control and prevention.
Topics: Anti-Bacterial Agents; Child; Cross Infection; Disease Outbreaks; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Infection Control; Intensive Care Units, Pediatric; Male; Program Evaluation; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2012 |
Healthcare-associated risk factors of vancomycin-resistant Enterococci colonization among outpatients undergoing hemodialysis.
Topics: Aged; Blood Urea Nitrogen; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Feces; Female; Genetic Variation; Gram-Positive Bacterial Infections; Hemoglobins; Hospitalization; Humans; Male; Middle Aged; Platelet Count; Prevalence; Renal Dialysis; Risk Factors; Serum Albumin; Vancomycin; Vancomycin Resistance | 2012 |
True bacteremias caused by coagulase negative Staphylococcus are difficult to distinguish from blood culture contaminants.
Topics: Adult; Aged; Aged, 80 and over; Bacteremia; Blood Pressure; Body Temperature; Central Venous Catheters; Coagulase; Community-Acquired Infections; Cross Infection; Diagnosis, Differential; Female; Gentian Violet; Hematologic Diseases; Humans; Male; Middle Aged; Phenazines; Retrospective Studies; Staphylococcal Infections; Staphylococcus; Vancomycin | 2012 |
Vancomycin-resistant Enterococci in Singaporean hospitals: 5-year results of a multi-centre surveillance programme.
Topics: Anti-Bacterial Agents; Cross Infection; Enterococcus; Gram-Positive Bacterial Infections; Hospitals, Public; Humans; Population Surveillance; Singapore; Vancomycin; Vancomycin Resistance | 2012 |
Potential for transmission of Clostridium difficile by asymptomatic acute care patients and long-term care facility residents with prior C. difficile infection.
Topics: Aged; Anti-Bacterial Agents; Asymptomatic Infections; Bacterial Shedding; Clostridioides difficile; Clostridium Infections; Critical Care; Cross Infection; Female; Hospitals, Veterans; Humans; Male; Ohio; Patient Isolation; Residential Facilities; Time Factors; Vancomycin | 2012 |
Evaluation of a hand-held far-ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens.
Topics: Clostridioides difficile; Colony Count, Microbial; Cross Infection; Decontamination; Disinfection; Drug Resistance; Enterococcus; Enterocolitis, Pseudomembranous; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Ultraviolet Rays; Vancomycin | 2012 |
A 5-year retrospective review of experience with Clostridium difficile-associated diarrhea.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hospitals, Military; Humans; Incidence; Inpatients; Male; Medical Records Systems, Computerized; Metronidazole; Middle Aged; Military Medicine; Outpatients; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; United States; Vancomycin; Veterans | 2012 |
High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Kaplan-Meier Estimate; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Republic of Korea; Retrospective Studies; Shock, Septic; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2012 |
Association between drug resistance & production of biofilm in staphylococci.
Topics: Biofilms; Cross Infection; Drug Resistance; Humans; Methicillin-Resistant Staphylococcus aureus; Teicoplanin; Vancomycin | 2012 |
Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cohort Studies; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Gastrointestinal Tract; Germany; Humans; Logistic Models; Male; Middle Aged; Neoplasms; Prospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance; Young Adult | 2012 |
Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage.
Topics: Alabama; Anti-Bacterial Agents; Ceftriaxone; Contraindications; Cross Infection; Enterococcus; Female; Hospitals, Urban; Humans; Male; Middle Aged; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2012 |
Hot and steamy: outbreak of Bacillus cereus in Singapore associated with construction work and laundry practices.
Topics: Anti-Bacterial Agents; Bacillus cereus; Cross Infection; Disease Outbreaks; Environmental Microbiology; Gram-Positive Bacterial Infections; Hospital Design and Construction; Hospitals, University; Humans; Laundry Service, Hospital; Singapore; Vancomycin | 2012 |
Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospital Mortality; Hospitals, University; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Staphylococcal Infections; Taiwan; Vancomycin; Vancomycin Resistance | 2012 |
Isolation and molecular characterization of methicillin-resistant staphylococci from horses, personnel and environmental sites at an equine hospital in Turkey.
Topics: Animal Technicians; Animals; Cross Infection; DNA Primers; Electrophoresis, Gel, Pulsed-Field; Genes, MDR; Horse Diseases; Horses; Humans; Methicillin Resistance; Polymerase Chain Reaction; Rifampin; Species Specificity; Staphylococcal Infections; Staphylococcus; Turkey; Vancomycin; Virginiamycin | 2012 |
Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; France; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 500 and over; Hospitals, Teaching; Humans; Infection Control; Microbial Sensitivity Tests; Practice Guidelines as Topic; Program Evaluation; Prospective Studies; Vancomycin; Vancomycin Resistance | 2012 |
Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Cohort Studies; Community-Acquired Infections; Cross Infection; Female; Genotype; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Penicillin-Binding Proteins; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2012 |
Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia: implications of the ZEPHyR trial.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin | 2012 |
Pet animals and foreign travel are risk factors for colonisation with extended-spectrum β-lactamase-producing Escherichia coli.
Topics: Animals; beta-Lactamases; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Multivariate Analysis; Pets; Prevalence; Risk Factors; Surveys and Questionnaires; Time Factors; Travel; Vancomycin; Vancomycin Resistance | 2012 |
A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Culture Media; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Nasal Cavity; Pharynx; Pneumonia; Retrospective Studies; Survival Analysis; Vancomycin | 2013 |
Accessory gene regulator (agr) dysfunction in Staphylococcus aureus bloodstream isolates from South Korean patients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clone Cells; Cross Infection; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Mutation; Republic of Korea; Staphylococcal Infections; Tertiary Care Centers; Trans-Activators; Vancomycin; Vancomycin Resistance | 2013 |
Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
Topics: Academic Medical Centers; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Cross Infection; Female; Hospitals; Humans; Length of Stay; Male; Middle Aged; Patient Readmission; Retrospective Studies; Severity of Illness Index; Treatment Outcome; United States; Vancomycin | 2012 |
Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Hospitals; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Prospective Studies; Risk Factors; Spain; Staphylococcal Infections; Survival Analysis; Treatment Outcome; Vancomycin | 2013 |
[Comparison of Phoenix Automated System, API ID 32 Strep System and LightCycler Enterococcus MGRADE System in the Identification of Clinical Enterococcus Isolates].
Topics: Cross Infection; Enterococcus; Germany; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Streptococcal Infections; Vancomycin | 2013 |
Timing of initiating glycopeptide therapy for methicillin-Resistant Staphylococcus aureus bacteremia: the impact on clinical outcome.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cross Infection; Female; Hospital Mortality; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Staphylococcal Infections; Survival Rate; Teicoplanin; Time Factors; Treatment Outcome; Vancomycin | 2013 |
Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features.
Topics: Adolescent; Belgium; Cross Infection; Drug Therapy, Combination; Female; Fusidic Acid; Genotype; Hospitals, University; Humans; Infusions, Intravenous; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2002 |
The killer bug.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Industry; Drug Resistance, Bacterial; Humans; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin | 2002 |
Empirical treatment of adult postsurgical nosocomial meningitis.
Topics: Adult; Aged; Cefotaxime; Central Nervous System Diseases; Cerebrospinal Fluid Shunts; Craniotomy; Cross Infection; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Meningitis, Aseptic; Meningitis, Bacterial; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Staphylococcal Infections; Surgical Wound Infection; Treatment Outcome; Vancomycin | 2002 |
Effectiveness of pharmacy policies designed to limit inappropriate vancomycin use: a population-based assessment.
Topics: Anti-Bacterial Agents; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Utilization Review; Gram-Positive Bacterial Infections; Health Services Misuse; Humans; Infection Control; Oregon; Organizational Policy; Pharmacy Service, Hospital; Practice Guidelines as Topic; United States; Vancomycin; Vancomycin Resistance | 2002 |
A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cross Infection; Enterococcus faecium; Genes, Bacterial; Humans; Hyaluronoglucosaminidase; Membrane Proteins; Vancomycin; Vancomycin Resistance; Virulence | 2003 |
Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
Topics: Anti-Bacterial Agents; Bacteremia; Clindamycin; Cross Infection; Erythromycin; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin | 2002 |
Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Child, Preschool; Clostridioides difficile; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Enterococcus faecium; Enterocolitis, Pseudomembranous; Female; Gram-Positive Bacterial Infections; Hospitals, Urban; Humans; Korea; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance | 2003 |
Examination of severe, hospital acquired infections affecting extremely low birthweight (ELBW) infants.
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Japan; Methicillin Resistance; Prognosis; Staphylococcal Infections; Vancomycin | 2003 |
Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid.
Topics: Acetamides; Aged; Cross Infection; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Oxazolidinones; Point Mutation; RNA, Ribosomal, 23S; Vancomycin; Vancomycin Resistance | 2003 |
Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in a Greek tertiary care hospital, over an 8-year-period.
Topics: Cross Infection; Drug Resistance, Multiple, Bacterial; Gentamicins; Greece; Hospitals, General; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Screening and electronic labelling of ward contacts of vancomycin-resistant Enterococcus faecium vanB carriers during a single-strain hospital outbreak and after discharge from hospital.
Topics: Carrier State; Contact Tracing; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Mass Screening; Patient Discharge; Rectum; Risk Factors; Vancomycin | 2003 |
Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital.
Topics: Anti-Bacterial Agents; Cross Infection; Endemic Diseases; Enterococcus; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Infection Control; Vancomycin; Vancomycin Resistance | 2003 |
Surgical-site infection following spinal fusion: a case-control study in a children's hospital.
Topics: Adolescent; Antibiotic Prophylaxis; Bacterial Infections; Case-Control Studies; Cefazolin; Child; Child, Preschool; Cross Infection; Female; Hospitals, Pediatric; Hospitals, University; Humans; Male; Nervous System Malformations; Outcome and Process Assessment, Health Care; Quebec; Risk Factors; Spinal Fusion; Surgical Wound Infection; Vancomycin | 2003 |
Phenotypic and genotypic characterization of VanA Enterococcus isolated during the first nosocomial outbreak in Brazil.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Brazil; Carbon-Oxygen Ligases; Cross Infection; DNA Primers; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance | 2003 |
Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit.
Topics: Aged; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Intensive Care Units; Length of Stay; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance | 2003 |
TREATMENT OF RESISTANT INFECTIONS.
Topics: Amphotericin B; Anti-Bacterial Agents; Bacitracin; Chloramphenicol; Cross Infection; Drug Hypersensitivity; Drug Resistance; Drug Resistance, Microbial; Erythromycin; Kanamycin; Methicillin; Mycoses; Penicillins; Staphylococcal Infections; Streptococcal Infections; Tetracycline; Toxicology; Vancomycin | 1964 |
[PRESENCE OF PATHOGENIC STAPHYLOCOCCI IN A PEDIATRIC CLINIC AND THEIR SENSITIVITY TO ANTIBIOTICS].
Topics: Anti-Bacterial Agents; Bacitracin; Chloramphenicol; Chlortetracycline; Cross Infection; Czechoslovakia; Drug Resistance; Drug Resistance, Microbial; Erythromycin; Hospitals; Kanamycin; Outpatient Clinics, Hospital; Pediatrics; Penicillin G; Staphylococcus; Streptomycin; Vancomycin | 1964 |
[PRESENT STATUS OF THE TREATMENT OF STAPHYLOCOCCAL DISEASES].
Topics: Anti-Bacterial Agents; Cross Infection; Drug Therapy; Humans; Methicillin; Oxacillin; Penicillin G; Penicillins; Probenecid; Rifamycins; Staphylococcal Infections; Vancomycin | 1965 |
[Enterococcal infections in critically ill patients admitted to ICU].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Critical Illness; Cross Infection; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Prospective Studies; Urinary Tract Infections; Vancomycin | 2003 |
Nosocomial pneumonia: therapy is just not good enough.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin | 2003 |
Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Double-Blind Method; Female; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Randomized Controlled Trials as Topic; Regression Analysis; Vancomycin | 2003 |
Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Ceftazidime; Cross Infection; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, Urban; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Severity of Illness Index; Vancomycin; Vancomycin Resistance | 2003 |
Finance. There shall come a great profit.
Topics: Cross Infection; Health Priorities; Humans; Planning Techniques; Social Responsibility; Staphylococcus aureus; State Medicine; United Kingdom; Vancomycin; Vancomycin Resistance | 2003 |
Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin.
Topics: Acetamides; Adult; Aged; Anti-Infective Agents; Cross Infection; Female; Gram-Positive Bacterial Infections; Humans; Linezolid; Logistic Models; Male; Middle Aged; Oxazolidinones; Pneumonia, Bacterial; Respiration, Artificial; Retrospective Studies; Survival Analysis; Survival Rate; Vancomycin | 2004 |
Linezolid in VAP by MRSA: a better choice?
Topics: Acetamides; Anti-Infective Agents; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Respiration, Artificial; Vancomycin | 2004 |
Vancomycin usage in central venous catheters in a neonatal intensive care unit.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Catheterization, Central Venous; Cross Infection; Female; Humans; Infant, Newborn; Intensive Care, Neonatal; Male; Retrospective Studies; Vancomycin | 2004 |
Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units.
Topics: Anti-Bacterial Agents; Cross Infection; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Infection Control; Intensive Care Units; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2004 |
For nosocomial vancomycin-resistant enterococcal infections: the ounce of prevention or the pound of cure?
Topics: Anti-Bacterial Agents; Cross Infection; Enterococcus; Gram-Positive Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance | 2004 |
Linezolid better than vancomycin in treating drug-resistant pneumonia.
Topics: Acetamides; Anti-Infective Agents; Cross Infection; Humans; Methicillin Resistance; Oxazolidinones; Pneumonia, Bacterial; Protein Synthesis Inhibitors; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2004 |
High incidence of vancomycin resistance in Enterococcus faecalis strains in a French hospital.
Topics: Anti-Bacterial Agents; Cross Infection; DNA, Bacterial; Enterococcus faecalis; Enterococcus faecium; France; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Teicoplanin; Vancomycin; Vancomycin Resistance | 2004 |
Effects of linezolid on staphylococcal adherence versus time of treatment.
Topics: Acetamides; Anti-Bacterial Agents; Bacterial Adhesion; Cross Infection; Humans; In Vitro Techniques; Linezolid; Microscopy, Electron, Scanning; Oxazolidinones; Staphylococcal Infections; Staphylococcus epidermidis; Time Factors; Vancomycin | 2004 |
Unresolved questions with the use of linezolid vs vancomycin for nosocomial pneumonia.
Topics: Acetamides; Cross Infection; Female; Follow-Up Studies; Humans; Linezolid; Male; Oxazolidinones; Pneumonia, Bacterial; Risk Assessment; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2004 |
In-vitro activity of nisin against clinical isolates of Clostridium difficile.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Microbial Sensitivity Tests; Nisin; Vancomycin | 2004 |
Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage among patients with femoral neck fractures: implication for antibiotic prophylaxis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Carrier State; Cross Infection; Female; Femoral Neck Fractures; France; Housing; Humans; Male; Methicillin Resistance; Nasal Mucosa; Nursing Homes; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Vancomycin | 2004 |
Methicillin-resistant Staphylococcus aureus bacteraemia in neonatal intensive care units: an analysis of 90 episodes.
Topics: Anti-Bacterial Agents; Bacteremia; Birth Weight; Cross Infection; Female; Humans; Incidence; Infant, Newborn; Intensive Care Units, Neonatal; Male; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Taiwan; Treatment Outcome; Vancomycin | 2004 |
Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Randomized Controlled Trials as Topic; Vancomycin | 2004 |
Vancomycin therapy and the progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cross Infection; Disease Progression; Female; Humans; Male; Methicillin Resistance; Middle Aged; Osteomyelitis; Spinal Diseases; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2004 |
Nosocomial infection with vancomycin-dependent enterococci.
Topics: Anti-Bacterial Agents; Cross Infection; Enterococcus; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin | 2004 |
Local genetic patterns within a vancomycin-resistant Enterococcus faecalis clone isolated in three hospitals in Portugal.
Topics: Anti-Bacterial Agents; Chromosomes; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Portugal; Reverse Transcriptase Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance | 2004 |
Clonal dissemination of VanA-type glycopeptide-resistant Enterococcus faecalis between hospitals of two cities located 100 km apart.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Brazil; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Vancomycin; Vancomycin Resistance | 2004 |
Chryseobacterium meningosepticum infections in a dialysis unit.
Topics: Chryseobacterium; Ciprofloxacin; Cross Infection; Equipment Contamination; Flavobacteriaceae Infections; Hemodialysis Units, Hospital; Hospitals, General; Hospitals, Teaching; Humans; Peritoneal Dialysis; Peritonitis; Retrospective Studies; Sepsis; Sri Lanka; Vancomycin | 2004 |
Nosocomial infections: what needs to be done?
Topics: Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cross Infection; Disease Outbreaks; Humans; Vancomycin | 2004 |
Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Chi-Square Distribution; Child; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Progression; Female; Humans; Incidence; Logistic Models; Male; Metronidazole; Middle Aged; Quebec; Retrospective Studies; Severity of Illness Index; Vancomycin | 2004 |
[Analysis of the distribution characteristics and drug sensitivity of infection pathogens in hematology department ward].
Topics: Cross Infection; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Diseases; Humans; Imipenem; Microbial Sensitivity Tests; Vancomycin | 2004 |
Use of enteral vancomycin for the control of methicillin-resistant Staphylococcus aureus in intensive care units.
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Infection Control; Intensive Care Units; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2005 |
No mercy for MRSA: treatment alternatives to vancomycin and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Liability, Legal; Linezolid; Methicillin Resistance; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin | 2005 |
[Central clinical laboratory and infection control team: an essential partnership controlling health care-associated infections].
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Drug Monitoring; Drug Resistance, Multiple, Bacterial; Drug Utilization Review; Hospitals, University; Humans; Infection Control; Intensive Care Units; Japan; Laboratories, Hospital; Methicillin Resistance; Patient Care Team; Prevalence; Staphylococcal Infections; Vancomycin | 2005 |
In vitro activity of daptomycin versus linezolid and vancomycin against gram-positive uropathogens and ampicillin against enterococci, causing complicated urinary tract infections.
Topics: Acetamides; Ampicillin; Anti-Bacterial Agents; Cross Infection; Daptomycin; Enterococcus; Genotype; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Urinary Tract Infections; Vancomycin | 2005 |
Bugs gain vital ground in their battle against drugs.
Topics: Cross Infection; Drug Resistance, Bacterial; Humans; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin; Virulence | 2005 |
Determining the clinical significance of coagulase-negative staphylococci isolated from blood cultures.
Topics: Algorithms; Analysis of Variance; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Blood Specimen Collection; Coagulase; Cross Infection; Decision Trees; Drug Utilization; Fever; Hospitals, Teaching; Humans; Infection Control; Iowa; Leukocyte Count; Likelihood Functions; Prospective Studies; Sensitivity and Specificity; Staphylococcal Infections; Staphylococcus; Vancomycin | 2005 |
Clinical and economic outcomes of pharmacist-managed aminoglycoside or vancomycin therapy.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cost-Benefit Analysis; Cross Infection; Diagnosis-Related Groups; Drug Monitoring; Drug Utilization Review; Humans; Length of Stay; Medicare; Outcome and Process Assessment, Health Care; Patient Care Team; Pharmacists; Pharmacy Service, Hospital; Professional Role; United States; Vancomycin | 2005 |
MRSA pneumonia: better outcome through continuous infusion of vancomycin?
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Infusions, Intravenous; Intensive Care Units; Methicillin Resistance; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin | 2005 |
Nosocomial urinary tract infection due to Leuconostoc mesenteroides at a tertiary care centre in north India.
Topics: Adolescent; Adult; Aged; Animals; Anti-Bacterial Agents; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; India; Leuconostoc; Male; Middle Aged; Urinary Catheterization; Urinary Tract Infections; Vancomycin | 2005 |
Differential growth of epidemic methicillin-resistant Staphylococcus aureus in vancomycin.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Dose-Response Relationship, Drug; Electrophoresis, Gel, Pulsed-Field; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2005 |
Cost-effectiveness of linezolid versus vancomycin in mechanical ventilation-associated nosocomial pneumonia caused by methicillin-resistant staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Drug Costs; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Respiration, Artificial; Staphylococcus aureus; Vancomycin | 2005 |
[Staphylococcus aureus bacteremia in the Dakar Fann University Hospital].
Topics: Adult; Aged; Bacteremia; Comorbidity; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; HIV Infections; Hospitals, University; Humans; Inpatients; Male; Methicillin Resistance; Middle Aged; Prevalence; Retrospective Studies; Senegal; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Systemic Inflammatory Response Syndrome; Vancomycin | 2004 |
Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.
Topics: Anti-Infective Agents; Candida glabrata; Candidiasis; Case-Control Studies; Cross Infection; Female; Fluconazole; Fungemia; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Vancomycin | 2005 |
Emergence and spread of rifampicin-resistant, methicillin-resistant Staphylococcus aureus during vancomycin-rifampicin combination therapy in an intensive care unit.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Genotype; Humans; Intensive Care Units; Methicillin Resistance; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Retrospective Studies; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
An audit demonstrating a reduction in MRSA infection in a specialised vascular unit resulting from a change in infection control protocol.
Topics: Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Carrier State; Cross Infection; Hospital Units; Humans; Infection Control; Medical Audit; Methicillin Resistance; Patient Isolation; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Vancomycin; Vascular Surgical Procedures | 2006 |
Microorganisms mistaken as vancomycin-resistant Staphylococcus aureus at a cancer hospital in Lahore, Pakistan: their true identity revealed.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cross Infection; Female; Humans; Male; Middle Aged; Neoplasms; Pakistan; Serum Bactericidal Test; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2006 |
Methicillin-resistant Staphylococcus aureus on orthopaedic wards: incidence, spread, mortality, cost and control.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Emergencies; England; Female; Femoral Fractures; Health Care Costs; Health Policy; Humans; Incidence; Length of Stay; Male; Mass Screening; Methicillin Resistance; Middle Aged; Orthopedic Procedures; Risk Factors; Staphylococcal Infections; Vancomycin; Wounds and Injuries | 2006 |
Antimicrobial therapy and local toxicity of intraventricular administration of vancomycin in a neonate with ventriculitis.
Topics: Anti-Bacterial Agents; Cerebral Ventricles; Cross Infection; Encephalitis; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Hydrocephalus; Infant, Newborn; Injections, Intraventricular; Male; Surgical Wound Infection; Vancomycin; Ventriculoperitoneal Shunt | 2006 |
A holistic approach to MRSA eradication in critically ill patients with MRSA pneumonia.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Critical Illness; Cross Infection; Drug Utilization; Female; Humans; Infection Control; Intensive Care Units; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2006 |
[Hospital-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus].
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Methicillin Resistance; Pneumonia, Staphylococcal; Prognosis; Respiration, Artificial; Staphylococcus aureus; Vancomycin; Virulence | 2005 |
Are antiseptic-coated central venous catheters effective in a real-world setting?
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Antisepsis; Catheterization, Central Venous; Catheters, Indwelling; Chlorhexidine; Cross Infection; Hospitals, University; Humans; Poisson Distribution; Regression Analysis; Sepsis; Silver Sulfadiazine; Treatment Outcome; Vancomycin | 2006 |
The clinical impact of linezolid susceptibility reporting in patients with vancomycin-resistant enterococci.
Topics: Academic Medical Centers; Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cohort Studies; Cross Infection; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Length of Stay; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2006 |
Nosocomial methicillin--resistant Staphylococcus aureus with reduced susceptibility to vancomycin.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center.
Topics: Academic Medical Centers; Acetamides; Adult; Aged; Aged, 80 and over; Alabama; Anti-Infective Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Vancomycin; Vancomycin Resistance | 2006 |
[The Dutch MRSA policy should be retained].
Topics: Anti-Bacterial Agents; Cross Infection; Hospital Costs; Hospitalization; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Netherlands; Policy Making; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2006 |
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Female; Health Care Costs; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Randomized Controlled Trials as Topic; Staphylococcus aureus; Vancomycin | 2006 |
Multilocus sequence typing and analysis of putative virulence factors in vancomycin-resistant and vancomycin-sensitive Enterococcus faecium isolates from Brazil.
Topics: Adhesins, Bacterial; Animals; Anti-Bacterial Agents; Bacterial Proteins; Brazil; Carrier State; Cross Infection; Enterococcus faecium; Feces; Gram-Positive Bacterial Infections; Hospitals; Humans; Hyaluronoglucosaminidase; Membrane Proteins; Microbial Sensitivity Tests; Species Specificity; Swine; Vancomycin; Vancomycin Resistance; Virulence Factors | 2006 |
Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci.
Topics: Adult; Bacteremia; Cross Infection; Enterococcus; Humans; Systemic Inflammatory Response Syndrome; Vancomycin; Vancomycin Resistance | 2006 |
Optimal therapy for methicillin-resistant Staphylococcus aureus pneumonia: what is the best dosing regimen?
Topics: Anti-Bacterial Agents; Biological Availability; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Infusions, Intravenous; Methicillin Resistance; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin; Ventilators, Mechanical | 2006 |
Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices.
Topics: Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Cohort Studies; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hospital Mortality; Humans; Male; Methicillin Resistance; Middle Aged; Missouri; Pneumonia, Staphylococcal; Retrospective Studies; Risk Factors; Staphylococcus aureus; Survival Analysis; Treatment Outcome; Vancomycin | 2006 |
Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.
Topics: Anti-Bacterial Agents; Communicable Diseases, Emerging; Cross Infection; Hospitals; Humans; India; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Vancomycin Resistance | 2006 |
Management of an outbreak of Clostridium difficile-associated disease among geriatric patients.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Clostridioides difficile; Cross Infection; Disease Outbreaks; Enterocolitis, Pseudomembranous; Feces; Female; Geriatrics; HeLa Cells; Hospital Units; Humans; Incidence; Infection Control; Male; Metronidazole; Saccharomyces; Treatment Outcome; Vancomycin | 2006 |
Coagulase negative Staphylococci from blood cultures: contaminants or pathogens?
Topics: Adult; Aged; Anti-Bacterial Agents; Coagulase; Cross Infection; Drug Resistance; Female; Hospitals, University; Humans; Jamaica; Male; Middle Aged; Sepsis; Staphylococcal Infections; Staphylococcus; Vancomycin | 2006 |
In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from hospitals in Beijing, China.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; China; Cross Infection; Dose-Response Relationship, Drug; Humans; Lysostaphin; Microbial Sensitivity Tests; Microbial Viability; Recombinant Proteins; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2007 |
[Staphylococcal infections as an important problem in intensive therapy--own clinical observations].
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Infection Control; Intensive Care Units; Methicillin Resistance; Microbial Sensitivity Tests; Poland; Species Specificity; Staphylococcal Infections; Vancomycin | 2006 |
Two studies feed the debate on active surveillance for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci carriage: to screen or not to screen?
Topics: Carrier State; Cross Infection; Diagnostic Tests, Routine; Humans; Methicillin; Methicillin Resistance; Population Surveillance; Sentinel Surveillance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
[Do we have adequate antimicrobials against methicillin-resistant Staphylococcus aureus?].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Cross Infection; Drug Design; Drug Resistance, Multiple, Bacterial; Drugs, Investigational; Europe; Humans; Methicillin Resistance; Penicillin-Binding Proteins; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin | 2006 |
Evolving EMRSA-15 epidemic in Singapore hospitals.
Topics: Anti-Bacterial Agents; Cluster Analysis; Cross Infection; Disease Outbreaks; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Genotype; Hospitals; Humans; Methicillin Resistance; Molecular Epidemiology; Repetitive Sequences, Nucleic Acid; Singapore; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2007 |
[Clostridium difficile associated diarrhea in the elderly patient].
Topics: Age Factors; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Recurrence; Vancomycin | 2007 |
What does it mean: appropriate therapy for methicillin-resistant Staphylococcus aureus?
Topics: Anti-Bacterial Agents; Cost Control; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Infusions, Intravenous; Intensive Care Units; Length of Stay; Methicillin Resistance; Pneumonia, Staphylococcal; Retrospective Studies; Staphylococcus aureus; Treatment Outcome; Vancomycin; Ventilators, Mechanical | 2007 |
Enteral vancomycin controls methicillin-resistant Staphylococcus aureus endemicity in an intensive care burn unit: a 9-year prospective study.
Topics: Adult; Anti-Bacterial Agents; Burns; Cross Infection; Female; Gels; Humans; Intensive Care Units; Male; Methicillin Resistance; Middle Aged; Prospective Studies; Staphylococcal Infections; Vancomycin | 2007 |
[Appropriate use of anti-MRSA drugs (discussion)].
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Dibekacin; Humans; Immunocompromised Host; Linezolid; Methicillin Resistance; Oxazolidinones; Practice Guidelines as Topic; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
Methicillin-resistant Staphylococcus aureus pneumonia after thoracic surgery: successful treatment with linezolid after failed vancomycin therapy.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Infective Agents; Cross Infection; Female; Humans; Linezolid; Male; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcus aureus; Thoracic Surgical Procedures; Treatment Failure; Treatment Outcome; Vancomycin | 2007 |
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Decision Support Techniques; Dose-Response Relationship, Drug; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Randomized Controlled Trials as Topic; Research Design; Retrospective Studies; Staphylococcus aureus; Survival Rate; Vancomycin | 2007 |
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Disclosure; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Peer Review, Research; Pneumonia, Staphylococcal; Research Design; Staphylococcus aureus; Vancomycin | 2007 |
Insufficient therapy for nosocomial meningitis negatively affects survival, sequellae and has social consequences.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Retrospective Studies; Treatment Failure; Vancomycin | 2007 |
Large variation in antibacterial use among Norwegian nursing homes.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Drug Therapy; Humans; Methenamine; Metronidazole; Norway; Nursing Homes; Pharmacoepidemiology; Retrospective Studies; Vancomycin | 2007 |
Predictors of vancomycin-resistant enterococcus (VRE) carriage in the first major VRE outbreak in Singapore.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Cross Infection; Disease Outbreaks; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Female; Humans; Infection Control; Male; Medical Audit; Middle Aged; Risk Factors; Singapore; Streptococcal Infections; Vancomycin; Vancomycin Resistance | 2007 |
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin | 2007 |
A case of recurrent Clostridium difficile diarrhea.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Lactobacillus; Metronidazole; Probiotics; Recurrence; Treatment Failure; Vancomycin | 2007 |
Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study.
Topics: Anti-Bacterial Agents; Brazil; Cohort Studies; Cross Infection; Drug Therapy; Female; Hospitals, Teaching; Hospitals, University; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance | 2007 |
A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Creatinine; Cross Infection; Dose-Response Relationship, Drug; Female; Humans; Kidney; Kidney Diseases; Male; Methicillin Resistance; Middle Aged; Pneumonia, Staphylococcal; Retrospective Studies; Risk Factors; Staphylococcus aureus; Vancomycin | 2007 |
Persistent strains of coagulase-negative staphylococci in a neonatal intensive care unit: virulence factors and invasiveness.
Topics: Bacterial Toxins; Biofilms; Coagulase; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Staphylococcal Infections; Staphylococcus; Vancomycin; Virulence Factors | 2007 |
Vancomycin dosing for methicillin-resistant staphylococcus aureus nosocomial pneumonia.
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Methicillin Resistance; Pneumonia, Staphylococcal; Research Design; Staphylococcus aureus; Vancomycin | 2007 |
Appropriate pharmacokinetic index for outcome in Staphylococcus aureus pneumonia.
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Methicillin Resistance; Pneumonia, Staphylococcal; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2007 |
Methicillin-resistant Staphylococcus aureus pneumonia treatment: do not confuse pharmacokinetics and pharmacodynamics.
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin | 2007 |
Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic viridans group streptococci in a tertiary Korean hospital.
Topics: Ceftriaxone; Chloramphenicol; Clindamycin; Cross Infection; Drug Resistance, Bacterial; Erythromycin; Humans; Immunoenzyme Techniques; Korea; Macrolides; Penicillin G; Phenotype; Polymerase Chain Reaction; Tetracycline; Vancomycin; Viridans Streptococci | 2007 |
Nosocomial bloodstream infection in a pediatric intensive care unit.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Incidence; India; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Medical Records; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome; Vancomycin | 2008 |
Impact of empiric antibiotic use on development of infections caused by extended-spectrum beta-lactamase bacteria in a neonatal intensive care unit.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; California; Cross Infection; Female; Hospitals; Humans; Incidence; Infant, Newborn; Intensive Care Units, Neonatal; Male; Retrospective Studies; Tobramycin; Vancomycin | 2008 |
Nosocomial outbreak of vancomycin-resistant Enterococcus faecium in a paediatric unit at a Turkish university hospital.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cross Infection; Disease Outbreaks; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospital Units; Hospitals, University; Humans; Infant; Infant, Newborn; Male; Turkey; Vancomycin; Vancomycin Resistance | 2008 |
Cost of the meticillin-resistant Staphylococcus aureus search and destroy policy in a Dutch university hospital.
Topics: Anti-Bacterial Agents; Bacteremia; Cost-Benefit Analysis; Cross Infection; Diagnostic Tests, Routine; Floxacillin; Health Care Costs; Health Policy; Hospitals, University; Humans; Infection Control; Methicillin Resistance; Netherlands; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |
Diagnostic and treatment delays in recurrent Clostridium difficile-associated disease.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cohort Studies; Cross Infection; Female; Hospitalists; Humans; Male; Metronidazole; Practice Patterns, Physicians'; Retrospective Studies; Secondary Prevention; Vancomycin | 2008 |
Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease.
Topics: Administration, Oral; Aged; Aged, 80 and over; Clostridioides difficile; Cross Infection; Enterococcus; Enterocolitis, Pseudomembranous; Female; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Vancomycin; Vancomycin Resistance | 2008 |
Methicillin-resistant Staphylococcus aureus in an Australian teaching hospital.
Topics: Adult; Aged; Australia; Cross Infection; Hospitals, Teaching; Humans; Methicillin; Middle Aged; Outpatient Clinics, Hospital; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Vancomycin | 1984 |
Vancomycin pharmacokinetics in critically ill patients.
Topics: Creatinine; Critical Care; Cross Infection; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Staphylococcal Infections; Vancomycin | 1984 |
Vancomycin treatment of bacteremia caused by oxacillin-resistant Staphylococcus aureus: comparison with beta-lactam antibiotic treatment of bacteremia caused by oxacillin-sensitive Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cross Infection; Female; Humans; Male; Middle Aged; Oxacillin; Penicillin Resistance; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1983 |
Vancomycin--new uses for an old drug.
Topics: Cross Infection; Hearing Disorders; Humans; Kinetics; Staphylococcal Infections; Vancomycin | 1984 |
Staphylococcus epidermidis endocarditis: a community-acquired methicillin-resistant isolate.
Topics: Cross Infection; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Male; Methicillin; Middle Aged; Mitral Valve; Penicillin Resistance; Rifamycins; Staphylococcal Infections; Staphylococcus; Vancomycin | 1983 |
[Use of vancomycin in the treatment of severe Staphylococcus aureus infection. Description of 3 cases].
Topics: Adolescent; Anti-Bacterial Agents; Child; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Infant; Male; Pneumonia, Staphylococcal; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1984 |
Sepsis with coagulase-negative staphylococci in critically ill newborns.
Topics: Coagulase; Cross Infection; Drug Resistance, Microbial; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Male; Sepsis; Staphylococcal Infections; Staphylococcus; Vancomycin | 1983 |
An outbreak of Clostridium difficile necrotizing enterocolitis: a case for oral vancomycin therapy?
Topics: Clostridium Infections; Cross Infection; Disease Outbreaks; Enterocolitis, Pseudomembranous; Humans; Infant, Newborn; Infant, Newborn, Diseases; Intensive Care Units, Neonatal; Vancomycin | 1983 |
Bacteremia due to methicillin-resistant Staphylococcus aureus.
Topics: Cross Infection; Female; Humans; Male; Methicillin; Middle Aged; Penicillin Resistance; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1982 |
Antibiotic-resistant staphylococci in a teaching hospital.
Topics: Adult; Australia; Cross Infection; Disease Outbreaks; Female; Hospitals, Teaching; Humans; Methicillin; Middle Aged; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1982 |
Antibiotic-associated diarrhoea and methicillin-resistant Staphylococcus aureus.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacitracin; Cross Infection; Diarrhea; Feces; Humans; Male; Methicillin; Microbiological Techniques; Middle Aged; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1982 |
Methicillin-resistant staphylococci: a sign of the times?
Topics: Australia; Cross Infection; Humans; Methicillin; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1982 |
Epidemic of hospital-acquired infection due to methicillin-resistant Staphylococcus aureus in major Victorian hospitals.
Topics: Australia; Cross Infection; Disease Outbreaks; Hospitals, Municipal; Hospitals, Teaching; Hospitals, University; Humans; Infant, Newborn; Methicillin; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1982 |
Administrative considerations in an infective outbreak.
Topics: Australia; Costs and Cost Analysis; Cross Infection; Disease Outbreaks; Fusidic Acid; Hospital Administration; Humans; Methicillin; Patient Care Planning; Patient Isolation; Penicillin Resistance; Personnel, Hospital; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1982 |
Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center.
Topics: Academic Medical Centers; Adult; Anti-Bacterial Agents; Cross Infection; Endocarditis, Bacterial; Female; Humans; Male; Methicillin; Michigan; Middle Aged; Nafcillin; Penicillin Resistance; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1982 |
Clostridium difficile: the epidemiology and prevention of hospital-acquired infection.
Topics: Anti-Bacterial Agents; Clostridium; Clostridium Infections; Cross Infection; Disinfection; Enterocolitis, Pseudomembranous; Equipment and Supplies, Hospital; Feces; Humans; Vancomycin | 1982 |
Studies on the epidemiology of colitis due to Clostridium difficile in hamsters.
Topics: Animals; Clostridium; Clostridium Infections; Colitis; Cricetinae; Cross Infection; Disinfection; Enterocolitis, Pseudomembranous; Mesocricetus; Vancomycin | 1981 |
Clinical Conferences at The Johns Hopkins Hospital: drug-resistant osteomyelitis in a diabetic patient.
Topics: Adult; Cross Infection; Diabetes Mellitus; Diabetes Mellitus, Type 1; Female; Foot; Foot Diseases; Humans; Neutrophils; Osteomyelitis; Radiography; Staphylococcal Infections; Vancomycin | 1980 |
Nosocomial meningitis caused by multiresistant enterococcus as a life-threatening complication of pelvic injury: case report.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Male; Meningitis, Bacterial; Pelvic Bones; Penicillins; Sacrum; Spinal Fractures; Vancomycin | 1995 |
Are serum levels of vancomycin useful in the first week of therapy?
Topics: Bacteremia; Cost Savings; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Vancomycin | 1995 |
Comparison of simple methods of methicillin-resistance detection and evaluation of some properties of methicillin-resistant Staphylococcus aureus strains.
Topics: Ciprofloxacin; Cross Infection; Evaluation Studies as Topic; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Teicoplanin; Vancomycin | 1993 |
New threats to the control of methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Reservoirs; Drug Resistance, Microbial; Hospital Costs; Humans; Infection Control; Methicillin Resistance; Mupirocin; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1995 |
Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections.
Topics: Age Factors; Aged; Anti-Bacterial Agents; APACHE; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Inpatients; Multivariate Analysis; New York City; Patient Compliance; Patient Isolation; Regression Analysis; Time Factors; Vancomycin | 1995 |
Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Male; Vancomycin | 1995 |
Failure of cefotaxime treatment in a patient with penicillin-resistant pneumococcal meningitis and confirmation of nosocomial spread by random amplified polymorphic DNA analysis.
Topics: Base Sequence; Cefotaxime; Cephalosporins; Cross Infection; DNA Primers; DNA, Bacterial; Drug Therapy, Combination; Female; Gentamicins; Humans; Infant; Meningitis, Pneumococcal; Molecular Sequence Data; Penicillin Resistance; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Streptococcus pneumoniae; Treatment Failure; Vancomycin | 1995 |
Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Critical Care; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Minnesota; Vancomycin | 1995 |
Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center.
Topics: Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Maryland; Prevalence; Regression Analysis; Vancomycin | 1995 |
Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection.
Topics: Adult; Aged; Bacteremia; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Risk Factors; Vancomycin | 1995 |
Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991.
Topics: Administration, Oral; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Feces; Hospitals, Veterans; Humans; Metronidazole; Minnesota; Population Surveillance; Prospective Studies; Vancomycin | 1994 |
The challenge of vancomycin-resistant enterococci: a clinical and epidemiologic study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Infection Control; Male; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections; Vancomycin | 1995 |
[Nosocomial infections].
Topics: Cross Infection; Disinfection; Granulocyte Colony-Stimulating Factor; Humans; Methicillin Resistance; Minocycline; Premedication; Pseudomonas Infections; Staphylococcal Infections; Vancomycin | 1993 |
[Combatting nosocomial intestinal infections with yeasts].
Topics: Combined Modality Therapy; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Metronidazole; Saccharomyces; Vancomycin; Yeast, Dried | 1995 |
Vancomycin therapy: resistance and appropriate usage guidelines.
Topics: Cross Infection; Drug Resistance, Microbial; Humans; Risk Factors; Staphylococcal Infections; Streptococcal Infections; Vancomycin | 1995 |
Keeping your patient safe from VRE.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Vancomycin | 1995 |
Clostridium difficile colitis: an increasing hospital-acquired illness.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Cholestyramine Resin; Cross Infection; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Fluid Therapy; Hospital Mortality; Humans; Immunosuppressive Agents; Incidence; Infant; Male; Metronidazole; Middle Aged; Premedication; Retrospective Studies; Surgical Procedures, Operative; Survival Rate; Vancomycin | 1995 |
[Enterococci as a new nosocomial problem. A Vancomycin-resistant strain was isolated in Sweden].
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Sweden; Vancomycin | 1995 |
Therapeutic beds: the Trojan horses of the 1990s?
Topics: Beds; Cross Infection; Enterococcus faecium; Equipment Contamination; Female; Gram-Positive Bacterial Infections; Humans; Middle Aged; Vancomycin | 1994 |
Vancomycin-resistant enterococci and bedpan washer machines.
Topics: Cross Infection; Disinfection; Drug Resistance, Microbial; Enterococcus faecium; Equipment and Supplies, Hospital; Equipment Contamination; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1994 |
Management and control of a large outbreak of diarrhoea due to Clostridium difficile.
Topics: Aged; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Disease Outbreaks; England; Enterotoxins; Hospitals, General; Humans; Infection Control; Metronidazole; Middle Aged; Recurrence; Vancomycin | 1994 |
Relative risks of ventriculostomy infection and morbidity.
Topics: Catheters, Indwelling; Cerebrospinal Fluid Shunts; Cross Infection; Equipment Contamination; Humans; Hydrocephalus; Intracranial Pressure; Nafcillin; Premedication; Proportional Hazards Models; Retrospective Studies; Risk Factors; Surgical Wound Infection; Vancomycin; Ventriculostomy | 1994 |
IS6770, an enterococcal insertion-like sequence useful for determining the clonal relationship of clinical enterococcal isolates.
Topics: Amino Acid Sequence; Bacterial Typing Techniques; Base Sequence; Cloning, Molecular; Cross Infection; Disease Outbreaks; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Agar Gel; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Molecular Epidemiology; Molecular Sequence Data; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA; Vancomycin | 1994 |
Vancomycin administration in cardiac surgical patients.
Topics: Cardiac Surgical Procedures; Cross Infection; Humans; Pneumonia; Premedication; Respiration, Artificial; Vancomycin | 1994 |
Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cross Infection; Diarrhea; Disease Outbreaks; Disease Reservoirs; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Middle Aged; Rhode Island; Vancomycin | 1994 |
Vancomycin-resistant enterococcus: an emerging nosocomial pathogen and its implications for the operating room setting.
Topics: Aged; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infection Control; Male; Operating Rooms; Vancomycin | 1993 |
Methicillin-resistant Staphylococcus aureus (mrsa) in a Malaysian hospital.
Topics: Adolescent; Adult; Child; Child, Preschool; Cross Infection; Female; Humans; Infant; Infant, Newborn; Infection Control; Malaysia; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
Special organism isolation: attempting to bridge the gap.
Topics: Acinetobacter; Bacteria; Clostridioides difficile; Connecticut; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Hospitals, Veterans; Humans; Infection Control; Patient Isolation; Practice Guidelines as Topic; Texas; Time Factors; Universal Precautions; Vancomycin | 1994 |
Emergence of vancomycin-resistant enterococci in New York City.
Topics: Aged; Base Sequence; Cross Infection; DNA Probes; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Vancomycin | 1993 |
Evidence for an animal origin of vancomycin-resistant enterococci.
Topics: Animals; Animals, Domestic; Chickens; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Food Microbiology; Gram-Positive Bacterial Infections; Humans; Meat; Sewage; Vancomycin | 1993 |
Vancomycin-resistant enterococci.
Topics: Carrier State; Catheterization, Central Venous; Cross Infection; Drug Resistance, Microbial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Length of Stay; Microbial Sensitivity Tests; Vancomycin | 1993 |
Neonatal suppurative parotitis: a vanishing disease?
Topics: Amikacin; Cross Infection; Drainage; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Parotitis; Suppuration; Vancomycin | 1993 |
Long-term efficacy of a program to control methicillin-resistant Staphylococcus aureus.
Topics: Carrier State; Cross Infection; Disease Outbreaks; Humans; Incidence; Infection Control; Intensive Care Units; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin | 1994 |
Nosocomial infection of a pancreatic pseudocyst due to Corynebacterium xerosis.
Topics: Aged; Corynebacterium; Corynebacterium Infections; Cross Infection; Humans; Male; Pancreatic Pseudocyst; Vancomycin | 1993 |
Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states.
Topics: Bacterial Typing Techniques; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Illinois; Michigan; Plasmids; Species Specificity; Vancomycin | 1993 |
Colonial variation in vancomycin resistant Enterococcus faecium.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus faecalis; Humans; Liver Diseases; Microbial Sensitivity Tests; Vancomycin | 1993 |
A nursing challenge: methicillin-resistant Staphylococcus aureus in long-term care.
Topics: Aged; Cross Infection; Humans; Infection Control; Long-Term Care; Methicillin Resistance; Staphylococcal Infections; Vancomycin | 1993 |
Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin.
Topics: Aged; Analysis of Variance; Chi-Square Distribution; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Infection Control; Intensive Care Units; Male; Microbial Sensitivity Tests; Penicillin Resistance; Restriction Mapping; Risk Factors; Vancomycin | 1993 |
Nosocomial enterococci resistant to vancomycin--United States, 1989-1993.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; United States; Vancomycin | 1993 |
[Sepsis caused by coagulase-negative Staphylococcus in the newborn infant. Clinical and therapeutic aspects].
Topics: Coagulase; Cross Infection; Female; Humans; Incidence; Infant, Newborn; Intensive Care Units, Neonatal; Male; Sepsis; Spain; Staphylococcal Infections; Vancomycin | 1993 |
[Basic and clinical knowledge of methicillin resistant Staphylococcus aureus].
Topics: Adolescent; Adult; Aged; Cross Infection; Female; Humans; Joint Prosthesis; Male; Methicillin Resistance; Middle Aged; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1993 |
From the Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin--United States, 1989-1993.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; United States; Vancomycin | 1993 |
Vancomycin-associated shock in neonates.
Topics: Cross Infection; Humans; Infant, Newborn; Shock; Staphylococcal Infections; Vancomycin | 1993 |
Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci.
Topics: Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; New York City; Vancomycin | 1993 |
Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Feces; Female; Gram-Positive Bacterial Infections; Hospitals; Humans; Infant, Newborn; Intestinal Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Risk Factors; Vancomycin | 1995 |
Vancomycin resistant enterococci in hospitals in the United Kingdom.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Incidence; United Kingdom; Vancomycin | 1995 |
Controlling vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; DNA Fingerprinting; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Prospective Studies; Seroepidemiologic Studies; United States; Vancomycin | 1995 |
Vancomycin-resistant enterococci. The 'superbug' scourge that's coming your way.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Risk Factors; Vancomycin | 1996 |
Bloodstream infections with vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Immunocompromised Host; Male; Middle Aged; Retrospective Studies; Vancomycin | 1996 |
Vancomycin-resistant enterococci: pervasive and persistent pathogens.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; United States; Vancomycin | 1995 |
Natural history of colonization with vancomycin-resistant Enterococcus faecium.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cross Infection; DNA Fingerprinting; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Middle Aged; Neoplasms; New York; Oncology Service, Hospital; Patient Isolation; Prevalence; Urinary Tract Infections; Vancomycin | 1995 |
Neonatal sepsis and meningitis due to Staphylococcus cohnii.
Topics: Adult; Asphyxia Neonatorum; Bacteremia; Cross Infection; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus; Vancomycin | 1996 |
Protecting your patients from VRE.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infection Control; Intensive Care Units; Surgical Wound Infection; Vancomycin | 1996 |
Practical management of patients infected with resistant organisms: an infection control perspective.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus faecium; Gloves, Protective; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 100 to 299; Hospitals, University; Humans; Microbial Sensitivity Tests; Rhode Island; Vancomycin | 1995 |
Control of endemic glycopeptide-resistant enterococci.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Kidney Diseases; Male; Middle Aged; Prevalence; Prospective Studies; Vancomycin | 1996 |
Random amplified polymorphic DNA typing versus pulsed-field gel electrophoresis for epidemiological typing of vancomycin-resistant enterococci.
Topics: Bacterial Typing Techniques; Base Sequence; Cross Infection; Disease Outbreaks; DNA Primers; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Evaluation Studies as Topic; France; Gram-Positive Bacterial Infections; Humans; Molecular Epidemiology; Molecular Sequence Data; Random Amplified Polymorphic DNA Technique; Vancomycin | 1996 |
Nosocomial bacteremia due to vancomycin-resistant Staphylococcus epidermidis in four patients with cancer, neutropenia, and previous treatment with vancomycin.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Catheterization, Central Venous; Cross Infection; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1996 |
Vancomycin-resistant enterococci at a large university hospital in Denmark.
Topics: Cross Infection; Denmark; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Vancomycin | 1996 |
Vascular infections: exceeding the threshold.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cross Infection; Drug Resistance, Microbial; Humans; Retrospective Studies; Surgical Wound Infection; Vancomycin; Vascular Surgical Procedures | 1995 |
Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital.
Topics: Ampicillin Resistance; Analysis of Variance; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Incidence; Logistic Models; North Carolina; Odds Ratio; Prevalence; Prospective Studies; Risk Factors; Vancomycin | 1996 |
Vancomycin-resistant enterococci on a renal ward in an Ontario hospital.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Incidence; Male; Middle Aged; Nephrology; Ontario; Vancomycin | 1996 |
Vancomycin resistant enterococci in hospitals in the United Kingdom--1995.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Incidence; United Kingdom; Vancomycin | 1996 |
Vancomycin resistant enterococci.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus; Humans; Opportunistic Infections; Risk Factors; Vancomycin | 1996 |
Vancomycin-resistant Enterococcus in the Singapore National Burns Centre: a case report.
Topics: Accidents, Home; Burn Units; Burns; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Male; Vancomycin | 1996 |
Selective isolation of vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Cross Infection; Culture Media; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1996 |
Vancomycin-resistant enterococcus: case reviews after transplantation.
Topics: Adult; Anti-Bacterial Agents; Clinical Protocols; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Male; Middle Aged; Organ Transplantation; Vancomycin | 1996 |
Investigation of an outbreak of vancomycin-resistant Enterococcus faecium by random amplified polymorphic DNA (RAPD) assay.
Topics: Adult; Anti-Bacterial Agents; Base Sequence; Child; Cluster Analysis; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Infection Control; Microbial Sensitivity Tests; Molecular Sequence Data; Random Amplified Polymorphic DNA Technique; Vancomycin | 1996 |
Screening patients for glycopeptide-resistant enterococci.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infection Control; Mass Screening; Vancomycin | 1996 |
Selective media for detecting gastrointestinal carriage of vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Carrier State; Cross Infection; Culture Media; Drug Resistance, Microbial; Enterococcus; Feces; Vancomycin | 1995 |
Surgical Infection Society position on vancomycin-resistant Enterococcus.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Vancomycin | 1996 |
Risk factors for mortality associated with enterococcal bloodstream infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cohort Studies; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Risk Factors; Streptococcal Infections; United States; Vancomycin | 1996 |
When normal flora turn nasty.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1996 |
Pseudo-outbreak of Enterococcus durans infections and colonization associated with introduction of an automated identification system software update.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Cross Infection; Diagnostic Errors; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Software; Species Specificity; United States; Vancomycin | 1996 |
Experience with a hospital-wide outbreak of vancomycin-resistant enterococci.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus; Epidemiologic Methods; Hospitals, Veterans; Humans; Infection Control; Middle Aged; New York City; Retrospective Studies; Vancomycin | 1996 |
Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality.
Topics: Anti-Bacterial Agents; Case-Control Studies; Chloramphenicol; Cross Infection; DNA, Bacterial; Doxycycline; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitalization; Humans; Intensive Care Units; Length of Stay; Liver Transplantation; Male; Regression Analysis; Renal Dialysis; Risk Factors; Vancomycin | 1996 |
Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States.
Topics: Adolescent; Adult; Animals; Animals, Domestic; Anti-Bacterial Agents; Chickens; Community-Acquired Infections; Cross Infection; Drug Resistance, Microbial; Enterococcus; Feces; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Middle Aged; Texas; Turkeys; Vancomycin | 1996 |
Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unit.
Topics: Adult; Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Microbial; England; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Leukemia; Male; Middle Aged; Vancomycin | 1996 |
Heat and chemical resistance of enterococci.
Topics: Alcohols; Chlorine; Cross Infection; Disinfectants; Disinfection; Drug Resistance, Microbial; Enterococcus; Glutaral; Gram-Positive Bacterial Infections; Hot Temperature; Humans; Vancomycin | 1996 |
The treatment and control of vancomycin resistant enterococci.
Topics: Animals; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Practice Guidelines as Topic; Risk Factors; Vancomycin | 1996 |
Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci.
Topics: Adult; Anti-Bacterial Agents; Cross Infection; Digestive System; Enterococcus; Environmental Microbiology; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Middle Aged; Respiration, Artificial; Skin; Vancomycin | 1996 |
Control of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide.
Topics: Algorithms; Bacterial Infections; Boston; Cross Infection; Developed Countries; Developing Countries; Drug Resistance, Microbial; Enterococcus; Global Health; Gram-Positive Bacterial Infections; Hospitals; Humans; Infection Control; Vancomycin | 1997 |
Enterococcal bacteremia in the surgical intensive care unit. Does vancomycin resistance affect mortality? The Johns Hopkins SICU Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Resistance, Microbial; Female; Gram-Positive Bacterial Infections; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Recovery Room; Retrospective Studies; Vancomycin | 1997 |
Vancomycin-resistant gram-positive cocci: risk factors for faecal carriage.
Topics: Aged; Anti-Bacterial Agents; Carrier State; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Feces; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Length of Stay; Male; Risk Factors; Vancomycin | 1997 |
Incidence and detection of multi-drug-resistant enterococci in Dublin hospitals.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Bacteremia; Cluster Analysis; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Feces; Gentamicins; Gram-Positive Bacterial Infections; Humans; Incidence; Ireland; Microbial Sensitivity Tests; R Factors; Teicoplanin; Vancomycin | 1997 |
Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit.
Topics: Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Enterococcus; Humans; Imipenem; Intensive Care Units; Outpatients; Pseudomonas aeruginosa; Vancomycin | 1997 |
Activity of disinfectants against vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Cross Infection; Disinfectants; Disinfection; Drug Resistance, Microbial; Enterococcus; Evaluation Studies as Topic; Humans; New York City; Time Factors; Vancomycin | 1997 |
Genotypic characterization of a nosocomial outbreak of VanA Enterococcus faecalis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Blotting, Southern; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Enterococcus faecalis; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Humans; Ligases; Microbial Sensitivity Tests; Nucleic Acid Hybridization; Plasmids; Polymerase Chain Reaction; Vancomycin | 1996 |
Plasmid-mediated vanB glycopeptide resistance in enterococci.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Conjugation, Genetic; Cross Infection; DNA Probes; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Enterococcus faecium; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Pheromones; Plasmids; Polymerase Chain Reaction; Vancomycin | 1995 |
Multiplicity of genetic backgrounds among vancomycin-resistant Enterococcus faecium isolates recovered from an outbreak in a New York City hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Blotting, Southern; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; DNA Fingerprinting; DNA Probes; Drug Resistance, Multiple; Electrophoresis, Polyacrylamide Gel; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Ligases; New York City; Plasmids; Vancomycin | 1996 |
Testing the efficacy of a molecular surveillance network: methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VREF) genotypes in six hospitals in the metropolitan New York City area. The BARG Initiative Pilot
Topics: Anti-Bacterial Agents; Communication; Cross Infection; DNA Fingerprinting; DNA Probes; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Enterococcus faecium; Genotype; Humans; Methicillin Resistance; Molecular Epidemiology; New York City; Nucleic Acid Hybridization; Staphylococcus aureus; Vancomycin | 1996 |
Emergence and dissemination of a highly vancomycin-resistant vanA strain of Enterococcus faecium at a large teaching hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Clindamycin; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Length of Stay; Male; Massachusetts; Middle Aged; Prospective Studies; Risk Factors; Vancomycin | 1997 |
Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactam Resistance; Cross Infection; Disease Outbreaks; Drug Costs; Drug Prescriptions; Drug Resistance, Microbial; Drug Utilization; Enterococcus faecium; Fever; Follow-Up Studies; Gram-Positive Bacterial Infections; Hospital Administration; Hospital Costs; Hospital Departments; Humans; Medical Audit; Neutropenia; Outcome Assessment, Health Care; Pediatrics; Pharmacology, Clinical; Pharmacy Service, Hospital; Policy Making; Practice Patterns, Physicians'; Surgery Department, Hospital; Surgical Procedures, Operative; Vancomycin | 1997 |
Inter-hospital spread of vancomycin-resistant Enterococcus faecium.
Topics: Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infection Control; Patient Transfer; United Kingdom; Vancomycin | 1997 |
Diarrhoea in the intensive care unit.
Topics: Anti-Bacterial Agents; Antitrichomonal Agents; Cross Infection; Diarrhea; Humans; Intensive Care Units; Metronidazole; Vancomycin | 1997 |
Control of vancomycin-resistant enterococcus.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gloves, Protective; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Protective Clothing; Rectal Diseases; Vancomycin | 1997 |
High level aminoglycoside resistance in enterococci isolated from hospitalized patients.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Humans; Penicillin Resistance; Tetracycline Resistance; Vancomycin | 1997 |
Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996.
Topics: Anti-Bacterial Agents; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Humans; Japan; Male; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1997 |
Intrahospital spread of vancomycin-resistant Enterococcus faecium in Sweden.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Ligases; Male; Middle Aged; Polymerase Chain Reaction; Sweden; Vancomycin | 1997 |
[Vancomycin resistant enterococci in Austria].
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Austria; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Female; Genotype; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Polymerase Chain Reaction; Vancomycin | 1997 |
[Antibiotic resistance of enterococci in Germany].
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Germany; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Vancomycin | 1997 |
Epidemiology and control of vancomycin-resistant enterococci in an adult and children's hospital.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, Special; Humans; Incidence; Infection Control; Male; Microbial Sensitivity Tests; New York; Risk Factors; Species Specificity; Vancomycin | 1997 |
Secular trends in bloodstream infection caused by antimicrobial-resistant bacteria in New Jersey hospitals, 1991 to 1995.
Topics: Bacteremia; Cross Infection; Data Collection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Private; Humans; Imipenem; Microbial Sensitivity Tests; New Jersey; Penicillin Resistance; Pneumococcal Infections; Prevalence; Species Specificity; Streptococcus pneumoniae; Vancomycin | 1997 |
Vancomycin-resistant Enterococcus raffinosus: molecular epidemiology, species identification error, and frequency of occurrence in a national resistance surveillance program.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Cross Infection; Drug Resistance, Microbial; Enterococcus; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Vancomycin | 1997 |
Natural history of colonization with vancomycin-resistant Enterococcus faecium.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enteritis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Vancomycin | 1997 |
Strains of glycopeptide-resistant Enterococcus faecium can alter their van genotypes during an outbreak.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Multigene Family; Plasmids; Teicoplanin; Vancomycin | 1997 |
Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Humans; Methicillin Resistance; Staphylococcus aureus; Vancomycin | 1997 |
A clinical data repository enhances hospital infection control.
Topics: Bacteremia; Cross Infection; Databases as Topic; Hospital Information Systems; Humans; Infection Control; Medical Records Systems, Computerized; Population Surveillance; Vancomycin | 1997 |
In vitro susceptibility studies and detection of vancomycin resistance genes in clinical isolates of enterococci in Nagasaki, Japan.
Topics: Anti-Bacterial Agents; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus; Genotype; Gram-Positive Bacterial Infections; Humans; Incidence; Infection Control; Japan; Microbial Sensitivity Tests; Polymerase Chain Reaction; Urban Health; Vancomycin | 1997 |
Antibiotic resistance. Epidemiology of resistance in intensive therapy units (ITUs).
Topics: 4-Quinolones; Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enzyme Induction; Gram-Negative Bacteria; Gram-Positive Bacterial Infections; Humans; Incidence; Intensive Care Units; Methicillin Resistance; Mutation; Prevalence; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; United Kingdom; Vancomycin | 1997 |
Epidemiological study of hospital-acquired infection with vancomycin-resistant Enterococcus faecium: possible transmission by an electronic ear-probe thermometer.
Topics: Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Equipment Contamination; Gram-Positive Bacterial Infections; Hospitals, Community; Hospitals, Teaching; Humans; Thermometers; Vancomycin | 1997 |
Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; Carrier State; Community-Acquired Infections; Cross Infection; DNA Primers; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Feces; Genotype; Gram-Positive Bacterial Infections; Humans; Netherlands; Polymerase Chain Reaction; Vancomycin | 1997 |
Clinical and epidemiological significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype)
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Carrier State; Case-Control Studies; Cross Infection; DNA Primers; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Female; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Molecular Epidemiology; Ontario; Polymerase Chain Reaction; Prospective Studies; Vancomycin | 1997 |
Antibiotic resistance. Of bugs and drugs.
Topics: Cross Infection; Drug Resistance, Microbial; Drug Utilization; Hospitals; Humans; Staphylococcal Infections; United States; Vancomycin | 1997 |
In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Cross Infection; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Vancomycin; Virginiamycin | 1997 |
Vancomycin-resistant enterococcus.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Neoplasms; Oncology Nursing; Vancomycin | 1997 |
Managing vancomycin-resistant enterococci. A winning team approach.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Patient Care Team; Vancomycin | 1997 |
Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group.
Topics: Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Cohort Studies; Cross Infection; Drug Resistance, Microbial; Erythromycin; Humans; Microbial Sensitivity Tests; Penicillins; Prevalence; Streptococcal Infections; Streptococcus; United States; Vancomycin | 1997 |
In vitro activity of cefepime and ceftazidime against 197 nosocomial blood stream isolates of streptococci: a multicenter sample.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Cross Infection; Erythromycin; Humans; Penicillins; Streptococcal Infections; Streptococcus; Vancomycin | 1997 |
Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation.
Topics: Adolescent; Anti-Bacterial Agents; Case-Control Studies; Child; Child, Preschool; Colony Count, Microbial; Confidence Intervals; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Male; Mass Screening; Odds Ratio; Oncology Service, Hospital; Risk Factors; Vancomycin | 1998 |
Controlling vancomycin-resistant enterococci.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus; Humans; Infection Control; Vancomycin | 1998 |
Vancomycin-resistant Enterococcus faecium in a Veterans Affairs Medical Center: association with antibiotic usage.
Topics: Analysis of Variance; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Drug Utilization; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Units; Hospitals, Veterans; Humans; Incidence; Infection Control; New Jersey; Regression Analysis; Retrospective Studies; Vancomycin | 1998 |
VRE & MRSA--putting bad bugs out of business.
Topics: Anti-Bacterial Agents; Cross Infection; Enterococcus; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1998 |
An investigation of vancomycin-resistant Enterococcus faecium within the pediatric service of a large urban medical center.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Intensive Care Units, Pediatric; Vancomycin | 1998 |
[Nursing care plans for renal hospitalized patients infected with antibiotic resistant enterococci].
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Infection Control; Kidney Diseases; Patient Care Planning; Vancomycin | 1998 |
Drug resistant enterococci in a south Indian hospital.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gentamicins; Humans; Tetracycline; Vancomycin | 1998 |
Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Metronidazole; Middle Aged; Multivariate Analysis; Risk Factors; Vancomycin | 1998 |
Number of centers reporting VRE cases in 1996 doubled. CDC survey also shows tuberculosis reappearing.
Topics: Anti-Bacterial Agents; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Population Surveillance; Renal Dialysis; Tuberculosis; United States; Vancomycin | 1998 |
Disinfection of hospital rooms contaminated with vancomycin-resistant Enterococcus faecium.
Topics: Anti-Bacterial Agents; Cross Infection; Disinfection; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Patients' Rooms; United States; Vancomycin | 1998 |
The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable.
Topics: Adult; Aged; Anti-Bacterial Agents; APACHE; Cephalosporins; Colony Count, Microbial; Cross Infection; Drug Resistance, Microbial; Enteral Nutrition; Enterococcus; Female; Humans; Infection Control; Male; Middle Aged; Proportional Hazards Models; Risk; Risk Factors; Vancomycin | 1998 |
Reduction in vancomycin-resistant Enterococcus and Clostridium difficile infections following change to tympanic thermometers.
Topics: Anti-Bacterial Agents; Clostridioides difficile; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterocolitis, Pseudomembranous; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 300 to 499; Hospitals, Community; Humans; Incidence; Poisson Distribution; Thermometers; United States; Vancomycin | 1998 |
First known outbreak of colonizing vancomycin-resistant enterococci in Quebec.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Quebec; Vancomycin | 1998 |
A guide to TB, VRE, and MRSA.
Topics: Anti-Bacterial Agents; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Methicillin Resistance; Staphylococcal Infections; Tuberculosis, Pulmonary; United States; Vancomycin | 1998 |
Environmental contamination with vancomycin-resistant enterococci in an outpatient setting.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Humans; Male; Middle Aged; Outpatient Clinics, Hospital; Vancomycin | 1998 |
Vancomycin-resistant enterococci in long-term-care facilities.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Humans; Long-Term Care; Patient Isolation; Vancomycin | 1998 |
Vancomycin-resistant Staphylococcus aureus: infection control considerations.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Humans; Infection Control; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1998 |
Should we use vancomycin as prophylaxis to prevent neonatal nosocomial coagulase-negative staphylococcal septicemia?
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Coagulase; Cross Infection; Humans; Infant, Newborn; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1998 |
Methicillin-resistant Staphylococcal enterocolitis.
Topics: Anti-Bacterial Agents; Cross Infection; Enterocolitis; Female; Humans; Methicillin Resistance; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1998 |
Vancomycin-resistant enterococcus in end-stage renal disease.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple; Enterococcus; Gram-Positive Bacterial Infections; Humans; Kidney Failure, Chronic; Metabolic Clearance Rate; Microbial Sensitivity Tests; Peritoneal Dialysis; Prospective Studies; Renal Dialysis; Risk Factors; Treatment Outcome; Vancomycin | 1998 |
Spread of vancomycin-resistant enterococci: differences between the United States and Europe.
Topics: Animals; Animals, Domestic; Anti-Bacterial Agents; Cross Infection; Disease Vectors; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Europe; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Practice Patterns, Physicians'; Prevalence; United States; Vancomycin | 1998 |
Molecular analysis of glycopeptide-resistant Enterococcus faecium isolates collected from Michigan hospitals over a 6-year period.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Chromosomes, Bacterial; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gene Transfer Techniques; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Michigan; Molecular Epidemiology; Nucleic Acid Hybridization; Plasmids; Vancomycin | 1998 |
Comparison of genomic methods for differentiating strains of Enterococcus faecium: assessment using clinical epidemiologic data.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Chicago; Cross Infection; Deoxyribonuclease HindIII; Deoxyribonucleases, Type II Site-Specific; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Agar Gel; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Genetic Techniques; Gram-Positive Bacterial Infections; Humans; Infection Control; Molecular Epidemiology; Prohibitins; Vancomycin | 1998 |
Failure to eradicate vancomycin-resistant enterococci in a university hospital and the cost of barrier precautions.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 300 to 499; Hospital Costs; Hospitals, University; Humans; Incidence; Infection Control; Massachusetts; Program Evaluation; Protective Clothing; Vancomycin | 1998 |
Control of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus in hospitalized children.
Topics: Anti-Bacterial Agents; Carrier State; Child; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1998 |
[Methicillin-resistant Staphylococcus aureus (MRSA)--clinical implications].
Topics: Cross Infection; Cross-Sectional Studies; Humans; Incidence; Infusions, Intravenous; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection; Vancomycin | 1998 |
Superbugs: are we at the threshold of a new Dark Age?
Topics: Community-Acquired Infections; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Methicillin Resistance; Vancomycin | 1998 |
Epidemiology and control of vancomycin-resistant enterococci (VRE) in a renal unit.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Hemodialysis Units, Hospital; Humans; Infection Control; Kidney Diseases; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Scotland; Vancomycin | 1998 |
Observations on the risk of resistance with the extended use of vancomycin.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Burns; Cross Infection; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Humans; Infection Control; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors; Vancomycin; Wound Infection | 1998 |
VRE: pay attention to your mom.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Hand Disinfection; Humans; Vancomycin | 1998 |
The toilet as a transmission vector of vancomycin-resistant enterococci.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; British Columbia; Cross Infection; Disease Reservoirs; DNA Primers; Drug Resistance, Microbial; Enterococcus; Fatal Outcome; Female; Hospitals, Teaching; Humans; Infection Control; Male; Toilet Facilities; Vancomycin | 1998 |
Vancomycin-resistant enterococci: risk related to the use of intravenous vancomycin in a university hospital.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Hospitals, University; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; North Carolina; Prospective Studies; Risk; Risk Factors; Vancomycin | 1998 |
Infection and colonization with vancomycin-resistant Enterococcus faecium in an acute care Veterans Affairs Medical Center: a 2-year survey.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carrier State; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitals, Veterans; Humans; Incidence; Infection Control; Male; Middle Aged; Pennsylvania; Prospective Studies; Risk Factors; Vancomycin | 1998 |
Detection of vancomycin-resistant enterococci colonization in a children's hospital.
Topics: Anti-Bacterial Agents; Carrier State; Cross Infection; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, Pediatric; Humans; Infection Control; Microbial Sensitivity Tests; Prevalence; Serotyping; Utah; Vancomycin | 1998 |
Clonal diversity of vancomycin-resistant enterococci from an outbreak in a tertiary care university hospital.
Topics: Anti-Bacterial Agents; Clone Cells; Cluster Analysis; Cross Infection; Disease Outbreaks; District of Columbia; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Infection Control; Phylogeny; Risk Factors; Serotyping; Vancomycin | 1998 |
The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Carbon-Oxygen Ligases; Chicago; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Female; Genotype; Gram-Positive Bacterial Infections; Hospitals, Teaching; Humans; Longitudinal Studies; Male; Middle Aged; Molecular Epidemiology; Polymerase Chain Reaction; Vancomycin | 1999 |
The effects of ultraviolet radiation on antibiotic-resistant bacteria in vitro.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Infection Control; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Ultraviolet Rays; Vancomycin; Wound Infection | 1998 |
External sources of vancomycin-resistant enterococci for intensive care units.
Topics: Anti-Bacterial Agents; Carrier State; Chicago; Community-Acquired Infections; Cross Infection; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 500 and over; Hospitals, Public; Humans; Infection Control; Intensive Care Units; Length of Stay; Prospective Studies; Risk Factors; Vancomycin | 1998 |
[Nosocomial infections].
Topics: Candida albicans; Cross Infection; Drug Resistance, Microbial; Enterococcus; Epidemiologic Studies; Humans; Lactams; Vancomycin | 1998 |
Molecular characterization of epidemic multiresistant Staphylococcus haemolyticus isolates.
Topics: Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefmetazole; Cross Infection; DNA Restriction Enzymes; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Hospital Bed Capacity, 500 and over; Humans; Imipenem; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Nursing; Nursing Staff, Hospital; Ofloxacin; Oxacillin; Phylogeny; Staphylococcal Infections; Staphylococcus; Tobramycin; Vancomycin | 1998 |
Vancomycin-resistant Enterococcus faecium colonization in children.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Cohort Studies; Cross Infection; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Hematology; Hospital Units; Hospitals, Pediatric; Humans; Logistic Models; Medical Oncology; Molecular Epidemiology; Population Surveillance; Regression Analysis; Risk Factors; Vancomycin | 1999 |
Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Community-Acquired Infections; Cross Infection; Echocardiography, Transesophageal; Endocarditis, Bacterial; Follow-Up Studies; Humans; Lactams; Male; Middle Aged; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 1999 |
Arkansas hospitals respond to threat of antibiotic-resistant bacteria.
Topics: Arkansas; Cross Infection; Drug Resistance, Microbial; Enterococcus; Hospitals; Humans; Organizational Policy; Vancomycin | 1999 |
Isolation and epidemiological study of vancomycin-resistant Enterococcus faecium from patients of a haematological unit in Poland.
Topics: Adult; Anti-Bacterial Agents; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hematology; Hospital Units; Humans; Infection Control; Male; Microbial Sensitivity Tests; Middle Aged; Poland; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Serotyping; Teicoplanin; Vancomycin | 1999 |
Should vancomycin susceptibility test be performed on enterococci isolated from nonsterile fluids or sites?
Topics: Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Drug Resistance, Microbial; Enterococcus; Humans; Mass Screening; Rectum; Urinary Tract Infections; Vancomycin | 1999 |
Control of vancomycin-resistant enterococci at a community hospital: efficacy of patient and staff cohorting.
Topics: Adult; Aged; Aged, 80 and over; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Guideline Adherence; Hospitals, Community; Humans; Infection Control; Male; Middle Aged; Patient Isolation; Personnel, Hospital; Prevalence; Vancomycin | 1999 |
Low faecal carrier rate of vancomycin resistant enterococci in Norwegian hospital patients.
Topics: Anti-Bacterial Agents; Carrier State; Cross Infection; Drug Resistance, Microbial; Enterococcus; Feces; Gram-Positive Bacterial Infections; Humans; Norway; Prevalence; Vancomycin | 1998 |
Transmission dynamics of epidemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in England and Wales.
Topics: Cross Infection; England; Enterococcus; Gram-Positive Bacterial Infections; Humans; Methicillin Resistance; New York City; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Wales | 1999 |
DNA banding pattern polymorphism in vancomycin-resistant Enterococcus faecium and criteria for defining strains.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Plasmids; Polymorphism, Genetic; Vancomycin | 1999 |
The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Resistance, Microbial; Fatal Outcome; Female; Gallbladder Neoplasms; Humans; Microbial Sensitivity Tests; Middle Aged; Nasal Mucosa; Personnel, Hospital; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1999 |
The prevalence of colonization with vancomycin-resistant Enterococcus at a Veterans' Affairs institution.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cross Infection; Disease Transmission, Infectious; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Female; Georgia; Gram-Positive Bacterial Infections; Hospitals, Veterans; Humans; Long-Term Care; Male; Middle Aged; Prevalence; Risk Factors; Vancomycin | 1999 |
Preventing the Spread of Vancomycin Resistance--A Report from the Hospital Infection Control Practices Advisory Committee prepared by the Subcommittee on Prevention and Control of Antimicrobial-Resistant Microorganisms in Hospitals; comment period and pub
Topics: Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Microbial; Hospitals; Humans; Infection Control; United States; Vancomycin | 1994 |
Hospital superbugs. Physician, wash thyself, and other medical safety tips.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Hand Disinfection; Humans; Infection Control; Methicillin; Penicillins; Personnel, Hospital; Pseudomonas aeruginosa; Staphylococcus aureus; United States; Vancomycin | 1997 |
Enemy within. Basic weapons can foil VRE (vancomycin-resistant enterococcus).
Topics: Anti-Bacterial Agents; Centers for Disease Control and Prevention, U.S.; Cross Infection; Enterococcus; Guidelines as Topic; Hand Disinfection; Hospitals; Humans; Infection Control; Methicillin Resistance; Protective Clothing; Staphylococcus aureus; United States; Vancomycin | 1997 |
Germ warfare. A drug-resistant staph strain has doctors on edge.
Topics: Adult; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Hospitals; Humans; Male; Michigan; Staphylococcal Infections; Staphylococcus; Vancomycin | 1997 |
Hospital's aggressive screening efforts save money in long run.
Topics: Admitting Department, Hospital; Bacterial Infections; Cross Infection; Diagnostic Tests, Routine; Drug Resistance, Microbial; Enterococcus; Humans; Infection Control; Methicillin; Ontario; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1997 |
CDC: staph super-strain is 'worrisome'.
Topics: Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Microbial; Guidelines as Topic; Hospitals; Humans; Infection Control; Patient Transfer; Population Surveillance; Staphylococcal Infections; United States; Vancomycin | 1998 |
Three cases of resistant staph cause concern. The culprit: vancomycin misuse.
Topics: Cross Infection; Drug Resistance, Microbial; Hospitals; Humans; Infection Control; Staphylococcal Infections; United States; Vancomycin | 1998 |
CDC VRE guidelines still relevant.
Topics: Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Microbial; Hospitals; Humans; Infection Control; Practice Guidelines as Topic; Staphylococcal Infections; United States; Vancomycin | 1998 |
Hospital policy fights resistant bacteria.
Topics: Arkansas; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Microbial; Guidelines as Topic; Hospitals, Community; Humans; Infection Control; Organizational Policy; United States; Vancomycin | 1998 |
Should genotypic testing be done on all phenotypically vancomycin- resistant enterococci detected in hospitals?
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Drug Resistance, Microbial; Enterococcus; Genes, Bacterial; Genotype; Gram-Positive Bacterial Infections; Humans; Phenotype; Polymerase Chain Reaction; Vancomycin | 1999 |
Epidemiology and control of vancomycin-resistant enterococci in a regional neonatal intensive care unit.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Infection Control; Intensive Care Units, Neonatal; Risk Factors; Vancomycin | 1999 |
Detection of clinically relevant genotypes of vancomycin-resistant enterococci in nosocomial surveillance specimens by PCR.
Topics: Cross Infection; DNA, Ribosomal; Drug Resistance, Microbial; Enterococcus; Genotype; Gram-Positive Bacterial Infections; Humans; Polymerase Chain Reaction; RNA, Ribosomal, 16S; Vancomycin | 1999 |
Control of transmission of vancomycin-resistant Enterococcus faecium in a long-term-care facility.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Costs and Cost Analysis; Cross Infection; Disease Outbreaks; Disease Reservoirs; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Homes for the Aged; Humans; Infection Control; Long-Term Care; Male; Nursing Homes; Ontario; Vancomycin | 1999 |
Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Comorbidity; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Male; Middle Aged; Philadelphia; Retrospective Studies; Risk Factors; Statistics as Topic; Vancomycin | 1999 |
Lack of transmission of vancomycin-resistant enterococci in three long-term-care facilities.
Topics: Aged; Aged, 80 and over; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Infection Control; Long-Term Care; Prevalence; Prospective Studies; Quebec; Vancomycin | 1999 |
Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs.
Topics: Anti-Bacterial Agents; Communicable Disease Control; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Models, Theoretical; Vancomycin | 1999 |
Methicillin resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cause of Death; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Hand Disinfection; Hospitals, General; Humans; Intensive Care Units; Methicillin Resistance; Patient Isolation; Prevalence; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Surgery Department, Hospital; Surgical Wound Infection; Trinidad and Tobago; Vancomycin | 1999 |
Antimicrobial resistance in gram-positive pathogens isolated in the UK between October 1996 and January 1997.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Environmental Monitoring; Gram-Positive Bacteria; Hospitals; Humans; Microbial Sensitivity Tests; Staphylococcus; Streptococcus pneumoniae; United Kingdom; Vancomycin; Virginiamycin | 1999 |
Reduced susceptibility to vancomycin of nosocomial isolates of methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Greece; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 1999 |
Vancomycin use in a university medical center: effect of a vancomycin continuation form.
Topics: Academic Medical Centers; Anti-Bacterial Agents; Cross Infection; Drug Utilization; Drug Utilization Review; Humans; Infection Control; Kentucky; Practice Guidelines as Topic; Vancomycin | 1999 |
Regional dissemination of vancomycin-resistant enterococci resulting from interfacility transfer of colonized patients.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care Facilities; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Digestive System; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hospitals, Community; Humans; Iowa; Male; Middle Aged; Patient Transfer; Prevalence; Vancomycin | 1999 |
Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period.
Topics: Aged; Anti-Bacterial Agents; Boston; Cell Culture Techniques; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Humans; Intensive Care Units; Logistic Models; Male; Middle Aged; Population Surveillance; Prevalence; Prospective Studies; Risk Factors; Vancomycin | 1999 |
[Determination of the nosocomial origin of vancomycin-resistance strains of Enterococcus isolated from stool of patients in a hematology department].
Topics: Adult; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus faecium; Feces; France; Gram-Positive Bacterial Infections; Hospital Units; Hospitals, University; Humans; Leukemia; Phylogeny; Vancomycin | 1999 |
Clinical and molecular biological analysis of a nosocomial outbreak of vancomycin-resistant enterococci in a neonatal intensive care unit.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; DNA Primers; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Agar Gel; Enterococcus faecium; Female; Genes, Bacterial; Genetic Predisposition to Disease; Genotype; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Polymerase Chain Reaction; Retrospective Studies; Teicoplanin; Vancomycin | 1999 |
Nosocomial meningitis in children after ventriculoperitoneal shunt insertion.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross Infection; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Postoperative Complications; Retrospective Studies; Risk Factors; Vancomycin; Ventriculoperitoneal Shunt | 1999 |
Role of transposon Tn5482 in the epidemiology of vancomycin-resistant Enterococcus faecium in the pediatric oncology unit of a New York City Hospital.
Topics: Anti-Bacterial Agents; Child; Conjugation, Genetic; Cross Infection; DNA Fragmentation; DNA Probes; DNA Transposable Elements; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Units; Hospitals, Urban; Humans; Medical Oncology; Neoplasms; New York City; Nucleic Acid Hybridization; Pediatrics; Vancomycin | 1999 |
Determinants of vancomycin use in adult intensive care units in 41 United States hospitals.
Topics: Adult; Anti-Bacterial Agents; Cohort Studies; Cross Infection; Drug Costs; Drug Utilization; Female; Health Services Misuse; Humans; Intensive Care Units; Linear Models; Male; Methicillin Resistance; Practice Guidelines as Topic; Prospective Studies; Staphylococcus aureus; United States; Vancomycin | 1999 |
Managing antibiotic use--impact of infection control.
Topics: Adult; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Drug Utilization; Female; Humans; Infection Control; Male; Methicillin Resistance; Risk Factors; Vancomycin | 1999 |
Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting.
Topics: Adult; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Oncology Service, Hospital; Prospective Studies; Vancomycin | 1999 |
Vancomycin in Oregon: who's using it and why.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Prescriptions; Drug Resistance, Microbial; Guideline Adherence; Humans; Pharmacy Service, Hospital; Practice Patterns, Physicians'; Vancomycin | 1999 |
Vancomycin-resistant enterococci: causes and control.
Topics: Anti-Bacterial Agents; Cross Infection; DNA Transposable Elements; Drug Resistance, Microbial; Enterococcus; Gene Amplification; Gene Expression Regulation, Bacterial; Gram-Positive Bacterial Infections; Humans; Selection, Genetic; Vancomycin | 1999 |
Outcome of a screening program for vancomycin-resistant enterococci in a hospital in Victoria.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Colony Count, Microbial; Critical Care; Cross Infection; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Hospital Units; Humans; Kidney Diseases; Mass Screening; Oncology Service, Hospital; Outcome Assessment, Health Care; Penicillins; Peritoneal Dialysis; Renal Dialysis; Risk Factors; Vancomycin; Victoria | 1999 |
Evaluation of a vanA-specific PCR assay for detection of vancomycin-resistant Enterococcus faecium during a hospital outbreak.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Feces; Gram-Positive Bacterial Infections; Humans; Polymerase Chain Reaction; Vancomycin | 1999 |
Controlling VRE.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Vancomycin | 1999 |
Stopping the spread of vancomycin-resistant enterococci.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 300 to 499; Humans; Infection Control; Texas; Vancomycin | 1999 |
vanA and vanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain: effect on interpretation of clonality.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Enterococcus faecium; Finland; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Nucleic Acid Hybridization; Polymerase Chain Reaction; Sequence Analysis, DNA; Vancomycin | 1999 |
A case-control study to detect modifiable risk factors for colonization with vancomycin-resistant enterococci.
Topics: Aged; Anti-Bacterial Agents; Case-Control Studies; Cross Infection; Disease Outbreaks; Enterococcus; Female; Humans; Male; Ontario; Risk Factors; Vancomycin; Vancomycin Resistance | 1999 |
[Nosocomial pneumococcal meningitis complicating herpes meningoencephalitis].
Topics: Aged; Ceftriaxone; Cross Infection; Drug Therapy, Combination; Female; Herpes Simplex; Herpesvirus 1, Human; Humans; Meningitis, Pneumococcal; Meningoencephalitis; Vancomycin | 1999 |
Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: persistence of multiple species and multiple clones.
Topics: Cross Infection; Enterococcus; Hospitals, University; Humans; Polymerase Chain Reaction; Retrospective Studies; Taiwan; Vancomycin; Vancomycin Resistance | 1999 |
Vancomycin prescribing practices in hospitalized chronic hemodialysis patients.
Topics: Adult; Aged; beta-Lactam Resistance; Cohort Studies; Cross Infection; Drug Prescriptions; Drug Utilization; Enterococcus; Female; Hemodialysis Units, Hospital; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Renal Dialysis; Staphylococcus aureus; Vancomycin | 2000 |
Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animal Husbandry; Animals; Anti-Bacterial Agents; Carrier State; Cattle; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Feces; France; Gram-Positive Bacterial Infections; Hospitalization; Humans; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Prevalence; Vancomycin; Vancomycin Resistance | 2000 |
Feds warn hospitals about drug-resistant infections.
Topics: Anti-Bacterial Agents; Cause of Death; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Microbial; Humans; Staphylococcal Infections; United States; Vancomycin | 2000 |
Bacillus cereus fatal bacteremia and apparent association with nosocomial transmission in an intensive care unit.
Topics: Adenocarcinoma; Anti-Bacterial Agents; Bacillus cereus; Bacteremia; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Fatal Outcome; Female; Humans; Imipenem; Intensive Care Units; Lung Neoplasms; Microbial Sensitivity Tests; Middle Aged; Thienamycins; Vancomycin | 2000 |
A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; APACHE; Bacteremia; Case-Control Studies; Cross Infection; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Medical Records; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Regression Analysis; Risk Factors; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2000 |
Methicillin resistance among Trinidadian isolates of community and hospital strains of Staphylococcus aureus and their patterns of resistance to non-beta-lactam antibiotics.
Topics: Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Microbial; Erythromycin; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Tetracycline Resistance; Trimethoprim, Sulfamethoxazole Drug Combination; Trinidad and Tobago; Vancomycin | 1999 |
Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Community-Acquired Infections; Cross Infection; Female; Humans; Male; Methicillin Resistance; Middle Aged; Predictive Value of Tests; Retrospective Studies; Risk; Severity of Illness Index; Staphylococcal Infections; Survival Analysis; Vancomycin | 2000 |
Molecular epidemiology of Staphylococcus epidermidis in a neonatal intensive care unit over a three-year period.
Topics: Birth Weight; Candidiasis; Cross Infection; Drug Resistance, Microbial; Humans; Incidence; Infant, Low Birth Weight; Infant, Newborn; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Italy; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Pneumonia; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Time Factors; Vancomycin | 2000 |
Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals.
Topics: Anti-Bacterial Agents; Cross Infection; Culture Media; Drug Resistance, Microbial; France; Humans; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2000 |
[Determination of the in vitro activity of 2 glycopeptides (vancomycin and teicoplanin) against methicillin-resistant Staphylococcus aureus of intrahospital origin].
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2000 |
Infectious diseases pose new pressures but provide new opportunities for health care.
Topics: Communicable Disease Control; Communicable Diseases; Cross Infection; Drug Resistance, Microbial; Hospital Information Systems; Humans; Managed Care Programs; Sentinel Surveillance; Surgical Wound Infection; United States; Vancomycin | 2000 |
Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Erythromycin; Humans; Imipenem; Laboratories, Hospital; Meropenem; Ofloxacin; Oxacillin; Penicillins; Pseudomonas aeruginosa; Reproducibility of Results; Serratia marcescens; Staphylococcus aureus; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2000 |
Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit.
Topics: Burn Units; Cephalosporins; Clinical Protocols; Cross Infection; Drug Utilization; Enterococcus; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Methicillin Resistance; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Staphylococcal Infections; Staphylococcus aureus; Tazobactam; Vancomycin; Vancomycin Resistance; Wounds and Injuries | 2000 |
An outbreak of Staphylococcus aureus strains with reduced susceptibility to glycopeptides in a French general hospital.
Topics: Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; France; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2000 |
Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy.
Topics: Abnormalities, Multiple; Bacterial Infections; Candidiasis; Comorbidity; Cross Infection; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Meningitis; North Carolina; Oxacillin; Retrospective Studies; Sepsis; Staphylococcal Infections; Vancomycin; Virginia | 2000 |
Vancomycin-resistant enterococci among chronic hemodialysis patients: a prospective study of acquisition.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Patient Admission; Prospective Studies; Renal Dialysis; Time Factors; Vancomycin; Vancomycin Resistance | 2001 |
Nosocomial pneumonia: importance of recognition of aetiological agents to define an appropriate initial empirical therapy.
Topics: Anti-Bacterial Agents; Bacteria; Blood; Bronchoalveolar Lavage Fluid; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Humans; Lung; Pleural Effusion; Pneumonia, Bacterial; Vancomycin | 2001 |
Vancomycin resistance emerging in a clonal outbreak caused by ampicillin-resistant Enterococcus faecium.
Topics: Aged; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Female; Genotype; Gram-Positive Bacterial Infections; Humans; Incidence; Male; Microbial Sensitivity Tests; Norway; Penicillins; Vancomycin; Vancomycin Resistance | 2000 |
Emerging glycopeptide resistance in gram-positive organisms.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Prevalence; Teicoplanin; Vancomycin | 2000 |
Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals.
Topics: Bacterial Proteins; Cross Infection; DNA, Bacterial; Enterococcus faecium; Genetic Markers; Genotype; Humans; Membrane Proteins; Phylogeny; Polymorphism, Restriction Fragment Length; Vancomycin; Vancomycin Resistance; Virulence | 2001 |
Intraabdominal vancomycin-resistant enterococcus infections: the new threat.
Topics: Abdomen; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Drug Resistance, Microbial; Enterococcus; Female; Humans; Male; Vancomycin | 2001 |
Reality check: should we use vancomycin for the prophylaxis of intravascular catheter-associated infections?
Topics: Catheters, Indwelling; Cross Infection; Humans; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2001 |
Growing problem of methicillin resistant staphylococci--Indian scenario.
Topics: Animals; Anti-Bacterial Agents; Cross Infection; Humans; India; Methicillin Resistance; Microbial Sensitivity Tests; Netilmicin; Prevalence; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2000 |
Variant esp gene in vancomycin-sensitive Enterococcus faecium.
Topics: Bacterial Proteins; Cross Infection; Enterococcus faecalis; Humans; Membrane Proteins; Vancomycin; Vancomycin Resistance | 2001 |
Antibiotic susceptibility and phage typing of methicillin-resistant and -sensitive Staphylococcus aureus clinical isolates at three periods during 1991-1997.
Topics: Amikacin; Anti-Bacterial Agents; Bacteriophage Typing; Cross Infection; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2001 |
The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linear Models; Multivariate Analysis; Prevalence; Prospective Studies; Risk Factors; Statistics, Nonparametric; United States; Vancomycin | 2001 |
Summaires for patients. Factors associated with the development of antibiotic-resistant bacteria.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Prevalence; Prospective Studies; Risk Factors; United States; Vancomycin | 2001 |
Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients.
Topics: Ceftazidime; Cephalosporins; Critical Care; Cross Infection; Drug Incompatibility; Drug Stability; Drug Therapy, Combination; Humans; Infusions, Intravenous; Midazolam; Nicardipine; Pneumonia, Bacterial; Propofol; Temperature; Vancomycin | 2001 |
Two-stage evaluation and intervention program for control of methicillin-resistant Staphylococcus aureus in the hospital setting.
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Methicillin; Methicillin Resistance; Penicillins; Prevalence; Program Evaluation; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2001 |
Polyclonal Staphylococcus epidermidis intravascular catheter-related infections.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Equipment Contamination; Genotype; Humans; Infant, Newborn; Microbial Sensitivity Tests; Prevalence; Prospective Studies; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2001 |
Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin.
Topics: Anti-Bacterial Agents; Brazil; Cross Infection; Female; Hospitals, Public; Humans; Infection Control; Male; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2001 |
Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cost Control; Cost Savings; Cross Infection; Enterococcus; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 500 and over; Hospital Costs; Humans; Infection Control; Length of Stay; New York; Oncology Service, Hospital; Vancomycin; Vancomycin Resistance | 2001 |
Nosocomial endocarditis caused by Corynebacterium amycolatum and other nondiphtheriae corynebacteria.
Topics: Aged; Catheters, Indwelling; Corynebacterium; Corynebacterium Infections; Cross Infection; Endocarditis, Bacterial; Fatal Outcome; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Prosthesis-Related Infections; Rifampin; Vancomycin | 2002 |
Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Fluoroquinolones; Gentamicins; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Incidence; Lipoglycopeptides; Microbial Sensitivity Tests; Naphthyridines; Spain; Streptomycin; Vancomycin | 2001 |
[Nosocomial catheter-related sepsis secondary to central venous catheters].
Topics: Amikacin; Anti-Bacterial Agents; Catheterization, Central Venous; Cross Infection; Drug Resistance, Microbial; Female; Gram-Negative Aerobic Bacteria; Gram-Positive Cocci; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1999 |
Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Case-Control Studies; Child; Child, Preschool; Cross Infection; Enterococcus; Female; Humans; Infant; Male; Middle Aged; Neoplasms; Risk Factors; Texas; Vancomycin; Vancomycin Resistance | 2002 |
Staphylococcus warneri septicemia in preterm neonates - a reminder.
Topics: Cefotaxime; Cross Infection; Drug Therapy, Combination; Female; Humans; Infant, Newborn; Infant, Premature; Sepsis; Staphylococcal Infections; Vancomycin | 2002 |
E test susceptibility testing of nosocomial Clostridium difficile isolates against metronidazole, vancomycin, fusidic acid and the novel agents moxifloxacin, gatifloxacin, and linezolid.
Topics: Acetamides; Anti-Infective Agents; Aza Compounds; Clostridioides difficile; Clostridium Infections; Cross Infection; Diarrhea; Fluoroquinolones; Fusidic Acid; Gatifloxacin; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Oxazolidinones; Quinolines; Sensitivity and Specificity; Vancomycin | 2002 |
[Therapeutic impact of streptococcal and enterococcal bacteremia in hematology patients].
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Critical Care; Cross Infection; Drug Resistance; Drug Therapy, Combination; Enterococcus faecalis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Immunocompromised Host; Lactams; Male; Middle Aged; Mouth; Neutropenia; Opportunistic Infections; Pneumococcal Infections; Respiratory Distress Syndrome; Shock, Septic; Species Specificity; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae; Streptococcus sanguis; Treatment Outcome; Vancomycin | 2002 |
Nosocomial infections in left ventricular assist device recipients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Cohort Studies; Cross Infection; Enterococcus faecium; Female; Humans; Male; Middle Aged; Postoperative Complications; Prosthesis Implantation; Prosthesis-Related Infections; Risk Factors; Staphylococcus; Vancomycin | 2002 |
Duration of colonization with vancomycin-resistant Enterococcus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; Cross Infection; Enterococcus; Female; Health Services Research; Hospitals, University; Humans; Male; Middle Aged; Retrospective Studies; Vancomycin; Vancomycin Resistance; Virginia | 2002 |
Effectiveness of a multifaceted infection control policy in reducing vancomycin usage and vancomycin-resistant enterococci at a tertiary care cancer centre.
Topics: Anti-Bacterial Agents; Cancer Care Facilities; Cross Infection; Enterococcus; Humans; Incidence; Infection Control; Prospective Studies; Texas; Vancomycin; Vancomycin Resistance | 2002 |
Vancomycin susceptibility of oxacillin-resistant Staphylococcus aureus isolates causing nosocomial bloodstream infections.
Topics: Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Resistance, Bacterial; Hospitalization; Humans; Microbial Sensitivity Tests; Oxacillin; Penicillins; Population Surveillance; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin | 2002 |
Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Lactams; Time Factors; United States; Vancomycin | 2002 |
Monitoring antimicrobial use and resistance: comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Benchmarking; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Infection Control; Intensive Care Units; Methicillin; Quality Assurance, Health Care; Risk Factors; United States; Vancomycin; Vancomycin Resistance | 2002 |
[A case of staphylococcal enterocolitis caused by methicillin resistant Staphylococcus aureus].
Topics: Administration, Oral; Aged; Aged, 80 and over; Cross Infection; Enterocolitis; Humans; Immunocompromised Host; Male; Methicillin Resistance; Postoperative Complications; Prostatic Hyperplasia; Staphylococcal Infections; Vancomycin | 1992 |
Vancomycin-resistant enterococci.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; United Kingdom; Vancomycin | 1992 |
Vancomycin-resistant enterococcus faecium: headline news.
Topics: Cross Infection; Drug Resistance, Microbial; Drug Utilization; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1992 |
Vancomycin-resistant Enterococcus faecium in hospitalized children.
Topics: Bacterial Typing Techniques; Case-Control Studies; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Drug Utilization; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitalization; Hospitals, Pediatric; Humans; Infant; Oncology Service, Hospital; Vancomycin | 1992 |
Activity of vancomycin against recently isolated nosocomial gram-positive cocci.
Topics: Cross Infection; Drug Resistance, Microbial; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Staphylococcus; Streptococcus; Vancomycin | 1992 |
[Respiratory tract infections in the elderly, advances and limitations in the diagnosis and treatment].
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Cytomegalovirus Infections; Dibekacin; Erythromycin; Humans; Methicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Respiratory Tract Infections; Staphylococcal Infections; Vancomycin | 1992 |
[Nosocomial infections of methicillin-resistant Staphylococcus aureus and their detection].
Topics: Cross Infection; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin | 1992 |
Prophylactic low-dose vancomycin treatment in very-low-birth-weight infants.
Topics: Creatinine; Cross Infection; Half-Life; Humans; Infant, Low Birth Weight; Infant, Newborn; Staphylococcal Infections; Vancomycin | 1992 |
Vancomycin-resistant Enterococcus durans.
Topics: Cross Infection; DNA Restriction Enzymes; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Kidney Transplantation; Vancomycin | 1992 |
Vancomycin-resistant enterococci in a district general hospital.
Topics: Cross Infection; Drug Resistance, Microbial; Enterococcus; Hospitals, General; Humans; Male; Middle Aged; Vancomycin | 1992 |
Postoperative complications due to methicillin-resistant Staphylococcus aureus (MRSA) in an elderly patient: management and control of MRSA.
Topics: Adenocarcinoma; Aged; Bacteremia; Colonic Neoplasms; Cross Infection; Disease Outbreaks; Female; Humans; Methicillin Resistance; Pneumonia, Staphylococcal; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1992 |
[Present status of MRSA infections].
Topics: Carrier State; Coagulase; Cross Infection; Humans; Methicillin Resistance; Mupirocin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
[Hospital acquired infection in surgical field and its countermeasure present situation of anaerobes, P. aeruginosa and MRSA infection].
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Environmental Microbiology; Humans; Methicillin Resistance; Postoperative Complications; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit.
Topics: Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 300 to 499; Humans; Infection Control; Intensive Care Units; Microbial Sensitivity Tests; New York City; Population Surveillance; Prospective Studies; Retrospective Studies; Risk Factors; Vancomycin | 1992 |
Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Electronics, Medical; Enterococcus faecium; Equipment Contamination; Gram-Positive Bacterial Infections; Hospital Bed Capacity, 300 to 499; Hospitals, Teaching; Humans; Middle Aged; Odds Ratio; Population Surveillance; Risk Factors; Thermometers; Vancomycin | 1992 |
[Methicillin resistant Staphylococcus aureus].
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Imipenem; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
Hygienic hand disinfection for the removal of epidemic vancomycin-resistant Enterococcus faecium and gentamicin-resistant Enterobacter cloacae.
Topics: Adult; Chlorhexidine; Cross Infection; Disease Outbreaks; Drug Evaluation; Drug Resistance, Microbial; Enterobacter cloacae; Enterobacteriaceae Infections; Enterococcus faecium; Female; Gentamicins; Gram-Positive Bacterial Infections; Hand Disinfection; Humans; Vancomycin | 1991 |
Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enterococcus faecium strains in a pediatric hospital.
Topics: Adolescent; Child; Child, Preschool; Cross Infection; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Microbial; Enterococcus faecium; Epidemiologic Methods; Female; Gram-Positive Bacterial Infections; Humans; Infant; Male; Phenotype; Polymorphism, Restriction Fragment Length; Vancomycin | 1991 |
Bone and joint infections caused by multiply resistant Staphylococcus aureus in a neonatal intensive care unit.
Topics: Arthritis, Infectious; Cross Infection; Female; Hospitals, University; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Methicillin Resistance; New South Wales; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
Corynebacterium JK: a new pathogen in ventriculostomy infections.
Topics: Corynebacterium Infections; Cross Infection; Dexamethasone; Drug Delivery Systems; Eye Neoplasms; Humans; Male; Melanoma; Meningeal Neoplasms; Middle Aged; Thiotepa; Vancomycin | 1991 |
Importation of methicillin-resistant Staphylococcus aureus from Baghdad to Dublin and subsequent nosocomial spread.
Topics: Adult; Cross Infection; Drug Resistance, Microbial; Gentamicins; Humans; Iraq; Ireland; Male; Methicillin; Penicillin Resistance; Phenotype; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1990 |
Methicillin-resistant Staphylococcus aureus (MRSA) bacteriuria in nursing home-residents.
Topics: Adult; Aged; Bacteriuria; Cross Infection; Disease Outbreaks; Female; Humans; Male; Methicillin Resistance; Middle Aged; Nursing Homes; Staphylococcus aureus; United States; Vancomycin | 1991 |
[Drug therapy of intractable methicillin-resistant staphylococcal infections].
Topics: Cefotiam; Cross Infection; Drug Therapy, Combination; Glycopeptides; Humans; Imipenem; Methicillin Resistance; Minocycline; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1990 |
[Treatment of infectious diseases due to methicillin-resistant Staphylococcus aureus (MRSA)].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Disinfectants; Humans; Lactams; Macrolides; Methicillin Resistance; Postoperative Complications; Quinolones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tetracyclines; Vancomycin | 1990 |
Extra hospital stay and antibiotic usage with nosocomial coagulase-negative staphylococcal bacteremia in two neonatal intensive care unit populations.
Topics: Cross Infection; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Length of Stay; Male; Sepsis; Staphylococcal Infections; Vancomycin | 1990 |
Aerosolized vancomycin for treatment of airway colonization by methicillin-resistant Staphylococcus aureus.
Topics: Administration, Inhalation; Child, Preschool; Cross Infection; Female; Humans; Methicillin; Penicillin Resistance; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1990 |
High-level vancomycin-resistant enterococci causing hospital infections.
Topics: Acute Kidney Injury; Conjugation, Genetic; Cross Infection; DNA, Bacterial; Drug Resistance, Microbial; Enterococcus faecalis; Humans; Kidney Diseases; R Factors; Streptococcal Infections; Streptococcus; Vancomycin | 1989 |
Clostridium difficile infection in health-care workers.
Topics: Administration, Oral; Adult; Clostridium Infections; Cross Infection; Humans; Male; Nurses; Vancomycin | 1989 |
The prevention of infection with Staphylococcus aureus in continuous ambulatory peritoneal dialysis.
Topics: Anti-Infective Agents, Local; Asepsis; Catheters, Indwelling; Chlorhexidine; Cross Infection; Female; Floxacillin; Humans; Male; Occlusive Dressings; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Vancomycin; Wound Infection | 1989 |
A laboratory-confirmed outbreak of rifampicin-methicillin resistant Staphylococcus aureus (RMRSA) in a newborn nursery.
Topics: Bacterial Typing Techniques; Bacteriophage Typing; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Female; Humans; Infant, Newborn; Male; Methicillin; Nurseries, Hospital; Rifampin; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1989 |
A hospital outbreak of Clostridium difficile?
Topics: Age Factors; Aged; Anti-Bacterial Agents; Clostridium; Clostridium Infections; Cross Infection; Disease Outbreaks; Environmental Microbiology; Equipment Contamination; Feces; Female; Humans; Male; Patient Isolation; Retrospective Studies; Vancomycin | 1985 |
Prevention of Clostridium difficile outbreaks in hospitals.
Topics: Clostridium; Clostridium Infections; Cross Infection; Diarrhea; Disease Outbreaks; Feces; Humans; Vancomycin | 1986 |
Osteomyelitis with methicillin-resistant Staphylococcus aureus.
Topics: Adult; Aged; Child; Cross Infection; Debridement; Female; Fracture Fixation, Internal; Fractures, Bone; Humans; Male; Methicillin; Middle Aged; Osteomyelitis; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1986 |
Methicillin-resistant Staphylococcus aureus bacteraemia in Hong Kong.
Topics: Cross Infection; Hong Kong; Humans; Methicillin; Penicillin Resistance; Plasmids; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1988 |
Epidemic methicillin-gentamicin-resistant Staphylococcus aureus in a neonatal intensive care unit.
Topics: Cross Infection; Drug Resistance; Gentamicins; Hexachlorophene; Humans; Infant, Low Birth Weight; Infant, Newborn; Intensive Care Units, Neonatal; Methicillin; Plasmids; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1989 |
Short-course therapy for catheter-associated Staphylococcus aureus bacteremia.
Topics: Anti-Bacterial Agents; Catheterization; Cephalothin; Cross Infection; Endocarditis, Bacterial; Follow-Up Studies; Humans; Oxacillin; Prospective Studies; Recurrence; Risk Factors; Sepsis; Staphylococcal Infections; Time Factors; Vancomycin | 1989 |
[A case of septicemia caused by Alcaligenes dentrificans subspecies xylosoxidans and a review of the literature].
Topics: Aged; Alcaligenes; Aortic Valve Insufficiency; Cross Infection; Drug Therapy, Combination; Humans; Hypertension; Male; Minocycline; Sepsis; Vancomycin | 1986 |
Corynebacterium JK: surgical infections in non-immunosuppressed patients.
Topics: Adult; Corynebacterium Infections; Cross Infection; Female; Humans; Immunosuppression Therapy; Male; Middle Aged; Surgical Wound Infection; Vancomycin | 1988 |
Epidemiology and prevention of Clostridium difficile infections in a leukemia unit.
Topics: Carrier State; Clostridium; Cross Infection; Disease Outbreaks; Enterocolitis, Pseudomembranous; Hospital Units; Humans; Leukemia; Prospective Studies; Serotyping; Vancomycin | 1987 |
Methicillin-susceptible "methicillin-resistant Staphylococcus aureus": a sheep in wolves' clothing.
Topics: Communicable Disease Control; Cross Infection; Humans; Methicillin; Penicillin Resistance; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1986 |
Staphylococcal infections in hospital.
Topics: Catheters, Indwelling; Cephalosporins; Cross Infection; Gentamicins; Humans; Methicillin; Penicillin Resistance; Penicillins; Peritoneal Dialysis, Continuous Ambulatory; Prostheses and Implants; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; United Kingdom; Vancomycin | 1986 |
Outbreak due to methicillin- and rifampin-resistant Staphylococcus aureus: epidemiology and eradication of the resistant strain from the hospital.
Topics: Carrier State; Cross Infection; Disease Outbreaks; Female; Hospital Bed Capacity, 500 and over; Humans; Intensive Care Units; Male; Methicillin; Middle Aged; Penicillin Resistance; Personnel, Hospital; Retrospective Studies; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginia | 1987 |
Methicillin-resistant Staphylococcus aureus: clinical and laboratory features.
Topics: Cross Infection; Disease Outbreaks; Drug Interactions; Hand Disinfection; Humans; Methicillin; Penicillin Resistance; Rifampin; Staphylococcal Infections; Staphylococcus aureus; United States; Vancomycin | 1985 |
Pseudomembranous colitis following prophylactic antibiotic use in primary cesarean section.
Topics: Adult; Cesarean Section; Clostridium; Clostridium Infections; Cross Infection; Enterocolitis, Pseudomembranous; Feces; Female; Humans; Postoperative Complications; Pregnancy; Vancomycin | 1985 |
Clostridium difficile-associated colitis in uremic patients.
Topics: Adult; Aged; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Uremia; Vancomycin | 1985 |
Anal carriage as the probable source of a streptococcal epidemic.
Topics: Adolescent; Adult; Carrier State; Child; Cross Infection; Female; Humans; Male; Middle Aged; Penicillin Resistance; Penicillins; Streptococcal Infections; Streptococcus pyogenes; Vancomycin | 1966 |
Growing clinical significance of methcillin-resistant Staphylococcus aureus.
Topics: Cephalosporins; Cross Infection; Humans; Methicillin; Oxacillin; Penicillin Resistance; Penicillins; Staphylococcal Infections; Staphylococcus; Vancomycin | 1968 |
Diphtheroid endocarditis after insertion of a prosthetic heart valve. Report of two cases.
Topics: Ampicillin; Cephalothin; Chloramphenicol; Corynebacterium diphtheriae; Cross Infection; Endocarditis, Bacterial; Extracorporeal Circulation; Heart Valve Prosthesis; Humans; Male; Methicillin; Middle Aged; Penicillin G; Streptomycin; Tetracycline; Vancomycin | 1968 |
[Sensitivity of methicillin-resistant Staphylococcus aureus to vancomycin, gentamicin and pristinamycin].
Topics: Anti-Bacterial Agents; Cross Infection; Gentamicins; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Staphylococcal Infections; Staphylococcus; Vancomycin | 1971 |
Staphylococcal infections in nurseries.
Topics: Ampicillin; Bacitracin; Cephalosporins; Chloramphenicol; Cross Infection; Erythromycin; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Methicillin; Novobiocin; Penicillin G; Sepsis; Tetracycline; Troleandomycin; Vancomycin | 1966 |
Bacteriophage types and antibiotic susceptibility of Staphylococcus aureus. Boston City Hospital, 1967.
Topics: Anti-Bacterial Agents; Bacitracin; Bacteriophage Typing; Boston; Cephaloridine; Chloramphenicol; Cross Infection; Drug Resistance, Microbial; Erythromycin; Humans; Kanamycin; Lincomycin; Microbial Sensitivity Tests; Novobiocin; Penicillin Resistance; Staphylococcal Infections; Staphylococcus; Tetracycline; Vancomycin | 1970 |
Nosocomial meningitis of the newborn caused by a flavobacterium.
Topics: Birth Weight; Cross Infection; Erythromycin; Female; Flavobacterium; Humans; Infant, Newborn; Infant, Newborn, Diseases; Injections, Intravenous; Injections, Spinal; Male; Meningitis; Vancomycin | 1966 |